Science.gov

Sample records for gruppo abeliano senza

  1. Pharmacosurveillance in hospitalized patients in Italy. Study design of the 'Gruppo Italiano di Farmacovigilanza nell'Anziano' (GIFA).

    PubMed

    Carosella, L; Pahor, M; Pedone, C; Zuccalà, G; Manto, A; Carbonin, P

    1999-09-01

    The Italian Group of Pharmacoepidemiology in the Elderly (Gruppo Italiano di Farmacovigilanza nell'Anziano, GIFA) is a collaborative pharmacosurveillance study in hospitalized patients, sponsored by the Italian National Research Council (CNR) and the Italian Society of Gerontology and Geriatrics. It was founded in 1987 with the aim to constitute a multicentre research group to study quality of care and problems related to pharmacological therapy in the elderly. Until now the GIFA study has completed seven periodical surveys and enrolled a total of 28,411 hospitalized patients in 83 clinical centres. The database of the study contains approximately 174,000 in-hospital drug prescriptions, approximately 88,000 discharge diagnoses and a great deal of data on topical geriatric items such as cognitive performance, disability, comorbidity, adverse drug reactions and incontinence. This paper describes the general organization and the methods of the GIFA study and shows in detail the type of data collected. PMID:10479475

  2. Spontaneous monitoring of adverse reactions to drugs by Italian dermatologists: a pilot study. Gruppo Italiano Studi Epidemiologici in Dermatologia.

    PubMed

    1991-01-01

    During 1988, the Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED) coordinated a pilot study aimed at evaluating the feasibility of a system for spontaneous monitoring of adverse drug reactions in dermatological practice in Italy. Approximately 400 dermatologists were asked to collaborate, and 141 agreed to the study. Procedures similar to those well established in other surveillance programs (including the use of standard forms and standardized assessment procedure) were adopted. In a 2-month period 775 reports were collected, of which 711 were maintained after careful evaluation. The general profile of the adverse reactions reported was in accordance with the experience derived by other spontaneous surveillance programs. The main purpose of spontaneous reporting systems is the identification of new reactions, and a model analysis was proposed, in our study, with reference to skin reactions to bamifylline. The demonstration of the feasibility of a drug-monitoring program in Italy, where little tradition exists in the area, is the most important result of our study.

  3. The management of hip fracture in the older population. Joint position statement by Gruppo Italiano Ortogeriatria (GIOG).

    PubMed

    Pioli, Giulio; Barone, A; Mussi, C; Tafaro, L; Bellelli, G; Falaschi, P; Trabucchi, M; Paolisso, G

    2014-10-01

    This document is a Joint Position Statement by Gruppo Italiano di OrtoGeriatria (GIOG) supported by Società Italiana di Gerontologia e Geriatria (SIGG), and Associazione Italiana Psicogeriatria (AIP) on management of hip fracture older patients. Orthogeriatric care is at present the best model of care to improve results in older patients after hip fracture. The implementation of orthogeriatric model of care, based on the collaboration between orthopaedic surgeons and geriatricians, must take into account the local availability of resources and facilities and should be integrated into the local context. At the same time the programme must be based on the best available evidences and planned following accepted quality standards that ensure the efficacy of the intervention. The position paper focused on eight quality standards for the management of hip fracture older patients in orthogeriatric model of care. The GIOG promotes the development of a clinic database with the aim of obtaining a qualitative improvement in the management of hip fracture. PMID:24566982

  4. Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.

    PubMed

    Buccisano, Francesco; Piccioni, Anna Lina; Nobile, Carolina; Criscuolo, Marianna; Niscola, Pasquale; Tatarelli, Caterina; Fianchi, Luana; Villivà, Nicoletta; Neri, Benedetta; Carmosino, Ida; Gumenyuk, Svitlana; Mancini, Stefano; Voso, Maria Teresa; Maurillo, Luca; Breccia, Massimo; Zini, Gina; Venditti, Adriano; Fenu, Susanna; Spiriti, Maria Antonietta Aloe; Latagliata, Roberto

    2016-06-01

    The Gruppo Romano Mielodisplasie (GROM) conducted a retrospective study in 543 patients with myelodysplastic syndromes (MDS) to evaluate the safety and efficacy of erythropoiesis-stimulating agents (ESAs) in "real-life" clinical practice. The 40.000-UI/week erythropoietin (EPO)-alpha and 30.000-UI/week EPO-beta starting dose were defined "standard," and 80,000 UI/week EPO-alpha and 60.000 UI/week EPO-beta were defined "high." Response was defined according to International Working Group (IWG) 2006 criteria. At ESA's start, median age was 74.2 years (interquartile range (IR) 67.8-79.5) and median hemoglobin was 8.9 g/dl (IR 8.2-9.6). Median time from diagnosis to ESAs start was 3.8 months (IR 0.8-13.2). ESA starting dose was "standard" in 361 patients (66.5 %) and "high" in 182 patients (33.5 %). Erythroid response was observed in 82/185 (44.3 %) transfusion dependent (TD) patients as compared with 226/329 (68.6 %) transfusion independent (TI) ones (p < 0.001). At multivariate analysis, in TD patients, only endogenous EPO levels <50 mU/l were significant (p = 0.046), whereas in TI patients, high-dose ESAs (p < 0.001), abnormal creatinine levels (0.009), and endogenous EPO levels <50 mU/l (p = 0.014) were predictors of response. Responders showed a higher 5-year overall survival (OS) (57.8 vs. 32.2 %, p < 0.001) and leukemia-free survival (76.0 vs. 49.8 %, p < 0.001). At multivariable analysis for OS, response to ESA, low International Prognostic Scoring System (IPSS), no transfusion need, and female sex showed an independent favorable prognostic role. Our results confirm that treatment with ESAs is effective in a real-life MDS setting, particularly at high dose and in TI patients. Prospective studies are needed to define the optimal starting dose.

  5. Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.

    PubMed

    Buccisano, Francesco; Piccioni, Anna Lina; Nobile, Carolina; Criscuolo, Marianna; Niscola, Pasquale; Tatarelli, Caterina; Fianchi, Luana; Villivà, Nicoletta; Neri, Benedetta; Carmosino, Ida; Gumenyuk, Svitlana; Mancini, Stefano; Voso, Maria Teresa; Maurillo, Luca; Breccia, Massimo; Zini, Gina; Venditti, Adriano; Fenu, Susanna; Spiriti, Maria Antonietta Aloe; Latagliata, Roberto

    2016-06-01

    The Gruppo Romano Mielodisplasie (GROM) conducted a retrospective study in 543 patients with myelodysplastic syndromes (MDS) to evaluate the safety and efficacy of erythropoiesis-stimulating agents (ESAs) in "real-life" clinical practice. The 40.000-UI/week erythropoietin (EPO)-alpha and 30.000-UI/week EPO-beta starting dose were defined "standard," and 80,000 UI/week EPO-alpha and 60.000 UI/week EPO-beta were defined "high." Response was defined according to International Working Group (IWG) 2006 criteria. At ESA's start, median age was 74.2 years (interquartile range (IR) 67.8-79.5) and median hemoglobin was 8.9 g/dl (IR 8.2-9.6). Median time from diagnosis to ESAs start was 3.8 months (IR 0.8-13.2). ESA starting dose was "standard" in 361 patients (66.5 %) and "high" in 182 patients (33.5 %). Erythroid response was observed in 82/185 (44.3 %) transfusion dependent (TD) patients as compared with 226/329 (68.6 %) transfusion independent (TI) ones (p < 0.001). At multivariate analysis, in TD patients, only endogenous EPO levels <50 mU/l were significant (p = 0.046), whereas in TI patients, high-dose ESAs (p < 0.001), abnormal creatinine levels (0.009), and endogenous EPO levels <50 mU/l (p = 0.014) were predictors of response. Responders showed a higher 5-year overall survival (OS) (57.8 vs. 32.2 %, p < 0.001) and leukemia-free survival (76.0 vs. 49.8 %, p < 0.001). At multivariable analysis for OS, response to ESA, low International Prognostic Scoring System (IPSS), no transfusion need, and female sex showed an independent favorable prognostic role. Our results confirm that treatment with ESAs is effective in a real-life MDS setting, particularly at high dose and in TI patients. Prospective studies are needed to define the optimal starting dose. PMID:27091349

  6. Cutaneous reactions to analgesic-antipyretics and nonsteroidal anti-inflammatory drugs. Analysis of reports to the spontaneous reporting system of the Gruppo Italiano Studi Epidemiologici in Dermatologia.

    PubMed

    1993-01-01

    We analyzed the cutaneous reactions to systemic analgesic-antipyretics and non-steroidal anti-inflammatory drugs reported to the spontaneous reporting system of the Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED). The system has been active since 1988, with periodic intensive surveillance exercises, and 202 dermatologists have collaborated. Up to December 1991, 2,137 reactions had been collected, of which 713 were reactions to systemic analgesic-antipyretics and nonsteroidal anti-inflammatory drugs. A general profile of the reactions was identifiable. It included, in order of frequency, urticaria/angioedema, fixed eruptions, exanthemas, erythema multiforme and Stevens Johnson syndrome. Fixed eruptions and Stevens Johnson syndrome were reported with exceedingly high frequency in association with feprazone. Our system also revealed previously unreported reactions, including fixed eruption to nimesulide, fixed eruption to piroxicam and fixed eruption to flurbiprofen.

  7. Epidemiological evidence of the association between lichen planus and two immune-related diseases. Alopecia areata and ulcerative colitis. Gruppo Italiano Studi Epidemiologici in Dermatologia.

    PubMed

    1991-05-01

    Between September 1986 and February 1988, a case-control study involving 27 Italian dermatological centers collaborating in the Gruppo Italiano Studi Epidemiologici in Dermatologia was conducted, concerning the relationship between history of several medical conditions and exposures to drugs and the risk of lichen planus. The cases were all consecutive patients with a new diagnosis of lichen planus, and the controls were patients under dermatological care observed under the same conditions. A total of 711 cases and 1395 controls met the admission criteria and were interviewed by trained investigators. Patients with histories of alopecia areata were found to be at risk for lichen planus (relative risk = 2.7; 95% confidence interval, 1.1 to 6.5). Five patients (0.7%) in the group with lichen planus had a history of ulcerative colitis, while none of the controls had this disease. The risk of lichen planus was also increased in patients with a history of chronic active hepatitis, but this increase was not statistically significant (relative risk = 4.7; 95% confidence interval, 0.7 to 29.4).

  8. AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study.

    PubMed

    Avvisati, G; Lo Coco, F; Diverio, D; Falda, M; Ferrara, F; Lazzarino, M; Russo, D; Petti, M C; Mandelli, F

    1996-08-15

    at successive testing performed 2 months later. As of September 30, 1995, after a median follow-up period from diagnosis of 27 months (range, 24 to 31 months), the overall survival and event-free survival durations are 85% and 69%, respectively; moreover, 14 of 18 (78%) patients who achieved CR are still alive and in first molecular and hematologic CR. Of the 4 relapsed patients, 3 achieved a second CR with ATRA and, after further treatment, are now in molecular and hematologic CR after 4+, 16+, and 17+ months from the second CR. These results indicate that (1) the AIDA protocol is highly effective in treating APL; (2) after 3 consolidation courses, the majority of patients who achieved CR are RT-PCR- for the hybrid gene PML-RAR alpha; (3) the persistence of an RT-PCR positivity for the PML-RAR alpha hybrid gene after 3 consolidation courses is indicative of early relapse, thus these patients still require additional treatment. These results have prompted the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) to initiate, in cooperation with the Associazione Italiana di Ematologia ed Oncologia Pediatrica and some European Organization for Research and Treatment of Cancer (EORTC) centers, a new multicentric clinical trial named AIDA LAP 0493 for the treatment of adult and pediatric APL patients. All patients are considered eligible if APL diagnosis is confirmed with molecular or cytogenetic studies for PML-RAR alpha hybrid gene or t(15;17) and are enrolled to receive the same induction and consolidation therapy of this pilot study. After consolidation, patients who are RT-PCR- for PML-RAR alpha hybrid gene are randomized to four arms, whereas patients who are RT-PCR+ after consolidation undergo, if eligible, an allogenic transplantation procedure.

  9. Comparison of frequency, diagnostic and prognostic significance of pericardial involvement in acute myocardial infarction treated with and without thrombolytics. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI).

    PubMed

    Correale, E; Maggioni, A P; Romano, S; Ricciardiello, V; Battista, R; Salvarola, G; Santoro, E; Tognoni, G

    1993-06-15

    Data from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI) trial were reviewed to describe the epidemiology of pericardial involvement in patients treated with or without thrombolysis, and to establish its role as a marker of the extent of myocardial infarction and its prognostic value. In both GISSI-1 (n = 11,806) and 2 (n = 12,381), a specific item regarding presence/absence of clinically detected pericardial involvement was included in the study forms. In GISSI-1, patients with ST elevation and depression at the onset of myocardial infarction were admitted, whereas GISSI-2 included only those with ST elevation. Results of univariate analysis are presented as Mantel-Haenszel-Peto odds ratios with 95% confidence intervals. Cox proportional hazards models were used to assess the independent prognostic significance of pericardial involvement for in-hospital and long-term mortality. The main results indicate that: (1) the incidence of pericardial involvement in patients treated with thrombolytic agents is approximately half of that in the control group (6.7 vs 12.0%); (2) the earlier is the treatment, the lower is the incidence of pericardial involvement; (3) pericardial involvement is strongly associated with infarction size, evaluated by electrocardiograms, creatine kinase peak and echo assessments; and (4) pericardial involvement is associated with a higher long-term mortality, but is not an independent prognostic factor (RR 1.02; 95% confidence interval 0.82-1.26). Pericardial involvement is a reliable bedside, cost-free marker of myocardial infarction size and poorer outcome. Because it may elude detection owing to its transitory and often short duration, it should be given greater attention.

  10. Red blood cell oleic acid levels reflect olive oil intake while omega-3 levels reflect fish intake and the use of omega-3 acid ethyl esters: The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Heart Failure trial.

    PubMed

    Harris, William S; Masson, Serge; Barlera, Simona; Milani, Valentina; Pileggi, Silvana; Franzosi, Maria Grazia; Marchioli, Roberto; Tognoni, Gianni; Tavazzi, Luigi; Latini, Roberto

    2016-09-01

    The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Heart Failure (GISSI-HF) study reported benefits of n-3 fatty acid (FA) treatment on cardiovascular (CV) events, but the effects of treatment on a putative CV disease risk factor, the red blood cell (RBC) n-3 FA level (the omega-3 index), have not been examined in this context. We hypothesized that treatment with prescription omega-3 acid ethyl esters (O3AEE) would increase the omega-3 index to the proposed cardioprotective value of 8%. RBCs were collected from a subset of patients participating in the GISSI-HF study (n=461 out of 6975 randomized), at baseline and after 3 months of treatment with either an olive oil placebo or O3AEE (1 g/d). RBC FA levels were expressed as a percentage of total FA. Patients also reported their typical olive oil and fish intakes. RBC oleic acid levels were directly correlated with reported frequency of olive oil consumption, and the omega-3 index was correlated with reported fish intake (P for trends <0.001 for both). After treatment, the omega-3 index increased from 4.8±1.7% to 6.7±1.9% but was unchanged in the placebo group (4.7±1.7 to 4.8±1.5%) (P<.0001 for changes between groups). At 3 months, more patients reached the proposed target omega-3 index level of 8%-12% in the treated vs placebo group (22.6% vs. 1.3%, P<.0001), however, what omega-3 index levels were ultimately achieved after four years in this trial are unknown.

  11. Red blood cell oleic acid levels reflect olive oil intake while omega-3 levels reflect fish intake and the use of omega-3 acid ethyl esters: The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Heart Failure trial.

    PubMed

    Harris, William S; Masson, Serge; Barlera, Simona; Milani, Valentina; Pileggi, Silvana; Franzosi, Maria Grazia; Marchioli, Roberto; Tognoni, Gianni; Tavazzi, Luigi; Latini, Roberto

    2016-09-01

    The Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Heart Failure (GISSI-HF) study reported benefits of n-3 fatty acid (FA) treatment on cardiovascular (CV) events, but the effects of treatment on a putative CV disease risk factor, the red blood cell (RBC) n-3 FA level (the omega-3 index), have not been examined in this context. We hypothesized that treatment with prescription omega-3 acid ethyl esters (O3AEE) would increase the omega-3 index to the proposed cardioprotective value of 8%. RBCs were collected from a subset of patients participating in the GISSI-HF study (n=461 out of 6975 randomized), at baseline and after 3 months of treatment with either an olive oil placebo or O3AEE (1 g/d). RBC FA levels were expressed as a percentage of total FA. Patients also reported their typical olive oil and fish intakes. RBC oleic acid levels were directly correlated with reported frequency of olive oil consumption, and the omega-3 index was correlated with reported fish intake (P for trends <0.001 for both). After treatment, the omega-3 index increased from 4.8±1.7% to 6.7±1.9% but was unchanged in the placebo group (4.7±1.7 to 4.8±1.5%) (P<.0001 for changes between groups). At 3 months, more patients reached the proposed target omega-3 index level of 8%-12% in the treated vs placebo group (22.6% vs. 1.3%, P<.0001), however, what omega-3 index levels were ultimately achieved after four years in this trial are unknown. PMID:27632919

  12. La relatività debole. La fisica dello spazio e del tempo senza paradossi

    NASA Astrophysics Data System (ADS)

    Selleri, Franco

    2011-06-01

    Secondo Einstein e Poincaré la simultaneità di eventi che hanno luogo in punti diversi dello spazio può essere definita solo per convenzione. Dal punto di vista matematico si dimostra, quindi, che due diverse definizioni di simultaneità corrispondono a due diversi valori del coefficiente e1 della variabile spaziale x presente nelle trasformazioni di Lorentz. A partire da premesse normalmente accettate otterremo diverse dimostrazioni della necessità di reintrodurre il concetto di simultaneità assoluta. Le conseguenze cosmologiche della nuova struttura dello spazio e del tempo andranno contro la cosmologia del Big Bang. Inoltre, dopo questi risultati, il relativismo sopravviverà in una forma meno aspra ("relatività debole") perché risulter privo di quel campionario di paradossi portato dalla teoria della Relatività Speciale.

  13. Upper-miocene submarine volcanism in the strait of sicily (banco senza nome)

    NASA Astrophysics Data System (ADS)

    Beccaluva, L.; Colantoni, P.; Savelli, C.; di Girolamo, P.

    1981-09-01

    Two basaltic fragments dredged from a volcanic seamount in the Sicilian continental slope of the Strait of Sicily show petrochemical features typical of within plate alkalibasaltic lavas and K/Ar age of about 10 m.y. The data represent the first volcanic evidence of Upper Miocene tensional tectonics in this sector of the African plate.

  14. Capodanno Senza Danno: the effects of an intervention program on fireworks injuries in Naples.

    PubMed Central

    D'Argenio, P; Cafaro, L; Santonastasi, F; Taggi, F; Binkin, N

    1996-01-01

    To study the effects of a comprehensive, multifaceted intervention program to reduce fireworks-related injuries during the Italian New Year's holiday season, active surveillance was conducted in the 18 public emergency rooms of Naples, Italy, before and after implementation of the program. Preintervention data collected between December 24, 1992, and January 6, 1993, were compared with data collected during the same period in 1993-1994. The number of injuries decreased by 48% from 353 to 183, with the greatest declines seen among 10- to 12-year-olds. The broad-based intervention implemented during the 1993-1994 holiday season appears to have substantially reduced the number of injuries. PMID:8561250

  15. Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG)).

    PubMed

    Marsoni, S; Torri, V; Valsecchi, M G; Belloni, C; Bianchi, U; Bolis, G; Bonazzi, C; Colombo, N; Epis, A; Favalli, G

    1990-09-01

    The data on 914 patients enrolled in four randomised trials in advanced ovarian cancer, consecutively conducted by the same cooperative group between 1978 and 1986, were analysed with the aims of: (1) determining the impact of selected prognostic variables on survival; (2) finding, from the interaction of favourable prognostic factors and treatment, an approximate estimate of the magnitude of the survival advantage associated with the use of platinum-based combination chemotherapy. The overall 3-year survival in this series of patients is twice that reported historically (22%; 95% CL 18.7-25.4). The proportional hazard regression model was used to perform the analysis on survival. Residual tumour size, age, FIGO stage and cell type were all independent determinants of survival. Differences in survival from the various prognostic groups were impressive with 5-year survival rates ranging from 7 to 62%. However, these differences were not qualitative (i.e. the kinetics of survival were similar for the best and the worst groups) suggesting that current prognostic factors are of little use for selecting 'biologically' different sub-populations. Platinum-based regimens were associated to an overall prolonged median survival, but this benefit was not observable in the subgroup with most favourable prognosis (less than 2 cm residual tumour size). The implications of these observations for clinical research and ovarian cancer patients care are discussed.

  16. Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG)).

    PubMed Central

    Marsoni, S.; Torri, V.; Valsecchi, M. G.; Belloni, C.; Bianchi, U.; Bolis, G.; Bonazzi, C.; Colombo, N.; Epis, A.; Favalli, G.

    1990-01-01

    The data on 914 patients enrolled in four randomised trials in advanced ovarian cancer, consecutively conducted by the same cooperative group between 1978 and 1986, were analysed with the aims of: (1) determining the impact of selected prognostic variables on survival; (2) finding, from the interaction of favourable prognostic factors and treatment, an approximate estimate of the magnitude of the survival advantage associated with the use of platinum-based combination chemotherapy. The overall 3-year survival in this series of patients is twice that reported historically (22%; 95% CL 18.7-25.4). The proportional hazard regression model was used to perform the analysis on survival. Residual tumour size, age, FIGO stage and cell type were all independent determinants of survival. Differences in survival from the various prognostic groups were impressive with 5-year survival rates ranging from 7 to 62%. However, these differences were not qualitative (i.e. the kinetics of survival were similar for the best and the worst groups) suggesting that current prognostic factors are of little use for selecting 'biologically' different sub-populations. Platinum-based regimens were associated to an overall prolonged median survival, but this benefit was not observable in the subgroup with most favourable prognosis (less than 2 cm residual tumour size). The implications of these observations for clinical research and ovarian cancer patients care are discussed. PMID:2119684

  17. Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo

    PubMed Central

    Rotta, Marcello; Patriarca, Francesca; Mattei, Daniele; Allione, Bernardino; Carnevale-Schianca, Fabrizio; Sorasio, Roberto; Rambaldi, Alessandro; Casini, Marco; Parma, Matteo; Bavaro, Pasqua; Onida, Francesco; Busca, Alessandro; Castagna, Luca; Benedetti, Edoardo; Iori, Anna Paola; Giaccone, Luisa; Palumbo, Antonio; Corradini, Paolo; Fanin, Renato; Maloney, David; Storb, Rainer; Baldi, Ileana; Ricardi, Umberto; Boccadoro, Mario

    2009-01-01

    Despite recent advances, allografting remains the only potential cure for myeloma. From July 1999 to June 2005, 100 newly diagnosed patients younger than 65 years were enrolled in a prospective multicenter study. First-line treatment included vincristin, adriamycin, and dexamethasone (VAD)–based induction chemotherapy, a cytoreductive autograft (melphalan 200 mg/m2) followed by a single dose of nonmyeloablative total body irradiation and allografting from an human leukocyte antigen (HLA)–identical sibling. Primary end points were the overall survival (OS) and event-free survival (EFS) from diagnosis. After a median follow-up of 5 years, OS was not reached, and EFS was 37 months. Incidences of acute and chronic graft-versus-host disease (GVHD) were 38% and 50%, respectively. Complete remission (CR) was achieved in 53% of patients. Profound cytoreduction (CR or very good partial remission) before allografting was associated with achievement of posttransplantation CR (hazard ratio [HR] 2.20, P = .03) and longer EFS (HR 0.33, P < .01). Conversely, development of chronic GVHD was not correlated with CR or response duration. This tandem transplantation approach allows prolonged survival and long-term disease control in patients with reduced tumor burden at the time of allografting. We are currently investigating the role of “new drugs” in intensifying pretransplantation cytoreduction and posttransplantation graft-versus-myeloma effects to further improve clinical outcomes. (http://ClinicalTrials.gov; NCT-00702247.) PMID:19064724

  18. Low-dose aspirin in polycythaemia vera: a pilot study. Gruppo Italiano Studio Policitemia (GISP).

    PubMed

    1997-05-01

    In this pilot study, aimed at exploring the feasibility of a large-scale trial of low-dose aspirin in polycythaemia vera (PV), 112 PV patients (42 females, 70 males. aged 17-80 years) were selected for not having a clear indication for, or contraindication to, aspirin treatment and randomized to receive oral aspirin (40 mg/d) or placebo. Follow-up duration was 16 +/- 6 months. Measurements of thromboxane A2 production during whole blood clotting demonstrated complete inhibition of platelet cyclooxygenase activity in patients receiving aspirin. Aspirin administration was not associated with any bleeding complication. Within the limitations of the small sample size, this study indicates that a biochemically effective regimen of antiplatelet therapy is well tolerated in patients with polycythaemia vera and that a large-scale placebo-controlled trial is feasible.

  19. [Assessing the effectiveness of Gelclair® in the prevention and therapy of stomatitis in patients undergoing hematopoietic stem-cell transplantation: a randomized trial].

    PubMed

    Rasero, Laura; Marsullo, Mauro; Dal Molin, Alberto

    2014-01-01

    Introduzione: La stomatite da farmaci chemioterapici è un importante effetto collaterale del trattamento. I protocolli per la cura del cavo orale, si basano su due livelli di intervento: senza e con uso di medicamenti . La letteratura descrive numerosi interventi di profilassi e terapia ma ad oggi non esiste ancora un intervento considerato gold standard. Obiettivo: Valutare l’efficacia del Gelclair® nella prevenzione e trattamento di pazienti sottoposti a trapianto di cellule staminali emopoietiche. Materiale metodi: 57 pazienti (28 gruppo di controllo e 29 gruppo sperimentale ) hanno utilizzato i colluttori 3 volte al giorno, la valutazione è stata effettuata con i seguenti strumenti: scala di valutazione della stomatite (WHO), scala VAS per dolore e Likert per gradimento. I pazienti sono stati osservati mediamente per 17 giorni. Risultati: 38/57 pazienti osservati (61%) hanno manifestato stomatiti .Non è stata rilevata differenza tra i due gruppi in termine di grado di stomatite p= 0.75 in tutto il periodo di osservazione. Il dolore è stato registrato in 31 soggetti su 57 (54%). Non si sono registrate differenze tra i due gruppi per quanto riguarda il valore medio di dolore riferito prima dell’utilizzo dei colluttori per tutti i giorni di osservazione p=0,06, gli utenti del gruppo sperimentale hanno dimostrato una riduzione del grado di dolore dopo l’utilizzo del collutorio p=0,04. Conclusioni: Gelclair® non influenza i tempi di insorgenza e l’andamento della stomatite. E’ in grado di ridurre il dolore, sono necessari però ulteriori studi multicentrici per confermare la reale utilità di utilizzo nei pazienti sottoposti a Trapianto.

  20. Is the control of disease progression within our grasp? Review of the GRISAR study. (Gruppo Reumatologi Italiani Studio Artrite Reumatoide).

    PubMed

    Ferraccioli, G F; Della Casa-Alberighi, O; Marubini, E; Priolo, F; Mathieu, A; Fantini, F; Cutolo, M; Pasero, G

    1996-09-01

    A prospective, open, multicentre, randomized study with a blinded radiological end-point was started in 1991. The aim of the study was to assess whether cyclosporin A (CyA) controls ongoing anatomical damage in active early rheumatoid arthritis (RA) better than conventional disease-modifying anti-rheumatic drugs (DMARDs) as used in everyday clinical practice. A total of 340 consenting patients with early RA (mean duration 1.4 yr) were recruited; 167 were randomized to CyA 3mg/kg per day and 173 to DMARDs. Hand, wrist and foot X-rays were blindly scored by a central committee of three radiologists using the Larsen-Dale method. Any side-effects were carefully recorded. The control of clinical symptoms was similar in both groups. Radiological evaluation of 284 patients (141 on CyA; 143 on DMARDs) after 12 months showed a significant decrease in the mean progression in the eroded joint count (1.3 +/- 3.1 vs 2.4 +/- 3.0, P < 0.001). There was also better maintenance on treatment with CyA than in the group treated with DMARDs (89.2 vs 77.5%, respectively; P = 0.002). CyA seems to offer greater control of ongoing anatomical joint damage in early RA than conventional DMARDs after 12 months.

  1. Standards for oesophageal manometry. A position statement from the Gruppo Italiano di Studio Motilità Apparato Digerente (GISMAD).

    PubMed

    Passaretti, S; Zaninotto, G; Di Martino, N; Leo, P; Costantini, M; Baldi, F

    2000-01-01

    Manometry is an important tool in the diagnosis of oesophageal motility, disorders, but proper instruments and methods are needed to obtain useful clinical information. The authors reviewed the minimal technical requirements, operative aspects, which information the final report should contain as well as indications and contraindications of the text itself. Technical requirements: At least a three-channel, multiple-lumen catheter perfused with a pneumo-hydraulic capillary infusion system which ensures deltaP/deltaT>150-200 mmHg/sec.; data should be recorded at a sampling rate of > or =8 Hz to study the oesophageal body and lower oesophageal sphincter; lower oesophageal sphincter tonic (pressure) and phasic activity (relaxations) and oesophageal body amplitude and peristaltic activity should be recorded. The final report must contain the patient's details, the indication for the test and a manometric diagnosis. Indications for manometry: Dysphagia (after ruling out any organic pathology); non- cardiac chest pain (after ruling out any cardiopulmonary involvement); systemic collagenosis (to investigate oesophageal involvement); gastro-oesophageal reflux disease (if surgery is planned). Contraindications are limited to: pharyngeal or upper oesophageal obstructions, oesophageal bullous disorder, cardiac conditions in which vagal stimulation may not be tolerated, severe coagulopathy and patient non-compliance.

  2. [Funzioni esecutive metacognitive ed emozionali/motivazionali nel disturbo dello spettro dell'autismo e nel disturbo da deficit di attenzione con iperattività: risultati preliminari].

    PubMed

    Panerai, Simonetta; Tasca, Domenica; Ferri, Raffaele; Catania, Valentina; Genitori D'Arrigo, Valentina; Di Giorgio, Rosa; Zingale, Marinella; Trubia, Grazia; Torrisi, Anna; Elia, Maurizio

    2016-01-01

    RIASSUNTO. Scopo. I deficit delle funzioni esecutive (FE) sono frequentemente osservati nei disturbi dello spettro dell'autismo (ASD) e nel disturbo da deficit di attenzione con iperattività (ADHD). Lo scopo di questo studio è quello di valutare e confrontare le funzioni esecutive metacognitive ed emozionali/motivazionali di bambini con ASD e ADHD, sia fra di loro che con un gruppo di controllo. Metodi. Il campione è costituito da un totale di 58 soggetti, di cui 17 con ASD senza disabilità intellettiva, 18 con ADHD-manifestazione combinata e 23 con sviluppo tipico, abbinati per genere, età cronologica e livello intellettivo. Le valutazioni hanno riguardato alcune aree del funzionamento esecutivo, nello specifico pianificazione, flessibilità mentale, generatività e inibizione della risposta, che rappresentano sia le funzioni esecutive metacognitive sia quelle emozionali/motivazionali. Risultati. I risultati hanno rilevato un'ampia sovrapposizione delle disfunzioni esecutive nei due gruppi clinici con ASD e ADHD, e non sono stati indicativi della presenza di due profili realmente distinti del funzionamento esecutivo. Tuttavia, nell'ADHD è stato trovato un deficit più severo nell'inibizione della risposta prepotente (funzione emozionale/motivazionale). Conclusioni. I risultati del nostro studio sono parzialmente in accordo con quelli della letteratura. Ulteriori ricerche con gruppi più numerosi potranno chiarire più approfonditamente quali punti di forza e debolezza, nell'ampio spettro delle funzioni esecutive, differenzino fra loro le prestazioni di persone con ASD e ADHD. PMID:27362821

  3. [Funzioni esecutive metacognitive ed emozionali/motivazionali nel disturbo dello spettro dell'autismo e nel disturbo da deficit di attenzione con iperattività: risultati preliminari].

    PubMed

    Panerai, Simonetta; Tasca, Domenica; Ferri, Raffaele; Catania, Valentina; Genitori D'Arrigo, Valentina; Di Giorgio, Rosa; Zingale, Marinella; Trubia, Grazia; Torrisi, Anna; Elia, Maurizio

    2016-01-01

    RIASSUNTO. Scopo. I deficit delle funzioni esecutive (FE) sono frequentemente osservati nei disturbi dello spettro dell'autismo (ASD) e nel disturbo da deficit di attenzione con iperattività (ADHD). Lo scopo di questo studio è quello di valutare e confrontare le funzioni esecutive metacognitive ed emozionali/motivazionali di bambini con ASD e ADHD, sia fra di loro che con un gruppo di controllo. Metodi. Il campione è costituito da un totale di 58 soggetti, di cui 17 con ASD senza disabilità intellettiva, 18 con ADHD-manifestazione combinata e 23 con sviluppo tipico, abbinati per genere, età cronologica e livello intellettivo. Le valutazioni hanno riguardato alcune aree del funzionamento esecutivo, nello specifico pianificazione, flessibilità mentale, generatività e inibizione della risposta, che rappresentano sia le funzioni esecutive metacognitive sia quelle emozionali/motivazionali. Risultati. I risultati hanno rilevato un'ampia sovrapposizione delle disfunzioni esecutive nei due gruppi clinici con ASD e ADHD, e non sono stati indicativi della presenza di due profili realmente distinti del funzionamento esecutivo. Tuttavia, nell'ADHD è stato trovato un deficit più severo nell'inibizione della risposta prepotente (funzione emozionale/motivazionale). Conclusioni. I risultati del nostro studio sono parzialmente in accordo con quelli della letteratura. Ulteriori ricerche con gruppi più numerosi potranno chiarire più approfonditamente quali punti di forza e debolezza, nell'ampio spettro delle funzioni esecutive, differenzino fra loro le prestazioni di persone con ASD e ADHD.

  4. Nutritional support in patients undergoing haematopoietic stem cell transplantation: a multicentre survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programmes

    PubMed Central

    Botti, Stefano; Liptrott, Sarah Jayne; Gargiulo, Gianpaolo; Orlando, Laura

    2015-01-01

    A survey within Italian haematopoietic stem cell transplant (HSCT) programmes was performed, in order to obtain a snapshot of nutritional support (NS) in patients undergoing HSCT. The primary objective was to verify whether an evidence-based practice (EBP) approach to NS was implemented in HSCT centres. A multicentre survey was performed by questionnaire, covering the main areas of NS (screening, treatment planning, monitoring, nutritional counselling, and methods of nutritional support). The results indicated a significant variation between clinical practice and evidence-based guidelines in terms of clinical pathways, decision-making, and care provision regarding NS. Further research is required to identify reasons for the limited application of EBP and measures that may be undertaken to address such issues. Development of a multidisciplinary educational programme in order to raise awareness of the issue should be undertaken. PMID:26180544

  5. Haemorrhagic cystitis in haematopoietic stem cell transplantation (HSCT): a prospective observational study of incidence and management in HSCT centres within the GITMO network (Gruppo Italiano Trapianto Midollo Osseo)

    PubMed Central

    Gargiulo, G; Orlando, L; Alberani, F; Crabu, G; Di Maio, A; Duranti, L; Errico, A; Liptrott, S; Pitrone, R; Santarone, S; Soliman, C; Trunfio, A; Selleri, C; Bruno, B; Mammoliti, S; Pane, F

    2014-01-01

    Haemorrhagic cystitis (HC) is a recognised complication in patients undergoing allogeneic haematopoietic stem cell transplantation (HSCT). This study evaluates the incidence and severity of HC in patients undergoing allogeneic HSCT during hospitalisation and within the first 100 days following transplant, looking at the use of prophylaxis, management of HC, outcomes at 100 days post transplant, and to identify any correlations between development of HC and the different conditioning regimens for transplant or HC prevention methods used. Results Four hundred and fifty patients (412 adult and 38 paediatric) were enrolled in this prospective, multicentre, and observational study. HC was observed in 55 patients (12.2%) of which 8/38 were paediatric (21% of total paediatric sample) and 47/412 adults (11.4% of total adult sample). HC was observed primarily in the non-related HSCT group (45/55; 81.8%, p= 0.001) compared to sibling and myeloablative transplant protocols (48/55; 87.3%; p= 0.008) and with respect to reduced intensity conditioning regimens (7/55;12.7%). In 33 patients with HC (60%), BK virus was isolated in urine samples, a potential co-factor in the pathogenesis of HC. The median day of HC presentation was 23 days post HSCT infusion, with a mean duration of 20 days. The most frequent therapeutic treatments were placement of a bladder catheter (31/55; 56%) and continuous bladder irrigation (40/55; 73%). The range of variables in terms of conditioning regimens and so on, makes analysis difficult. Conclusions This multi-centre national study reported similar incidence rates of HC to those in the literature. Evidence-based guidelines for prophylaxis and management are required in transplant centres. Further research is required to look at both prophylactic and therapeutic interventions, which also consider toxicity of newer conditioning regimens. PMID:24834115

  6. Prevalence of bands other than 160 and 130 kDa in pemphigus sera (a multicenter immunoblotting study). Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED).

    PubMed

    Cozzani, E; Parodi, A; Rebora, A

    1998-05-01

    Patients with pemphigus may produce antibodies against molecules other than the classical transmembranal ones. Recently, for example antibodies to 230 kDa antigens have been found in association with antibodies to intercellular substance. To better understand their prevalence, clinical correlates and prognostic significance of bands other than 130 and 160 kDa, we studied 67 pemphigus sera. About one-fourth of patients revealed multiple heterogeneous bands and 13% the 230 kDa band. When challenged with the recombinant protein rBP55, the carbossiterminal portion of bullous pemphigoid major antigen, all 230 kDa-positive-sera proved negative. Caution is to be recommended in interpreting pemphigus sera with a band migrating at the 230 kDa level.

  7. Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata.

    PubMed

    Maurillo, Luca; Breccia, Massimo; Buccisano, Francesco; Voso, Maria Teresa; Niscola, Pasquale; Trapè, Giulio; Tatarelli, Caterina; D'Addosio, Ada; Latagliata, Roberto; Fenu, Susanna; Piccioni, Anna Lina; Fragasso, Alberto; Aloe Spiriti, Maria A; Refrigeri, Marco; Criscuolo, Marianna; Musto, Pellegrino; Venditti, Adriano

    2015-07-01

    Deferasirox (DFX) is an orally administered iron chelator approved for use in patients with transfusion-dependent iron overload due to myelodysplastic syndromes (MDS). The safety and efficacy of DFX has been explored in clinical trial settings, but there is little data on unselected patients with MDS. The aim of this study was to retrospectively evaluate the safety, compliance, efficacy and effect on haematopoiesis of DFX in a large 'real-world' MDS population. One hundred and eighteen patients with transfusion-dependent MDS were treated with DFX across 11 centres in Italy. Serum ferritin levels, haematological response, dosing, adverse events and transfusion dependence were recorded at baseline, 3, 6, 12 and 24 months following initiation of treatment. DFX reduced mean serum ferritin levels from 1790 to 1140 ng/mL (P < 0.001), with 7.1% of patients achieving transfusion independence. Significant haematological improvement was seen in erythroid (17.6%), platelet (5.9%) and neutrophil counts (7.1%). Adverse events were reported in 47.5% of patients, including gastrointestinal and renal toxicity. Regression analysis showed that higher starting doses of DFX are associated with transfusion independence at 24 months. DFX is a safe, effective treatment for transfusion-dependent MDS that can lead to transfusion independence and haematological improvement in a subset of patients. PMID:25764148

  8. Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO).

    PubMed

    Brandes, A A; Tosoni, A; Cavallo, G; Bertorelle, R; Gioia, V; Franceschi, E; Biscuola, M; Blatt, V; Crinò, L; Ermani, M

    2006-11-01

    The efficacy of temozolomide strongly depends on O(6)-alkylguanine DNA-alkyl transferase (AGAT), which repairs DNA damage caused by the drug itself. Low-dose protracted temozolomide administration can decrease AGAT activity. The main end point of the present study was therefore to test progression-free survival at 6 months (PFS-6) in glioblastoma patients following a prolonged temozolomide schedule. Chemonaïve glioblastoma patients with disease recurrence or progression after surgery and standard radiotherapy were considered eligible. Chemotherapy cycles consisted of temozolomide 75 mg/m(2)/daily for 21 days every 28 days until disease progression. O(6)-methyl-guanine-DNA-methyl-tranferase (MGMT) was determined in 22 patients (66.7%). A total of 33 patients (median age 57 years, range 31-71) with a median KPS of 90 (range 60-100) were accrued. The overall response rate was 9%, and PFS-6 30.3% (95% CI:18-51%). No correlation was found between the MGMT promoter methylation status of the tumours and the overall response rate, time to progression and survival. In 153 treatment cycles delivered, the most common grade 3/4 event was lymphopoenia. The prolonged temozolomide schedule considered in the present study is followed by a high PFS-6 rate; toxicity is acceptable. Further randomised trials should therefore be conducted to confirm the efficacy of this regimen.

  9. Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).

    PubMed

    Franceschi, E; Cavallo, G; Lonardi, S; Magrini, E; Tosoni, A; Grosso, D; Scopece, L; Blatt, V; Urbini, B; Pession, A; Tallini, G; Crinò, L; Brandes, A A

    2007-04-10

    To investigate the role of gefitinib in patients with high-grade gliomas (HGGs), a phase II trial (1839IL/0116) was conducted in patients with disease recurrence following surgery plus radiotherapy and first-line chemotherapy. Adult patients with histologically confirmed recurrent HGGs following surgery, radiotherapy and first-line chemotherapy, were considered eligible. Patients were treated with gefitinib (250 mg day(-1)) continuously until disease progression. The primary end point was progression-free survival at 6 months progression-free survival at 6 months (PFS-6). Tissue biomarkers (epidermal growth factor receptor (EGFR) gene status and expression, phosphorylated Akt (p-Akt) expression) were assessed. Twenty-eight patients (median age, 55 years; median ECOG performance status, 1) were enrolled; all were evaluable for drug activity and safety. Sixteen patients had glioblastoma, three patients had anaplastic oligodendrogliomas and nine patients had anaplastic astrocytoma. Five patients (17.9%, 95% CI 6.1-36.9%) showed disease stabilisation. The overall median time to progression was 8.4 (range 2-104+) weeks and PFS-6 was 14.3% (95% CI 4.0-32.7%). The median overall survival was 24.6 weeks (range 4-104+). No grade 3-4 gefitinib-related toxicity was found. Gefitinib showed limited activity in patients affected by HGGs. Epidermal growth factor receptor expression or gene status, and p-Akt expression do not seem to predict activity of this drug.

  10. Randomised comparison of cisplatin with cyclophosphamide/cisplatin and with cyclophosphamide/doxorubicin/cisplatin in advanced ovarian cancer. Gruppo Interegionale Cooperativo Oncologico Ginecologia.

    PubMed

    1987-08-15

    565 patients with stage III-IV epithelial ovarian cancer were randomly assigned to receive cisplatin (P), cyclophosphamide and cisplatin (CP), or cyclophosphamide, doxorubicin, and cisplatin (CAP). Data on 531 patients were analysed. Treatment with CAP resulted in a significantly higher overall (complete and partial) response rate (66 vs 56 vs 49% for CAP, CP, and P, respectively), but the rate of complete surgical response for the three treatment arms was similar (26, 21, and 20%). Size of residual tumour after first surgery and Karnofsky index were the best predictors of complete remission. Survival and disease-free survival were not significantly different in the three arms, although progression-free survival was significantly longer after CAP. However, tumour size, cell type, and Karnofsky index, but not therapy, were independent predictors for survival. Haematological toxicity was highest with CAP. The addition of cyclophosphamide or doxorubicin and cyclophosphamide to cisplatin does not substantially increase the number of potentially curable, advanced ovarian cancer patients.

  11. A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. Gruppo Italiano Malattie Ematologiche dell'Adulto, Gruppo Italiano Trapianto di Midollo Osseo, Associazione Italiana Ematologia ed Oncologia Pediatrica, Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Sorveglianza Epidemiologica delle Infezioni Fungine nelle Emopatie Maligne.

    PubMed

    Girmenia, Corrado; Aversa, Franco; Busca, Alessandro; Candoni, Anna; Cesaro, Simone; Luppi, Mario; Pagano, Livio; Rossi, Giuseppe; Venditti, Adriano; Nosari, Anna Maria

    2013-09-01

    In the attempt to establish key therapy definitions and provide shared approaches to invasive fungal diseases in neutropenic patients, trials of empiric, preeemptive and targeted antifungal therapy (EAT, PAT and TAT) were reviewed, and a Consensus Development Conference Project was convened. The Expert-Panel concurred that all antifungal treatments, including EAT, should always follow an adequate diagnostic strategy and that the standard definition of PAT may be misleading: being PAT guided by the results of a diagnostic work-up, it should better be termed diagnostic-driven antifungal therapy (DDAT). The Expert-Panel agreed that radiological findings alone are insufficient for the choice of a TAT and that the identification of the etiologic pathogen is needed. The Consensus Agreement proceeded identifying which clinical and microbiological findings were sufficient to start a DDAT and which were not. Finally, an algorithm to rationalize the choice of antifungal drugs on the basis of clinical manifestations, antifungal prophylaxis, instrumental and laboratory findings was drawn up.

  12. Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA/AIEOP experience. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Associazione Italiana Ematologìa ed Ocologia Pediatrica.

    PubMed

    Giona, F; Testi, A M; Annino, L; Amadori, S; Arcese, W; Camera, A; Di Montezemolo, L C; Ladogana, S; Liso, V; Meloni, G

    1994-01-01

    One hundred and forty-seven patients aged < 55 years with advanced acute lymphoblastic leukaemia (ALL) were enrolled in an Italian cooperative study (ALL R-87). This protocol consists of an induction phase with idarubicin (IDA) plus intermediate-dose cytarabine (IDARA-C), followed by a consolidation phase and bone marrow transplant (BMT). Complete remission (CR) was achieved in 97/147 patients (66%) with a CR rate of 77% in children versus 51% in adults (P < 0.01). 48 responders (50%) underwent BMT. Probability of event-free survival (EFS +/- SE) was 10.2 +/- 3.1% at 56 months. EFS was 14.3 +/- 4.51% at 56 months for children versus 3.8 +/- 3.41% at 37 months for adults (P < 0.0001). Among patients treated in first relapse, EFS was 14.2 +/-7.79% for patients with CR > 18 months verus 6.6 +/- 3.17% for those with CR < 18 months (P < 0.0001). Projected disease-free survival (DFS +/- SE) was 15.4 +/- 4.61% at 55 months for all responders and 43.3 +/- 14.34% at 52 months for allografted patients. Projected overall probability of survival +/- SE for all patients was 18.8 +/- 4.13% at 56 months. This study confirms the efficacy of IDA plus IDARA-C in poor-risk. ALL patients. A more intensive post-remission therapy or alternative approach must be designed to improve long-term results.

  13. [The evolution of hospital mortality due to acute myocardial infarct in the first 2 GISSI studies. Participants in the GISSI 1 and GISSI 2 studies. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].

    PubMed

    Mauri, F; De Vita, C; Staszewsky, L; Piantadosi, F R; Bosi, S; Mantini, L; Matta, F; Negrini, M; Valente, S; Martini L [corrected to Mantini, L

    1994-12-01

    During the short while of 5 years, between 1984 and 1985, two large clinical trials have been performed in Italy concerning fibrinolytic therapy in Acute Myocardial Infarction: GISSI 1 and GISSI 2. They made possible to evaluate the evolution of demographic and clinical features, the in-hospital mortality rate, and the causes of death of a huge number of patients admitted to CCU throughout the whole country. Out of 31,826 patients with acute myocardial infarction admitted to 176 CCU participating to the GISSI 1 16.9% were 75 years old and 24.7% were females; 21.8% and 26.4% were the percentages in the 38,086 patients admitted to the 223 CCU participating in the GISSI 2. Despite the higher prevalence of the two demographic characteristic with the worse prognosis, the in-hospital mortality rates were respectively 12.2% in the GISSI 1 and 10.0% in the GISSI 2 studies, with a statistically significant decrease (RR 0.84; C.L. 0.80-0.88). The significant decrease in the in-hospital mortality concerns also the patients populations selected according to the same criteria of inclusion in the two trials (within 6 hours from the onset of symptoms and with only ST elevation at the ECG of admission) and to the treatment with fibrinolytic drug (SK or rtPA). As a matter of fact 468 patients died of the 4,696 (10.0%) treated with SK in the GISSI 1 against 1,092 patients of 12,381 (8.8%) enrolled in the GISSI 2 and treated with SK or rtPA (RR 0.87; L.C. 0.78-0.98). The reduction of in-hospital mortality may be explained by some differences in the two groups.(ABSTRACT TRUNCATED AT 250 WORDS)

  14. Allogeneic bone marrow transplantation in children with acute myelogenous leukemia in first remission. Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO).

    PubMed

    Dini, G; Boni, L; Abla, O; Uderzo, C; Polchi, P; Locatelli, F; Di Bartolomeo, P; Arcese, W; Iori, A P; Rossetti, F

    1994-06-01

    Fifty-nine children, aged 1-15 years, with acute myelogenous leukemia (AML) received a bone marrow transplant (BMT) from an HLA-identical sibling (n = 57) or from an identical twin (n = 2), while in first remission (CR). These children represent, to the best of our knowledge, all children grafted in first CR in 11 Italian centers between 1980 and 1990. Patients were prepared with total body irradiation (TBI) plus cyclophosphamide (CY) (n = 50) or melphalan (n = 2) or with busulfan plus CY (n = 7). GVHD prophylaxis consisted of cyclosporin A (n = 48), methotrexate (n = 7) or cyclosporin and methotrexate (n = 2). Survivors have been followed for 21-137 months (median 59 months). Actuarial relapse-free survival was 58% at 66-137 months (95% confidence interval (CI) 44-72). Actuarial risk of relapse was 23% at 48 months (95% CI 10.9-34.8). Risk of non-relapse deaths was 33% in the period 1980-87 and 4% in the period 1988-90 (p = 0.02). In multivariate analysis patients with a blood cell count > 14 x 10(9)/l at diagnosis showed a lower relapse-free survival compared with patients with counts < 14 x 10(9)/l (p = 0.006). We could not detect an effect of FAB subtype, patient age, time to achieve remission or transplant-related variables, including year of BMT, on relapse-free survival. In conclusion, allogeneic marrow transplantation can achieve long-term relapse-free survival in over 50% of children with AML and should be considered as consolidation therapy if a matched sibling is available.(ABSTRACT TRUNCATED AT 250 WORDS)

  15. Allogeneic bone marrow transplantation versus chemotherapy in high-risk childhood acute lymphoblastic leukaemia in first remission. Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) and the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

    PubMed

    Uderzo, C; Valsecchi, M G; Balduzzi, A; Dini, G; Miniero, R; Locatelli, F; Rondelli, R; Pession, A; Arcese, W; Bacigalupo, A; Polchi, P; Andolina, M; Messina, C; Conter, V; Aricó, M; Galimberti, S; Masera, G

    1997-02-01

    We compared the outcome of children with high-risk acute lymphoblastic leukaemia (HR-ALL) in first complete remission (first CR) treated with chemotherapy (CHEMO) or with allogeneic bone marrow transplantation (BMT) in a multicentre study. All children treated by the Italian Paediatric Haematology Oncology Association for HR-ALL in first CR between 1986 and 1994 were eligible for the study. 30 children were given BMT at a median of 4 months from first CR, with preparative regimens including total-body irradiation (n = 25/30). 130 matched controls for BMT patients were identified among 397 HR-ALL CHEMO patients. Matching on main prognostic factors and duration of first CR was adopted to control the selection and time-to-transplant biases. The comparative analysis was based on the results of a stratified Cox model. The estimated hazard ratios of BMT versus CHEMO at 6 months, 1 year and 2 years after CR were 1.38 (CI 0.59-3.24), 0.69 (CI 0.27-1.77) and 0.35 (CI 0.06-1.91), with an overall non-significant difference between the two groups (P = 0.34). With a median follow-up of 4 years, the disease-free survival was 58.5% (SE 9.3) in the BMT group and 47.7% (SE 4.8) in the CHEMO group, at 4 years from CR. Non-leukaemic death occurred in 4% of CHEMO and 10% of BMT patients. In the BMT group the estimated cumulative incidence of relapse at 1.5 years from CR was 31.5% (SE 8.8) and did not change thereafter, whereas in the CHEMO group the corresponding figure was 29.2% (SE 4.1) and the incidence continued to increase thereafter (48.2% (SE 4.8) at 4 years from CR). The results of this study suggest that, with respect to the CHEMO group, the higher risk of early failure in the BMT group is outweighed by the lower risk of relapse after 1 year. Results prompt the need for a prospective study, in order to demonstrate the likely advantage of BMT in HR childhood ALL in first CR.

  16. Frequency of consumption of selected indicator foods and serum cholesterol. GISSI-EFRIM investigators. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto--Epidemiologia dei Fattori di Rischio dell'Infarto Miocardico.

    PubMed

    D'Avanzo, B; Negri, E; Nobili, A; La Vecchia, C

    1995-06-01

    The relationship between frequency of consumption of eleven indicator foods (milk, meat, liver, carrots, green vegetables, fruit, eggs, ham, fish, cheese and alcohol) and serum cholesterol was investigated in the comparison group of a case-control study of acute myocardial infarction conducted in Italy. Data were collected on 792 subjects from various Italian regions, admitted to hospital for acute conditions unrelated to any known or potential risk factor for myocardial infarction or to long-term modifications in diet. No statistically or epidemiologically meaningful relationship emerged between serum cholesterol level and frequency of consumption of any of these foods. Cholesterol levels rose according to increasing consumption tertiles for most of the indicator foods considered. Higher values for the higher tertile of consumption were observed for meat, ham and eggs, but also for fruit, carrots and green vegetables. However, correlation coefficients between frequency of consumption of various food items and serum cholesterol level were uniformly low for all food items considered, ranging between -0.09 (for milk) and 0.19 (for ham). Although a more comprehensive diet history may lead to different indications, the present data are not suggestive of any major influence of long-term frequency of consumption of a few selected indicator foods on serum cholesterol levels.

  17. Physical activity and the risk of acute myocardial infarction. GISSI-EFRIM Investigators. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-Epidemiologia dei Fattori di Rischio dell'Infarto Miocardico.

    PubMed

    D'Avanzo, B; Santoro, L; La Vecchia, C; Maggioni, A; Nobili, A; Iacuitti, G; Franceschi, S

    1993-11-01

    The relationship between physical activity and acute myocardial infarction (AMI) was examined in a case-control study conducted in Italy in 1988 to 1989 within the framework of the GISSI-2 trial of streptokinase versus alteplase and heparin versus no heparin in the treatment of AMI. A total of 916 case patients admitted to coronary care units from various Italian regions for AMI were interviewed. Control subjects were 1106 patients admitted to the same network of hospitals for a broad spectrum of acute diseases not related to known or potential risk factors for myocardial infarction. Among various types of physical activity (occupational activity, walking, stair climbing, and sport and leisure-time physical activity), occupational physical exercise emerged as the most protective. Multivariate odds ratios (ORs) were 1.4 (95% confidence interval (CI), 1.0 to 2.0) and 1.6 (95% CI, 1.2 to 2.1) for the two lowest levels of occupational physical activity. The trends of increasing risk with decreasing activity were consistent, although less strong, when other types of activity were considered. The protection conveyed by occupational physical activity was similar across various strata of sex, age, education, smoking habits, and diabetes, and was not explained by serum cholesterol, body weight, or hypertension. This study therefore confirms that low physical activity is an indicator of subsequent risk of AMI.

  18. Cigarette smoking and acute myocardial infarction. A case-control study from the GISSI-2 trial. GISSI-EFRIM Investigators. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto--Epidemiologia dei Fattori di Rischio dell'infarto Miocardioco.

    PubMed

    Negri, E; La Vecchia, C; Nobili, A; D'Avanzo, B; Bechi, S

    1994-08-01

    To make a further quantitative assessment of the relationship between cigarette smoking and the risk of myocardial infarction, a multicentric case-control study was conducted in Italy between September 1988 and June 1989 within the framework of the GISSI-2 trial. Ninety hospitals in various Italian Regions participated. 916 cases of acute myocardial infarction with no history of ischaemic heart disease and 1106 controls admitted to hospital for acute conditions not related to known or suspected risk factors for ischaemic heart disease were studied. Relative risks (RR) and 95% confidence intervals (CI) of myocardial infarction according to various measures of tobacco smoking, were adjusted for identified potential confounding factors using multiple logistic regression. Compared to lifelong non-smokers, the RR was 1.3 (95% CI 1.0 to 1.9) for ex-smokers, 2.0 (95% CI 1.4 to 2.9) for current smokers of less than 15 cigarettes per day, 3.1 (95% CI 2.2 to 4.2) for 15-24 cigarettes per day and 4.9 (95% CI 3.4 to 7.1) for 25 or more cigarettes per day. No trend in risk was evident for the duration, the RR being around 3 for subsequent categories. There was a significant interaction between smoking and age. Below the age 45, smokers of 25 or more cigarettes per day had a 33 times higher risk than non-smokers, compared to 7.5 at in the age group 45-54, 4.4 between the ages 55-64 and 2.5 at the age of 65 or over. The risk estimates were higher in women (RR for > or = 25 cigarettes per day = 10.1), in subjects in the lowest cholesterol tertile (RR = 11.9), with no history of diabetes (RR = 6.8), hypertension (RR = 9.5), no family history ischaemic heart disease (RR = 9.1) and low body mass index (RR = 9.3). The importance of smoking is confirmed as a cause of acute myocardial infarction: about 50% of all nonfatal infarctions in this Italian population could be attributable to cigarette smoking.(ABSTRACT TRUNCATED AT 250 WORDS)

  19. Coffee consumption and risk of acute myocardial infarction in Italian males. GISSI-EFRIM. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto, Epidemiologia dei Fattori di Rischio del'Infarto Miocardico.

    PubMed

    D'Avanzo, B; La Vecchia, C; Tognoni, G; Franceschi, S; Franzosi, M G; Nobili, A; Santoro, L; Scarsi, G

    1993-11-01

    The relationship between coffee consumption and acute myocardial infarction (AMI) was analyzed using data from a case-control study conducted in 1988 to 1989 within the framework of the GISSI-2 trial on streptokinase versus alteplase and heparin versus no heparin in the treatment of AMI. A total of 801 male patients with AMI and 792 control subjects who were hospitalized in several Italian regions for diseases unrelated to known or potential risk factors for cardiovascular diseases were included. Compared with coffee nondrinkers, the multivariate relative risks (RRs), after allowance for age, education, body mass index, smoking habits, alcohol consumption, family history of AMI, cholesterol level, history of diabetes, and hypertension, were 0.8 (95% confidence interval (CI), 0.5 to 1.2) for consumption of one cup/d, 1.3 (95% CI, 0.9 to 2.0) for two cups/d, 1.8 (95% CI, 1.1 to 2.7) for three cups, 2.5 (95% CI, 1.5 to 4.1) for four cups, and 2.6 (95% CI, 1.6 to 4.2) for five cups or more. The trend in risk with dose was statistically significant (P < 0.001). Duration of coffee consumption was not associated with the risk of AMI. The RRs for daily coffee consumption were elevated across strata of various covariates, including age, smoking habits, cholesterol level, diabetes, and hypertension, with a particularly elevated (although not significantly heterogeneous) estimate in patients younger than 50 years (RR, 5.7; 95% CI, 3.0 to 10.9 for four or more cups/d). The RR in patients who drank four or more cups of coffee per day and were current smokers was 8.1 (95% CI, 5.1 to 13.0), suggesting an unfavorable effect on the combination of cigarette smoking and high coffee intake on the risk of AMI.

  20. Long-term results of a randomized trial comparing cisplatin with cisplatin and cyclophosphamide with cisplatin, cyclophosphamide, and adriamycin in advanced ovarian cancer. GICOG (Gruppo Interregionale Cooperativo Oncologico Ginecologia), Italy.

    PubMed

    1992-05-01

    We report the long-term results of a randomized trial comparing cisplatin (P) with cisplatin and cyclophosphamide (CP) with cisplatin, cyclophosphamide, and adriamycin (CAP) in advanced ovarian cancer. Overall, this update confirms previously published data on 529 cases. Median survival times for the three treatments--CAP, CP, and P--are, respectively, 23, 20, and 19 months. The differences among the three arms are still nonsignificant and the estimated percentage survival at 7 years and confidence limits are, respectively, 21.7 (14.9-28.4), 17.0 (11.0-22.9), and 12.2 (6.9-17.4). According to the results of the Cox regression model on prognostic factors, higher grading, a larger residual tumor size, and performance status less than 80 (Karnovsky) all were independently associated with a poorer outcome, while a serous histotype was related to a better prognosis. The other variables (age, stage, center, type of surgery) initially included in the model did not appear to be significantly related to prognosis. The implications of these long-terms results relative to the application of combination chemotherapy with CAP or CP are discussed.

  1. Evaluation of surgery risk factor associated to antithrombotic therapy in patients who underwent colorectal surgery.

    PubMed

    Del Rio, Paolo; Sozzi, Francesco; Bertocchi, Elisa; Dell'Abate, Paolo; Perrone, Gennaro; Arcuri, Maria Francesca; Sianesi, Mario

    2016-01-01

    I trattamenti antipiastrinici sono comuni nel mondo occidentale ed il rischio di sanguinamento correlato a procedure chirurgiche o comunque invasive è di conseguenza elevato e pertanto abbiamo volute analizzare la correlazione tra la chirurgia del colon.retto ,la terapia antipiastrinica e le complicanze chirurgiche postoperatorie. Sono stati studiati 176 pazienti operati per tumori del colon-retto considerando i seguenti dati:tipo di intervento xchirurgico,l’indice di massa corporea (BMI), il valore dell’emoglobina (Hb); PT preoperatorio e le trasfusioni di sangue pre epost-operatorie e durante lo stesso intervento chirurgico. L’analisi si è concentrata su due gruppi :pazienti sottoposti a trattamento antipiastrinico (ATterapia antiaggregante) e pazienti non trattati ( NAT: non terapia antiaggregante piastrinica). Nei gruppi di pazienti sottoposti a emicolectomia destra, i valori di emoglobina erano più bassi neri pazienti che hanno ricevuto la terapia antitrombotica rispetto ai pazienti che non hanno ricevuto questa terapia, con una significatività statistica (p <0,05); dati analoghi sono stati osservati nei pazienti sottoposti a emicolectomia sinistra. I pazienti dipeso normale trattati con terapia antiaggregante avevano valori più bassi di emoglobina senza significatività statistica (valore di p non significativo). I pazienti in sovrappeso sottoposti a trattamento antiaggregante hanno presentato valori di Hb inferiori a quelli non trattati (p < 0,05). La percentuale di emotrasfusioneè risultata maggiore nei pazienti sottoposti a trattamento antiaggregante (AT) a prescindere dal tipo di interveno chirurgico rispetto al secondo gruppo con significatività statistica. Tra i pazienti normopeso si è registrata una diversa incidenza di trasfusione di sangue nei pazienti trattati con AT (50%) e quelli non trattati (29%) con un significato statistico (p <0,05), mentre i pazienti in sovrappeso non hanno presenato questa significativa differenza. È stata

  2. Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups.

    PubMed

    Mandelli, F; Diverio, D; Avvisati, G; Luciano, A; Barbui, T; Bernasconi, C; Broccia, G; Cerri, R; Falda, M; Fioritoni, G; Leoni, F; Liso, V; Petti, M C; Rodeghiero, F; Saglio, G; Vegna, M L; Visani, G; Jehn, U; Willemze, R; Muus, P; Pelicci, P G; Biondi, A; Lo Coco, F

    1997-08-01

    Two hundred fifty-three patients with newly diagnosed acute promyelocytic leukemia (APL) were eligible to enter the multicentric GIMEMA-AIEOP "AIDA" trial during the period July 1993 to February 1996. As a mandatory prerequisite for eligibility, all patients had genetic evidence of the specific t(15;17) lesion in their leukemic cells confirmed by karyotyping or by reverse transcription-polymerase chain reaction (RT-PCR) of the PML/RAR alpha fusion gene (the latter available in 247 cases). Median age was 37.8 years (range, 2.2 to 73.9). Induction treatment consisted of oral all-trans retinoic acid (ATRA), 45 mg/m2/d until complete remission (CR), given with intravenous Idarubicin, 12 mg/m2/d on days 2, 4, 6, and 8. Three polychemotherapy cycles were given as consolidation. Hematologic and molecular response by RT-PCR was assessed after induction and after consolidation. At the time of analysis, 240 of the 253 eligible patients were evaluable for induction. Of these, 11 (5%) died of early complications and 229 (95%) achieved hematologic remission. No cases of resistant leukemia were observed. Of 139 cases studied by RT-PCR after induction, 84 (60.5%) were PCR-negative and 55 (39.5%) PCR-positive. One hundred sixty-two patients were evaluable by RT-PCR at the end of consolidation. Of these, 159 (98%) tested PCR-negative and 3 (2%), PCR-positive. After a median follow up of 12 months (range, 0 to 33), the estimated actuarial event-free survival for the whole series of 253 eligible patients was 83% +/- 2.6% and 79% +/- 3.2% at 1 and 2 years, respectively. This study indicates that the AIDA protocol is a well-tolerated regimen that induces molecular remission in almost all patients with PML/RAR alpha-positive APL. Preliminary survival data suggest that a remarkable cure rate can be obtained with this treatment.

  3. Sonographic examination of epiaortic vessels in patients with peripheral vertigo.

    PubMed

    Salvaggio, G; Gargano, R; Campisi, A; Cantisani, V; Ricci, P; Gallina, S; Midiri, M; Caruso, G

    2010-09-01

    Sommario INTRODUZIONE: Valutare l’utilità dell’eco-color Doppler (CDU) dei vasi epiaortici nei pazienti con vertigine periferica da causa sconosciuta. MATERAILI E METODI: Centocinquantasei pazienti (gruppo studio; 42 uomini e 114 donne; età media 61,86 ± 14,14) e 161 pazienti (gruppo controllo; 80 uomini e 81 donne; età media 62,31 ± 13,69) sono stati sottoposti a CDU dei vasi epiaortici. Sono stati valutati i seguenti parametri: presenza di placche ateromasiche a livello dell’arteria carotide (CA) comune e/o interna; spessore medio intimale (IMT) della CA comune; picco di velocità sistolica (PSV) e indice di resistenza (RI) a livello delle arterie vertebrali (VA).Sono stati utilizzati test parametrici (T-test) e non parametrici (Mann–Whitney U-test e Kolmogorov–Smirnov test). È stata eseguita un’analisi di regressione logistica per fornire un odds ratio indice di grandezza del rischio di vertigine. Sono state considerate variabili indipendenti (età, sesso), fattori di rischio vascolare (ipercolesterolemia, diabete, ipertensione) e variabili CDU (IMT, placche, PSV e RI). RISULTATI: Placche ed IMT > 1 mm sono stati trovati in 31 (19,8%) e 98 (62,8%) pazienti del gruppo di studio e in 43 (26,7%) e 125 (77,6%) pazienti del gruppo controllo. I test statistici, applicati a PSV e RI, non hanno dimostrato differenze significative (p-valore > 0,05). Alla regressione logistica le vertigini sono risultate associate ad età, sesso, ipercolesterolemia, diabete, ipertensione e IMT (p < 0,01), mentre placche, PSV ed RI non erano fattori significativi (p > 0,05). DISCUSSIONE: IMT è la sola variabile CDU significativamente associata alla vertigine, specialmente nelle classi di età inferiore (35-45 e 45-55) del gruppo studio.

  4. Explodet Project:. Methods of Automatic Data Processing and Analysis for the Detection of Hidden Explosive

    NASA Astrophysics Data System (ADS)

    Lecca, Paola

    2003-12-01

    The research of the INFN Gruppo Collegato di Trento in the ambit of EXPLODET project for the humanitarian demining, is devoted to the development of a software procedure for the automatization of data analysis and decision taking about the presence of hidden explosive. Innovative algorithms of likely background calculation, a system based on neural networks for energy calibration and simple statistical methods for the qualitative consistency check of the signals are the main parts of the software performing the automatic data elaboration.

  5. Autologous bone grafting with platelet-rich plasma for alveolar cleft repair in patient with cleft and palate.

    PubMed

    Giudice, Giuseppe; Cutrignelli, Daniela Anna; Leuzzi, Sara; Robusto, Fabio; Sportelli, Pasquale; Nacchiero, Eleonora

    2016-01-01

    L’innesto osseo è essenziale nella terapia chirurgica della labiopalatoschisi (LPS), ma i tempi di osteogenesi ed integrazione ossea nella sede ricevente possono procrastinare i successivi interventi di ortodonzia. Nel nostro studio è stata valutata la capacità della PRP (platelet-rich plasma) associata al trapianto osseo nel diminuire il tempo d’attesa e la durata del trattamento ortodontico in una coorte di 8 bambini, confrontandola con 8 controlli sottoposti a semplice innesto osseo. I risultati hanno mostrato come i soggetti sottoposti a trapianto osseo + PRP abbiano avuto la possibilità di essere sottoposti ad un trattamento ortodontico più precoce (155 giorni vs 298) e più breve (295 giorni vs 356) rispetto al gruppo di controllo. Inoltre nel gruppo di controllo si sono verificate con maggiore frequenza complicanze post-chirurgiche (quali fistole oro-nasali, disturbi periodontali, malattie dentali, perdita di spessore, massa o trabecolatura ossea) rispetto al gruppo sottoposto a PRP. Perciò l’associazione della PRP (platelet-rich plasma) al trapianto osseo è una metodica che sembra associarsi ad una diminuzione statisticamente significativa dei tempi di integrazione ossea nei pazienti affetti da LPS, con conseguente anticipazione della ortodonzia e miglioramento degli outcome chirurgici.

  6. Effects of cold therapy in the treatment of mandibular angle fractures: hilotherm system vs ice bag.

    PubMed

    Barca, Ida; Colangeli, Walter; Cristofaro, Maria Giulia; Giudice, Amerigo; Giofrè, Elio; Varano, Anna; Giudice, Mario

    2016-06-18

    La crioterapia dopo interventi di chirurgia maxillo-facciale è una metodica comunemente utilizzata sia a fini analgesici che di riduzione dell’edema e dell’ecchimosi dei tessuti molli. Hilotherapy è costituito da un’unità mobile elettrica refrigerante dotata di un termostato digitale regolabile e da un circuito chiuso di acqua distillata refrigerata che scorre all’interno di collettori e di maschere in gomma specificatamente conformate per i distretti anatomici del massiccio facciale. Abbiamo selezionato 40 pz affetti da frattura unifocale di angolo mandibolare e suddivisi in 2 gruppi, crioterapia con ice-bag (gruppo A) e Hiloterapy System (Gruppo B); entrambi sottoposti a medesimo trattamento farmacologico di base (antibiotico-antiedemigeno-antidolorifico). L’analisi dei dati ha dimostrato come l’utilizzo dell’Hiloterapy System nel post-operatorio per 48 ore a temperatura modulata ha garantito un più rapido decremento dell’edema dei tessuti molli e un miglior controllo del dolore, con conseguente minor richiesta di farmaci anti-infiammatori ed anti-dolorifici, rispetto al gruppo A.

  7. Cellular and humoral inflammatory response after laparoscopic and conventional colorectal surgery. Preliminary report.

    PubMed

    Laforgia, Rita; D'Elia, Giovanna; Lattarulo, Serafina; Mestice, Anna; Volpi, Annalisa

    La laparoscopia rappresenta un approccio ormai noto per trattare chirurgicamente le patologie benigne e maligne colorettali e numerosi autori hanno riportato una risposta immunologica migliore nei pazienti sottoposti a chirurgia laparoscopica eseguendo un confronto con la chirurgia colorettale tradizionale. Il trauma chirurgico determina una risposta immunitaria locale che può diventare una risposta sistemica in seguito agli stimoli infiammatori e ciò porta ad attivazione del sistema immunitario in difesa dal trauma chirurgico e contemporaneamente una modulazione negativa con immunosoppressione circa l’eventuale difesa dalle infezioni e la diffusione di cellule neoplastiche. Lo scopo del nostro studio è valutare la differente risposta bioumorale al trauma chirurgico in pazienti sottoposti a resezione colica per via videolaparoscopica ed in pazienti sottoposti ad analogo intervento per via laparotomica convenzionale. Sono stati arruolati quattordici pazienti, con patologia maligna colorettale, di cui 7 sottoposti a chirurgia laparoscopica e 7 a chirurgia tradizionale, selezionati in base all’anamnesi negativa per pregressa patologia neoplastica e/o per patologie particolarmente invalidanti ed in base alla stadiazione del tumore, per cui non vi era evidenza di metastasi a distanza. Tutti i campioni sono stati collezionati prima dell’intervento e dopo di esso, alle 24 ore e a 7 giorni e sottoposti ad analisi di laboratorio: analisi ELISA, determinazione PCR tramite dosaggio immunoturbidimetrico quantitativo, fenotipizzazione delle cellule immunitarie. Abbiamo osservato un incremento significativo dei livelli circolanti di Proteina CReattiva (PCR) alle 24h dall’intervento nel gruppo convenzionale. Il valore dell’Interleuchina-6 (IL-6) ha subito un aumento nell’immediato postoperatorio dopo approccio laparoscopico. I livelli delle sottopopolazioni linfocitarie subiscono minor elevazione nel gruppo laparoscopico. In conclusione, la produzione di mediatori

  8. Comparison of multiple training models of surgical rotation for third-year medical students A prospective study.

    PubMed

    Magistri, Paolo; Nigri, Giuseppe; Petrucciani, Niccolò; Aurello, Paolo; D'Angelo, Francesco; Ramacciato, Giovanni

    2016-01-01

    Considerata la necessità di elaborare un sistema di rotazione nei reparti di Chirurgia che venga incontro alle necessità degli studenti, abbiamo ideato questo studio prospettico presso la Facoltà di Medicina e Psicologia di “Sapienza, Università di Roma”. Nella nostra Istituzione, gli studenti del terzo anno del corso di laurea di Medicina e Psicologia trascorrono un periodo di 2 mesi presso il reparto di Chirurgia Generale per prepararsi all’esame di Semeiotica Medico-Chirurgica. Spesso i feedback di tale esperienza riportano una certa insoddisfazione, soprattutto per la scarsità dell’attività pratica al letto del paziente. Pertanto, abbiamo deciso di confrontare cinque modelli per stabilire il migliore approccio in termini di apprendimento e soddisfazione degli studenti. 28 studenti sono stati coinvolti nello studio e divisi in cinque gruppi (da A ad E). Il Gruppo A ha eseguito una rotazione standard così come prevista dall’ordine degli studi, 5 accessi in reparto seguiti dal proprio tutor. Gli studenti del gruppo B hanno frequentato il reparto una volta la settimana, arrivando dopo la visita della mattina, trascorrendo un’ora con il tutor ed il resto della mattina con gli specializzandi. Il gruppo C è stato diviso in piccoli gruppi, ciascuno assegnato per 2 volte all’ambulatorio chirurgico, 2 volte in reparto (standard) e 2 volte al servizio di preospedalizzazione. Gli studenti del gruppo D hanno frequentato il reparto una volta la settimana arrivando la mattina presto, trascorrendo 2 ore con il tutor ed il resto della mattina con gli specializzandi. Il gruppo E è stato diviso in 2 gruppi, ciascuno assegnato 3 volte al reparto (standard) e 3 volte alla sala operatoria. Ciascuno studente ha completato un questionario con 20 item di semeiotica all’inizio ed alla fine dello studio per valutare la progressione dell’apprendimento, ed un questionario finale di valutazione della soddisfazione. I risultati hanno dimostrato come tutti i gruppi

  9. Successful use of rFVIIa for major breast surgery prophylaxis in congenital factor VII deficiency.

    PubMed

    Varricchio, Antonio; Schettino, Michela; Ciampa, Antonio; Iannace, Carlo; Lo Conte, Domenico; Donnarumma, Bernadette; Vigorito, Raffaella; Lepore, Mariolina

    2014-06-24

    emorragiche. In questo articolo descriviamo un caso di una paziente di 46 anni con deficit congenito del fattore VII che si è sottoposta a trattamento chirurgico con successo grazie al trattamento con Novoseven prima della procedura. È stato utilizzato il modello riportato sotto per valutare i livelli di PTT e aPTT nel paziente. Per il prelievo ematico il sangue venoso della paziente è stato raccolto in provette di plastica (0.129 M di citrato di sodio, con sistema Vacutainer). Il tempo di protrombina è stato misurato con Recombiplastin (IL, Milano Italy), l’aPTT è stato misurato con l’APTT-SP (IL, Milano Italy). Come primo approccio profilattico alla paziente è stata utilizzata la vitamina K intramuscolo ma con scarsi risultati, poi si è valutato l’uso del Prothromplex, senza però ottenere un effetto significativo. L’ultimo step è stata la somministrazione di una terapia con Novoseven ® 15μg/kg somministrato 30 minuti prima dell’intervento and 4-5 h dopo la prima infusione. L’infusione del farmaco ha risolto i problemi di coagulazione permettendo il trattamento chirurgico, senza rischio nè emorragico nè trombotico per la paziente.

  10. Long waiting lists and health care spending: the example of cholecystectomy.

    PubMed

    Palmisano, Silvia; Benvenuto, Chiara; Casagranda, Biagio; Dobrinja, Chiara; Piccinni, Giuseppe; de Manzini, Nicolò

    2014-03-28

    Lo scopo dello studio è stato valutare l’incidenza di complicanze correlate alla calcolosi della colecisti in pazienti in lista d’attesa per l’intervento di colecistectomia e quantificare le implicazioni economiche di quest’attesa in termini di costi sanitari relativi agli esami ematochimici, strumentali, alla degenza, all’intervento chirurgico e alle terapie somministrate. La popolazione oggetto dello studio è stata di 86 pazienti, 39 uomini e 47 donne, inseriti in lista d’attesa per intervento chirurgico di colecistectomia in un periodo compreso fra aprile 2007 e aprile 2010. Di tali pazienti sono stati raccolti dati anagrafici, la durata del tempo d’attesa, dettagli sugli accessi in PS ed eventuali ricoveri durante l’attesa, esami e terapie eseguite, il tipo di intervento chirurgico effettuato e i giorni di degenza. È stato fatto uno studio comparativo di natura economica tra tre gruppi di pazienti: A: asintomatici durante l’attesa, B: complicati ma non operati in urgenza, C: complicati e operati in regime d’urgenza. Utilizzando il tariffario regionale delle prestazioni di assistenza specialistica ambulatoriale e quello delle prestazioni di assistenza ospedaliera per acuti erogate in regime di ricovero diurno abbiamo stimato che un singolo paziente complicato ma non operato in regime d’urgenza abbia determinato un ingente spesa per il sistema sanitario ( gruppo B: circa 3513,2 €) circa 1.9 volte in più se paragonata a un paziente che durante l’attesa non abbia sviluppato complicanze ( gruppo A: circa 1.849,4 €) o 1.36 volte in più di un paziente precocemente operato in regime d’urgenza (gruppo c: circa 2.584,6 €). Nel nostro limitato, ma a nostro parere esplicativo, campione abbiamo stimato i costi specifici legati alla lunghezza delle liste d’attesa pari a circa 26.112 €. In questo periodo di crisi economica, che ha portato numerosi tagli anche al sistema sanitario, questo significativo ammontare di denaro, a nostro

  11. Long waiting lists and health care spending The example of cholecystectomy.

    PubMed

    Palmisano, Silvia; Benvenuto, Chiara; Casagranda, Biagio; Dobrinja, Chiara; Piccinni, Giuseppe; de Manzini, Nicolò

    2015-01-01

    Lo scopo dello studio è stato valutare l’incidenza di complicanze correlate alla calcolosi della colecisti in pazienti in lista d’attesa per l’intervento di colecistectomia e quantificare le implicazioni economiche di quest’attesa in termini di costi sanitari relativi agli esami ematochimici, strumentali, alla degenza, all’intervento chirurgico e alle terapie somministrate. La popolazione oggetto dello studio è stata di 86 pazienti, 39 uomini e 47 donne, inseriti in lista d’attesa per intervento chirurgico di colecistectomia in un periodo compreso fra aprile 2007 e aprile 2010. Di tali pazienti sono stati raccolti dati anagrafici, la durata del tempo d’attesa, dettagli sugli accessi in PS ed eventuali ricoveri durante l’attesa, esami e terapie eseguite, il tipo di intervento chirurgico effettuato e i giorni di degenza. È stato fatto uno studio comparativo di natura economica tra tre gruppi di pazienti: A: asintomatici durante l’attesa, B: complicati ma non operati in urgenza, C: complicati e operati in regime d’urgenza. Utilizzando il tariffario regionale delle prestazioni di assistenza specialistica ambulatoriale e quello delle prestazioni di assistenza ospedaliera per acuti erogate in regime di ricovero diurno abbiamo stimato che un singolo paziente complicato ma non operato in regime d’urgenza abbia determinato un ingente spesa per il sistema sanitario ( gruppo B: circa 3513,2 €) circa 1.9 volte in più se paragonata a un paziente che durante l’attesa non abbia sviluppato complicanze ( gruppo A: circa 1.849,4 €) o 1.36 volte in più di un paziente precocemente operato in regime d’urgenza (gruppo c: circa 2.584,6 €). Nel nostro limitato, ma a nostro parere esplicativo, campione abbiamo stimato i costi specifici legati alla lunghezza delle liste d’attesa pari a circa 26.112 €. In questo periodo di crisi economica, che ha portato numerosi tagli anche al sistema sanitario, questo significativo ammontare di denaro, a nostro

  12. Long waiting lists and health care spending The example of cholecystectomy.

    PubMed

    Palmisano, Silvia; Benvenuto, Chiara; Casagranda, Biagio; Dobrinja, Chiara; Piccinni, Giuseppe; de Manzini, Nicolò

    2014-05-01

    Lo scopo dello studio è stato valutare l’incidenza di complicanze correlate alla calcolosi della colecisti in pazienti in lista d’attesa per l’intervento di colecistectomia e quantificare le implicazioni economiche di quest’attesa in termini di costi sanitari relativi agli esami ematochimici, strumentali, alla degenza, all’intervento chirurgico e alle terapie somministrate. La popolazione oggetto dello studio è stata di 86 pazienti, 39 uomini e 47 donne, inseriti in lista d’attesa per intervento chirurgico di colecistectomia in un periodo compreso fra aprile 2007 e aprile 2010. Di tali pazienti sono stati raccolti dati anagrafici, la durata del tempo d’attesa, dettagli sugli accessi in PS ed eventuali ricoveri durante l’attesa, esami e terapie eseguite, il tipo di intervento chirurgico effettuato e i giorni di degenza. È stato fatto uno studio comparativo di natura economica tra tre gruppi di pazienti: A: asintomatici durante l’attesa, B: complicati ma non operati in urgenza, C: complicati e operati in regime d’urgenza. Utilizzando il tariffario regionale delle prestazioni di assistenza specialistica ambulatoriale e quello delle prestazioni di assistenza ospedaliera per acuti erogate in regime di ricovero diurno abbiamo stimato che un singolo paziente complicato ma non operato in regime d’urgenza abbia determinato un ingente spesa per il sistema sanitario ( gruppo B: circa 3513,2 €) circa 1.9 volte in più se paragonata a un paziente che durante l’attesa non abbia sviluppato complicanze ( gruppo A: circa 1.849,4 €) o 1.36 volte in più di un paziente precocemente operato in regime d’urgenza (gruppo c: circa 2.584,6 €). Nel nostro limitato, ma a nostro parere esplicativo, campione abbiamo stimato i costi specifici legati alla lunghezza delle liste d’attesa pari a circa 26.112 €. In questo periodo di crisi economica, che ha portato numerosi tagli anche al sistema sanitario, questo significativo ammontare di denaro, a nostro

  13. Spigelian Hernias Treatment and Diagnosis in Our Experience.

    PubMed

    Citgez, Bulent; Yetkin, Gurkan; Uludag, Mehmet; Akgun, Ismail; Karakoc, Sinan

    2014-10-25

    L’ernia di Spiegel (SH) è un’ernia rara della parete addominale con elevato rischio di incercerazione ed occusione intestinale. In questo studio viene presentata l’esperienza degli autori in termine di diagnosi e relativo trattamento riguardante l’esame retrospettivo di 17 pazienti osservati tra il 2000 ed il 2010, con descrizione delle caratteristiche demografiche, i messi diagnositici e le tecniche chirurgiche adottate. Tutti i pazienti mostravano una tumefazione accompagnata da dolore, e tutti sono stati sottoposti ad una riparazione protesica, senza mortalità nè morbilità postoperatoria. Nel periodo in media di media di 73 mesi (da 13 a 115) del follow-up non è stata osservata nessuna recidiva. Questo tipo di rara ernia presenta varibili motivi di difficoltà diagnostica in fase preoperatoria. La riparazione protesica sembra ridurre l’incidenza delle complicanze e delle recidive.

  14. A giant inguinoscrotal hernia associated with other abdominal wall defects A case report.

    PubMed

    Iovino, Francesco; Auriemma, Pasquale Pio; Dani, Luca; Giordano, Giovanni; Barbarisi, Alfonso

    2016-04-29

    Le ernie giganti sono rare nei Paesi sviluppati ed ancora più raramente sono associate ad altre ernie della parete addominale, come un’ernia inguinale controlaterale o un’ernia ombelicale. La presenza di più difetti di parete facilità il riposizionamento in addome del contenuto di una voluminosa ernia inguinale senza compromettere la funzionalità cardiorespiratoria, ma il rischio di intasamento o strozzamento intestinale negli altri orifizi erniari aumenta. In letteratura non esistono opinioni convergenti se riparare simultaneamente o in maniera sequenziale, cioè in maniera distanziata nel tempo, le diverse ernie di parete, quando sono associate ad un’ernia gigante. Riportiamo in questo lavoro il caso clinico di un uomo di 60 anni, italiano, che si recò nel nostro ambulatorio di chirurgia lamentando da molti anni la presenza di un’ernia inguinale gigante associata ad un’ernia inguinale controlaterale ed un’ernia ombelicale. Il paziente alla visita presentava difficoltà di deambulazione, ma non riferiva disturbi di canalizzazione. Aveva diverse comorbidità e tra queste quella più importante era una insufficienza respiratoria severa. Dopo un accurato studio cardiologico, respiratorio e metabolico il paziente fu sottoposto a riparazione delle ernie a partire da quella gigante, in maniera sequenziale ed in anestesia spinale secondo la tecnica di Lichtenstein. L’ernia ombelicale fu riparata per ultima con tecnica diretta, senza protesi, ed anch’essa in anestesia spinale. Il decorso operatorio fu regolare dopo i tre interventi e non si ebbe alcuna complicanza respiratoria, cardiologica né di canalizzazione. In conclusione riteniamo che nei pazienti con importanti comorbidità la riparazione di un’ernia gigante associata ad altre ernie di parete debba avvenire in maniera sequenziale, monitorando con attenzione la canalizzazione e soprattutto il progressivo adattamento dei visceri in addome attraverso la palpazione degli orifizi erniari. I dati

  15. An Italian Education: IEEE Pulse talks with Riccardo Pietrabissa, president of Italy's National Bioengineering Group, about Italian progress and challenges in biomedical engineering education.

    PubMed

    Pietrabissa, Riccardo; Reynolds, Pamela

    2015-01-01

    From Leonardo da Vinci's designs for ball bearings to the incredible engineering wizardry behind the Ferrari, the inventive, inquisitive, and ingenious spirit of the engineer has always lived--and thrived--in Italy. From education to research to product development, Italy has always been regarded as an engineering leader. But does this apply to biomedical engineering (BME)? Despite many successes, questions loom, as they do at engineering schools worldwide. Concerns such as whether BME programs are providing students with enough focused, practical, hands-on training remain at the forefront, as does the question of whether graduates will be able to find jobs in industry after university studies are over. Here, IEEE Pulse explores these topics with Riccardo Pietrabissa, president of the Gruppo Nazionale di Bioingegneria (National Bioengineering Group) and a full professor in the Department of Chemistry, Materials, and Chemical Engineering at Politecnico di Milano.

  16. Italian consensus conference for colonic diverticulosis and diverticular disease

    PubMed Central

    Barbara, Giovanni; Pace, Fabio; Annese, Vito; Bassotti, Gabrio; Binda, Gian Andrea; Casetti, Tino; Colecchia, Antonio; Festi, Davide; Fiocca, Roberto; Laghi, Andrea; Maconi, Giovanni; Nascimbeni, Riccardo; Scarpignato, Carmelo; Villanacci, Vincenzo; Annibale, Bruno

    2014-01-01

    The statements produced by the Consensus Conference on Diverticular Disease promoted by GRIMAD (Gruppo Italiano Malattia Diverticolare, Italian Group on Diverticular Diseases) are reported. Topics such as epidemiology, risk factors, diagnosis, medical and surgical treatment of diverticular disease (DD) in patients with uncomplicated and complicated DD were reviewed by a scientific board of experts who proposed 55 statements graded according to level of evidence and strength of recommendation, and approved by an independent jury. Each topic was explored focusing on the more relevant clinical questions. Comparison and discussion of expert opinions, pertinent statements and replies to specific questions, were presented and approved based on a systematic literature search of the available evidence. Comments were added explaining the basis for grading the evidence, particularly for controversial areas. PMID:25360320

  17. An Italian Education: IEEE Pulse talks with Riccardo Pietrabissa, president of Italy's National Bioengineering Group, about Italian progress and challenges in biomedical engineering education.

    PubMed

    Pietrabissa, Riccardo; Reynolds, Pamela

    2015-01-01

    From Leonardo da Vinci's designs for ball bearings to the incredible engineering wizardry behind the Ferrari, the inventive, inquisitive, and ingenious spirit of the engineer has always lived--and thrived--in Italy. From education to research to product development, Italy has always been regarded as an engineering leader. But does this apply to biomedical engineering (BME)? Despite many successes, questions loom, as they do at engineering schools worldwide. Concerns such as whether BME programs are providing students with enough focused, practical, hands-on training remain at the forefront, as does the question of whether graduates will be able to find jobs in industry after university studies are over. Here, IEEE Pulse explores these topics with Riccardo Pietrabissa, president of the Gruppo Nazionale di Bioingegneria (National Bioengineering Group) and a full professor in the Department of Chemistry, Materials, and Chemical Engineering at Politecnico di Milano. PMID:26186055

  18. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.

    PubMed

    Cipolla, Calogero; Graceffa, Giuseppa; La Mendola, Roberta; Fricano, Salvatore; Fricano, Martina; Vieni, Salvatore

    2015-01-01

    Il significato prognostico delle micrometastasi nel linfonodo sentinella nelle pazienti affette da carcinoma della mammella è ancora ampiamente dibattuto. Anche se, in assenza di univoche linee guida, nella pratica clinica la linfadenectomia ascellare in queste pazienti non viene più eseguita di routine. Abbiamo condotto uno studio retrospettivo su 746 patienti affette da carcinoma invasivo della mammella con linfonodi ascellari negativi, sottoposte a chirurgia conservativa o a mastectomia totale con biopsia del linfonodo sentinella. Le pazienti in cui è stata diagnostica la presenza di micrometastasi del linfonodo sentinella sono state considerate in due diversi gruppi. In un primo gruppo, trattato con linfadenectomia ascellare totale è stata valutata l’incidenza di metastasi a carico dei rimanenti linfonodi ascellari. Un secondo gruppo non ha ricevuto alcun trattamento aggiuntivo dell’ascella e le pazienti sono state seguite con controlli periodici clinico strumentali. In entrambi i gruppi è stata valutata l’incidenza di eventuali recidive ascellari. All’esame istologico estemporaneo ed al successivo esame istologico definitivo del linfonodo sentinella, in 51 pazienti (6,83%) sono state evidenziate micrometastasi, in 8 pazienti (1,07%) erano presenti cellule tumorali isolate. Quindici di queste pazienti sono state sottoposte a linfadenectomia ascellare totale. Solo in 2 casi (13,33%) sono state ritrovate metastasi a carico dei rimanenti linfonodi ascellari. Quarantaquattro pazienti non hanno ricevuto alcun trattamento aggiuntivo dell’ascella. In queste pazienti nessuna recidiva ascellare è stata registrata durante un follow-up medio di 65,3±9,65 mesi (range 42-78 mesi). Sulla base dei risultati ottenuti in questo studio ed in linea con alcuni recenti trials randomizzati si ci sentiamo di concludere che la linfadenectomia ascellare può essere evitata nei casi con micrometastasi nel linfonodo sentinella. Una sua eventuale indicazione può essere

  19. Thoracic ultrasonography: A new method for the work-up of patients with dyspnea().

    PubMed

    Vitturi, N; Soattin, M; Allemand, E; Simoni, F; Realdi, G

    2011-09-01

    SommarioLa diagnosi differenziale di dispnea è fondamentale per la gestione dell’insufficienza respiratoria in cui, ai parametri routinari, può essere ora affiancata l’ecografia toracica. L’obiettivo di questo studio è stato valutare la validità e l’accuratezza di questa metodica anche in un reparto di medicina interna. MATERIALI E METODI: 152 pazienti ricoverati conseguentemente con diagnosi di dispnea sono stati esaminati dopo valutazione clinica, radiografia del torace, dosaggi bioumorali (NT-proBNP) e terapia d’emergenza. L’esame ecografico polmonare è stato considerato positivo qualora il numero totale di linee B fosse superiore ad 8. L’esame ecografico e il dosaggio dell’NT-proBNP sono stati ripetuti dopo 48 ore. Il gold standard di riferimento è stato la diagnosi clinica di scompenso cardiaco fatta da medici esperti secondo le linee guida dell’AHA. RISULTATI: Il gruppo di pazienti che mostrava un esame ecografico positivo riceveva in percentuale maggiore la diagnosi finale di insufficienza cardiaca (X 92.5; p < 0.005) e valori significativamente più elevati di NT-proBNP (10,384 ng/l vs 3889 ng/l; p < 0.05). Inoltre la diminuzione delle linee B a 48 ore era significativamente maggiore (p < 0.005) nel gruppo di pazienti trattati per scompenso cardiaco mentre non vi erano cambiamenti significativi nei valori di NT-proBNP (p = 0.37). DISCUSSIONE: In conclusione abbiamo dimostrato che anche in un reparto di medicina interna l’ecografia polmonare è uno strumento diagnostico utile per le gestione dell’insufficienza respiratoria e il suo monitoraggio durante la terapia.

  20. Rare extra-adrenal paraganglioma mimicking a painful Schwannoma: case report.

    PubMed

    Picchetto, Andrea; M Paganini, Alessandro; Balla, Andrea; Quaresima, Silvia; Cantisani, Vito; D'Ambrosio, Giancarlo; Lezoche, Emanuele

    2014-09-26

    I paragangliomi hanno un’incidenza annuale di circa 1/100000; essi originano dai tessuti cromaffini dei corpi di Zurckerkandl. In questo case report riportiamo il caso di un uomo di 53 anni, già trattato e seguito per un precedente limfoma di Hodkin che è stato sottoposta a RMN dell’addome per una lombalgia cronica che durava da due anni e che non riusciva ad alleviare con i FANS. La RMN ha rivelato un’incidentaloma: una massa in regione para-aortica, a livello della loggia surrenalica sinistra con le caratteristiche di una massa nodulare solida (29*25mm), che non sembrava originare direttamente dal surrene. Il pz ha inoltre eseguito un TC dell’addome che ha mostrato una massa localizzata di fronte al surrene di sinistra; il collega radiologo ha definito questa massa come un tumore maligno delle guaine nervose periferiche (Schwannoma) o come un linfonodo colliquato (essendo nota la patologia linfomatosa già descritta in anamnesi). Il paziente non riferiva cefalea, palpitazioni, picchi ipertensivi ne’ altri sintomi sistemici. Durante il suo ricovero, sono stati dosati i marker tumorali cromogranina e l’enolasi neurono-specifica che sono risultati essere rispettivamente 187.00 ng/mL and 7.7 ng/mL. La lombalgia è stata trattata inizialmente con Ketorolac, senza beneficio alcuno, quindi con Ketorolac più Tramadolo in pompa elastomerica, nuovamente senza beneficio per il paziente, infine con infusione continua di Morfina. Dato che l’esatta natura della neoformazione non era nota e che l’esecuzione di una biopsia TC guidata non era tecnicamente possibile, è stata eseguita un’escissione per via laparoscopica della massa, con approccio anteriore submesocolico trans peritoneale, così come gli Autori sono soliti eseguire per la surrenalectomia sinistra. Sin dai primi giorni postoperatori il paziente non ha più necessitato della morfina. Il decorso postoperatorio è stato del tutto regolare. L’esame istologico è risultato essere paraganglioma. I

  1. Malignant transformation in non-recurrent peritoneal cystic mesothelioma Our experience and review of the literature.

    PubMed

    Santangelo, Giuseppe; Accardo, Marina; De Vita, Ferdinando; Del Giudice, Santolo; Gallucci, Federica; Fabozzi, Alessio; De Falco, Massimo

    2016-01-29

    Il mesotelioma peritoneale cistico è un tumore raro. Si tratta di un tumore benigno, che tuttavia va incontro a recidive locali post-chirurgiche in oltre il 50% dei casi. È proprio a seguito di recidive ricorrenti che si possono determinare trasformazioni maligne di questa neoplasia, come descritto in Letteratura. Nel Giugno del 2004 un paziente di 73 anni è giunto presso la nostra struttura con una tumefazione addominale causa di dolore gravativo: si trattava di una massa di 16 cm, la cui struttura, agli esami strumentali (ecografia, TC con m.d.c. e RMN), appariva pluricistica. Attraverso una laparotomia mediana si è provveduto alla sua rimozione e il paziente è stato dimesso in VIII giornata post-operatoria senza complicanze. L’esame istologico, corredato da studio immunoistochimico e di microscopia elettronica, ha consentito di porre diagnosi di mesotelioma peritoneale pluricistico in trasformazione maligna. D’accordo con gli oncologi, in considerazione della scarsa efficacia dei trattamenti adiuvanti e della scarsità dei dati riportati in Letteratura sull’argomento, si è deciso di sottoporre il paziente unicamente ad uno stretto follow-up, con esecuzione di ecografia addominale ogni sei mesi e TC addominale ogni anno. Ad oggi, dieci anni dopo il trattamento, il paziente, di 83 anni, gode di un discreto stato di salute e non si sono verificate riprese o recidive di malattia, né locali, né a distanza. Oltre al fatto di essere risultato maligno alla sua prima manifestazione e non dopo ripetute recidive, il caso presenta altre particolarità: il mesotelioma peritoneale cistico, infatti, solitamente colpisce soggetti di sesso femminile (con un rapporto F:M di 4,5:1) ad un’età media di 60 anni, mentre il caso descritto riguarda un soggetto di sesso maschile di 73 anni. La nostra osservazione dimostra la possibilità che il mesotelioma peritoneale vada incontro a trasformazioni maligne già alla sua prima manifestazione e non esclusivamente dopo

  2. European Collaboration on Low-dose Aspirin in Polycythemia Vera (ECLAP): a randomized trial.

    PubMed

    Landolfi, R; Marchioli, R

    1997-01-01

    Thrombotic complications characterize the clinical course of polycythemia vera (PV) and represent the main cause of morbidity and mortality. However, uncertainty still exists as to the benefit/risk ratio of aspirin prophylaxis in this setting. In vivo platelet biosynthesis of thromboxane A2 is enhanced and can be suppressed by low-dose aspirin in PV, thus providing a rationale for assessing the efficacy and safety of a low-dose aspirin regimen in these patients. The Gruppo Italiano Studio Policitemia Vera has recently performed a pilot study on 112 patients randomized to receive aspirin, 40 mg daily, or placebo and followed for 16 +/- 6 months (mean +/- SD). This study showed that low-dose aspirin is well tolerated in PV patients, and that a large-scale efficacy trial is feasible in this setting. In this article we report the protocol of the European Collaboration on Low-dose Aspirin in Polycythemia Vera (ECLAP) study, which is a randomized trial designed to assess the risk/benefit ratio of low-dose aspirin in PV. To estimate the size and the follow-up duration required for the ECLAP trial, a retrospective analysis of the clinical epidemiology of a large PV population has recently been completed by the Gruppo Italiano Studio Policitemia Vera. On this basis, approximately 3500 patients will be enrolled in the ECLAP study with a follow-up of 3 to 4 years. The uncertainty principle will be used as the main eligibility criterion: Polycythemic patients of any age, having no clear indication for or contraindication to aspirin treatment, will be randomized in a double-blind fashion to receive oral aspirin (100 mg daily) or placebo. According to current therapeutic recommendations, the basic treatment of randomized patients should be aimed at maintaining the hematocrit value < or = 45% in subjects aged < or = 50, and hematocrit < 45% as well as platelet count < 400 x 10(9)/L in patients aged > 50. Randomization will be stratified by participating center. The study is

  3. Multidisciplinary approach to follicular thyroid carcinoma with giant mandibular and multiple sites metastases Case report.

    PubMed

    De Pasquale, Loredana; Rabbiosi, Dimitri; Bardazzi, Alessandro; Autelitano, Luca; Moro, Giacomina Pierina; Ghilardi, Giorgio

    2014-01-01

    I tumori metastatici in genere hanno una cattiva prognosi, con sopravvivenza breve e raramente sono candidabili al trattamento chirurgico. Nel caso dei carcinomi differenziati della tiroide, la prognosi è solitamente migliore, grazie alla possibilità di un approcio multidisciplinare e soprattutto al trattamento radiometabolico dei secodarismi, dopo l’asportazione del tumore primitivo. Il caso presentato riguarda una donna di 65 anni, che è giunta alla nostra osservazione per una tumefazione mandibolare, risultata successivamente una metastasi da carcinoma follicolare della tiroide, a partenza da un voluminoso gozzo cervico-mediastinico normofunzionante, con ulteriori secondarismi a livello polmonare. Dopo un accurato studio pre-operatorio la Paziente è stata sottoposta a resezione della mandibola sinistra con ricostruzione mediante una protesi metallica e a tiroidectomia totale. Successivamente è stata trattata con quattro cicli di terapia radiometabolica con buona risposta. La Paziente è viva, senza ulteriore progressione di malattia a un follow-up di quarantasei mesi. Anche nei casi di tumori differnziati della tiroide in fase metastatica, l’opzione chirurgica va presa in considerazione per consentire alle terapie complementari di migliorare la prognosi in termini di sopravvivenza.

  4. [Malattia di Marchiafava-Bignami con coinvolgimento della corteccia frontale e insorgenza tardiva di sintomi psichiatrici resistenti: un caso clinico].

    PubMed

    Gramaglia, Carla; Feggi, Alessandro; Vecchi, Camilla; Di Marco, Sarah; Venesia, Alessandra; Delicato, Claudia; Chieppa, Nunzia; De Marchi, Fabiola; Cantello, Roberto; Zeppegno, Patrizia

    2016-01-01

    RIASSUNTO. Scopo. Descrivere il management di un paziente con malattia di Marchiafava-Bignami (MBD) associata a lesioni frontali corticali, senza sintomi specifici al primo accesso in Pronto Soccorso, e insorgenza tardiva di sintomi psichiatrici atipici. Metodi. Descriviamo il caso di un paziente di 44 anni con storia di abuso cronico di alcol, a cui è stata diagnosticata la MBD. Risultati. La risonanza magnetica ha evidenziato lesioni nello splenio e corpo del corpo calloso e lesioni bilaterali della corteccia frontale. Il paziente ha sviluppato sintomi psichiatrici atipici a insorgenza tardiva, che sono risultati essere resistenti alle terapie farmacologiche impostate. Discussione. Il caso che descriviamo sembra supportare le attuali, ma ancora scarse evidenze che descrivono il coinvolgimento corticale nella MBD, suggerendone l'associazione con una prognosi peggiore. I sintomi psichiatrici possono risultare difficili da trattare a causa della resistenza alle terapie. Conclusione. Il coinvolgimento di psichiatri, radiologi e neurologi secondo un approccio di consultazione-liaison si è dimostrato di fondamentale importanza per la diagnosi e l'impostazione della terapia adeguata al paziente.

  5. Autotransplantation of pancreatic islets. A single-center first experience.

    PubMed

    Magistri, Paolo; Andreani, Sara; Lo Conte, Domenico; Ferrari, Giovanni Carlo; Forgione, Antonello; Pugliese, Raffaele

    2016-01-01

    L’autotrapianto d’isole pancreatiche (IAT) è una procedura ben nota che consente di migliorare il controllo glicemico dopo una pancreasectomia totale (o completamento di pancreasectomia dopo duodenocefalopancreasectomia) rispetto alla sola terapia insulinica. In questo lavoro presentiamo la nostra esperienza nel campo dell’ IAT riportando il caso clinico di una donna di sessanta anni, sottoposta a completamento di pancreasectomia per episodi ricorrenti di acuzie in un quadro di pancreatite cronica. Il trattamento IAT è stato somministrato mediante iniezione trans-epatica intra-portale. Il recupero post-procedurale è stato ottimale, fatta eccezione per un’infezione di ferita che ha richiesto un trattamento con tecnologia a pressione negativa. La paziente è stata dimessa in ventisettesima giornata postoperatoria, in buone condizioni generali, dopo regolare ripresa dell’alimentazione e della canalizzazione. I dati presenti in letteratura dimostrano che la IAT è una procedura sicura, garantendo nel lungo periodo un vantaggio rispetto alla terapia insulinica in termini di rapporto costo-beneficio. Riguardo alla procedura chirurgica, è qui utile ricordare che la mortalità a 30 giorni dopo pancreasectomia totale associata a IAT è del 5%, ed è pertanto sovrapponibile ai risultati della pancreasectomia totale senza IAT. Riportando questa esperienza intendiamo contribuire alla crescita della casistica chirurgica attuale in questo campo, proponendo nel futuro un più ampio sviluppo e una più estesa applicazione di tale approccio.

  6. New "all-in-one" device for mesh plug hernioplasty: the Trabucco repair.

    PubMed

    Gossetti, Francesco; Massa, Salvatore; Abbonante, Francesco; Calabria, Michele; Ceci, Francesca; Viarengo, Maria Antonietta; Manzi, Emy; D'Amore, Linda; Negro, Paolo

    2015-01-01

    Sebbene la tecnica Mesh Plug rappresenti una procedura di indubbia efficacia nel trattamento dell’ernia inguinale, tuttora permangono dubbi in relazione alla storia naturale del plug. In particolare, il plug può andare incontro a coartazione (shrinkage) con formazione di un “meshoma” responsabile di una sintomatologia dolorosa cronica. Più raramente, il plug può migrare e provocare erosione delle strutture anatomiche circostanti. Nel passato sono stati proposti alcuni devices per cercare di risolvere il problema della migrazione; nessuno di questi, tuttavia, ha raggiunto la popolarità dei plug conici o a forma di fiore. Il presente lavoro riporta i risultati di uno studio pilota condotto con l’impiego di un nuovo device tridimensionale, il NeT Plug & Patch. I risultati dopo 12 mesi di follow-up, hanno dimostrato una ridotta incidenza di dolore postoperatorio e cronico, senza rischio di migrazione. Inoltre è stata registrata una compliance soddisfacente sia dei pazienti che degli operatori. La protesi NeT Plug & Patch ha dimostrato di poter realizzare un’ernioplastica semplice ed efficace per la riparazione dell’ernia inguinale.

  7. [Parte III. Ethical and juridical aspects in end-stage chronic organ failures. A position paper on a shared care planning].

    PubMed

    Barbisan, Camillo; Casonato, Carlo; Palermo Fabris, Elisabetta; Piccinni, Mariassunta; Zatti, Paolo

    2014-01-01

    The specific target of an experts panel was to assess in terms of law and ethics the compliance of a new specific decision making algorithm described in the position paper proposed by the Gruppo di Lavoro Insufficienze Croniche d'Organo, with the main goal of the position paper consisting in the shared care planning process. The following specific aspects were assessed by the experts: a) the impact on case law and statute law of a new clinical pathway shared by scientific societies in light of good clinical practice and scientific evidence; b) the relevance of all tools useful to identify the appropriateness of care pathways, recognizing responsibilities and decision-making skills related to the end of life choices made by all stakeholders involved (healthcare professionals, patients and their beloved ones); c) the consistency of the healthcare professionals duties proposed in the position paper with the Italian legal order; d) the opportunity to take into account the role of all healthcare providers involved in care relationship; e) the consistency of the definition of patient rights at the end of life as proposed in the position paper with the Italian legal order and the relevance in this context of simultaneous palliative care; f) the relevance of shared care planning and its consistency with the proposed operative tools; g) the relevance of the conscientious objection issue and the compliance of management tools proposed in the position paper with the results of ethical and legal considerations; h) considerations about available resources allocation.

  8. Quadrantectomy with oxidized regenerated cellulose ("QUORC"): an innovative oncoplastic technique in breast conserving surgery.

    PubMed

    Franceschini, Gianluca; Sanchez, Alejandro Martin; Visconti, Giuseppe; Di Leone, Alba; Salgarello, Marzia; Masetti, Riccardo

    2015-01-01

    La chirurgia oncoplastica della mammella ha generato grande entusiasmo negli ultimi anni ed è diventata una componente integrante ed essenziale del trattamento chirurgico dei tumori del seno. Le tecniche oncoplastiche associano i migliori principi della chirurgia oncologica con i migliori principi della chirurgia plastica per ottenere margini indenni da malattia ed al tempo stesso ottimizzare i risultati estetici. Grazie a queste procedure, il trattamento conservativo della mammella è stato esteso ad includere un gruppo di pazienti che altrimenti richiederebbero una mastectomia per ottenere radicalità oncologica. Tuttavia, anche con l’uso delle procedure oncoplastiche, gli esiti cosmetici possono risultare insoddisfacenti nei tumori di voluminose dimensioni in cui è necessario eseguire ampie exeresi parenchimali in particolare in seni di medio-piccole dimensioni. Recentemente, è stato quindi proposto l’uso di Cellulosa Ossidata Rigenerata come biomateriale ricostruttivo per ottimizzare i risultati estetici dopo chirurgia oncoplastica. Lo scopo di questo articolo è quello di descrivere il modello standard di una innovativa tecnica oncoplastica con cellulose ossidata, che abbiamo denominato “QUORC“ (QUadrantectomy with Oxidized Regenerated Cellulose), grazie alla quale sembra possibile migliorare i risultati estetici e ridurre al minimo le possibili complicanze post-operatorie.

  9. Reduction mammoplasty using oxidized regenerated cellulose as a filler in breast conservation surgery.

    PubMed

    Franceschini, Gianluca; Sanchez, Alejandro Martin; Visconti, Giuseppe; Di Leone, Alba; D'Archi, Sabatino; Mulè, Antonino; Santoro, Angela; Salgarello, Marzia; Masetti, Riccardo

    La chirurgia oncoplastica della mammella ha suscitato grande interesse negli ultimi anni ed è progressivamente divenuta una componente integrante ed essenziale del trattamento chirurgico conservativo dei tumori del seno. Le tecniche di chirurgia oncoplastica combinano i migliori principi della chirurgia oncologica con in migliori principi della chirurgia plastica con lo scopo di ottenere margini indenni da malattia ed al tempo stesso ottimizzare i risultati estetici. In particolare le tecniche di mastoplastica riduttiva sono state applicate in pazienti con seni medio-grandi e ptosici per ottimizzare i risultati oncologici ed estetici. Grazie a queste procedure il trattamento conservativo della mammella è stato esteso ad includere un gruppo di pazienti che altrimenti avrebbero richiesto una mastectomia associata a complessi interventi di ricostruzione mammaria. Tuttavia anche con l’applicazione delle tecniche di mastoplastica riduttiva gli esiti cosmetici possono risultare insoddisfacenti, in particolar modo in pazienti con seni medi che richiedono ampie resezioni parenchimali per tumori di voluminose dimensioni, localizzati nei quadranti supero-interni o inferiori. Recentemente è stato quindi proposto l’utilizzo della cellulosa ossidata rigenerata come biomateriale ricostruttivo per ottimizzare i risultati estetici nella chirurgia oncoplastica. Lo scopo di questo articolo è quello di descrivere il modello standard di una innovativa tecnica oncoplastica con cellulosa ossidata rigenerata che abbiamo denominato “QUORC” (QUadrantectomy with Oxidized Regenerated Cellulose) grazie alla quale sembra possibile migliorare i risultati estetici e ridurre al minimo le possibile complicanze post-operatorie, come infezioni ed ematomi, nella chirurgia oncoplastica con tecnica di mastoplastica riduttiva.

  10. A History of Streptokinase Use in Acute Myocardial Infarction

    PubMed Central

    Sikri, Nikhil; Bardia, Amit

    2007-01-01

    A serendipitous discovery by William Smith Tillett in 1933, followed by many years of work with his student Sol Sherry, laid a sound foundation for the use of streptokinase as a thrombolytic agent in the treatment of acute myocardial infarction. The drug found initial clinical application in combating fibrinous pleural exudates, hemothorax, and tuberculous meningitis. In 1958, Sherry and others started using streptokinase in patients with acute myocardial infarction and changed the focus of treatment from palliation to “cure.” Initial trials that used streptokinase infusion produced conflicting results. An innovative approach of intracoronary streptokinase infusion was initiated by Rentrop and colleagues in 1979. Subsequently, larger trials of intracoronary infusion achieved reperfusion rates ranging from 70% to 90%. The need for a meticulously planned and systematically executed randomized multicenter trial was fulfilled by the Gruppo Italiano per la Sperimentazione della Streptochinasi nell'Infarto Miocardico (GISSI) trial in 1986, which not only validated streptokinase as an effective therapeutic method but also established a fixed protocol for its use in acute myocardial infarction. Currently, despite the wide use of tissue plasminogen activator in developed nations, streptokinase remains essential to the management of acute myocardial infarction in developing nations. PMID:17948083

  11. Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia.

    PubMed

    Falini, Brunangelo; Martelli, Maria Paola; Bolli, Niccolò; Bonasso, Rossella; Ghia, Emanuela; Pallotta, Maria Teresa; Diverio, Daniela; Nicoletti, Ildo; Pacini, Roberta; Tabarrini, Alessia; Galletti, Barbara Verducci; Mannucci, Roberta; Roti, Giovanni; Rosati, Roberto; Specchia, Giorgina; Liso, Arcangelo; Tiacci, Enrico; Alcalay, Myriam; Luzi, Lucilla; Volorio, Sara; Bernard, Loris; Guarini, Anna; Amadori, Sergio; Mandelli, Franco; Pane, Fabrizio; Lo-Coco, Francesco; Saglio, Giuseppe; Pelicci, Pier-Giuseppe; Martelli, Massimo F; Mecucci, Cristina

    2006-09-15

    Nucleophosmin (NPM) exon-12 mutations occur in 50% to 60% of adult acute myeloid leukemia (AML) with normal karyotype and are predictors of favorable prognosis. We evaluated bone marrow or peripheral blood samples from 450 adult patients with AML of the GIMEMA (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto)/AML12 EORTC (European Organization for Research and Treatment of Cancer) trial to (1) search for new exon-12 NPM mutations; (2) determine whether NPM immunostaining on paraffin-embedded biopsies predicts NPM mutations; and (3) investigate altered nucleocytoplasmic NPM traffic in primary AML cells. Fourteen NPM mutations, including 8 new variants, were identified. All 200 AML cases expressing cytoplasmic NPM (NPMc(+) AML) carried NPM mutations. None of the 250 cases with nucleus-restricted NPM (NPMc(-) AML) was mutated. At the C-terminus, NPM leukemic mutants carried mutations of only tryptophan 290 or of both tryptophans 288 and 290 and a new nuclear export signal (NES) motif, which appear to underlie their nuclear export. The specific Crm1/exportin-1 inhibitor leptomycin-B relocated NPM mutants from cytoplasm to nucleus of primary NPMc(+) AML cells, demonstrating that nuclear export is NES dependent. NPM mutants bound and recruited wild-type NPM into leukemic cell cytoplasm. Because alterations at C-terminus of leukemic NPM mutants are similar, immunohistochemistry detects all exon-12 NPM mutations and is a valuable, inexpensive tool in the diagnostic-prognostic work-up of patients with AML with normal karyotype.

  12. Veno-occlusive disease nurse management: development of a dynamic monitoring tool by the GITMO nursing group.

    PubMed

    Botti, Stefano; Orlando, Laura; Gargiulo, Gianpaolo; Cecco, Valentina De; Banfi, Marina; Duranti, Lorenzo; Samarani, Emanuela; Netti, Maria Giovanna; Deiana, Marco; Galuppini, Vera; Pignatelli, Adriana Concetta; Ceresoli, Rosanna; Vedovetto, Alessio; Rostagno, Elena; Bambaci, Marilena; Dellaversana, Cristina; Luminari, Stefano; Bonifazi, Francesca

    2016-01-01

    Veno-occlusive disease (VOD) is a complication arising from the toxicity of conditioning regimens that have a significant impact on the survival of patients who undergo stem cell transplantation. There are several known risk factors for developing VOD and their assessment before the start of conditioning regimens could improve the quality of care. Equally important are early identification of signs and symptoms ascribable to VOD, rapid diagnosis, and timely adjustment of support therapy and treatment. Nurses have a fundamental role at the stages of assessment and monitoring for signs and symptoms; therefore, they should have documented skills and training. The literature defines nurses' areas of competence in managing VOD, but in the actual clinical practice, this is not so clear. Moreover, there is an intrinsic difficulty in managing VOD due to its rapid and often dramatic evolution, together with a lack of care tools to guide nurses. Through a complex evidence-based process, the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO), cellule staminali emopoietiche e terapia cellulare nursing board has developed an operational flowchart and a dynamic monitoring tool applicable to haematopoietic stem cell transplantation patients, whether they develop this complication or not. PMID:27594906

  13. [Valutazione delle guardie di sicurezza privata attraverso la Suicide Probability Scale e la Brief Symptom Inventory].

    PubMed

    Dogan, Bulent; Canturk, Gurol; Canturk, Nergis; Guney, Sevgi; Özcan, Ebru

    2016-01-01

    RIASSUNTO. Scopo. Lo scopo di questo studio è stato quello di investigare l'influenza della probabilità di suicidio, con le sue caratteristiche sociodemografiche, e di procurare i dati per la prevenzione del suicidio tra le guardie di sicurezza privata che lavorano in condizioni di stress, essendo a contatto ininterrottamente con eventi negativi e traumatici di vita durante il loro lavoro. Metodi. Hanno partecipato allo studio 200 guardie di sicurezza privata e 200 persone dell'Università di Ankara. Per raccogliere i dati sono stati utilizzati un questionario riguardante le condizioni sociodemografiche dei partecipanti, la Suicide Probability Scale (SPS) e la Brief Symptom Inventory (BSI). Risultati. Genere, stato civile, stipendio, credenze religiose, vivere una situazione di pericolo di vita, passato di tentativi di suicidio, fumare e non avere una malattia cronica hanno causato statisticamente una differenza significativa sui punteggi di SPS tra il gruppo di guardie di sicurezza privata e quello di controllo. In aggiunta, c'è stata una correlazione positiva statisticamente significativa tra i punteggi totali delle sottoscale di SPS e quelli di BSI. Conclusioni. Allo stesso modo degli agenti di polizia e dei gendarmi, le guardie di sicurezza privata sono ad alto rischio di commettere e tentare il suicidio trovandosi in condizioni stressanti di lavoro e anche soffrendo del trauma secondario. È necessario che essi siano consapevoli della propria tendenza al suicidio e avere controlli psichiatrici regolari.

  14. Risks and benefits of low-dosage cyclosporin in rheumatoid arthritis.

    PubMed

    Pasero, G; Ferraccioli, G F; Portioli, I

    1997-05-01

    The effects of cyclosporin on the activity of rheumatoid arthritis have mainly been investigated in patients with active, refractory, long-standing disease. The data obtained in these trials suggest that cyclosporin is not only a symptomatic treatment for rheumatoid arthritis but can also be considered a disease-modifying antirheumatic drug (DMARD), since it seems to be capable of slowing the progression of cartilage and bone damage due to rheumatoid arthritis. The trials conducted so far have led to a better understanding of cyclosporin toxicity and, therefore, to better monitoring of patients in order to avoid it. The reasons for studying the role of cyclosporin in patients with early, active and potentially severe rheumatoid arthritis are the poor prognosis of the disease despite the use of the presently available DMARDs, and the hypothesis that the drug is more efficacious and better tolerated in early rheumatoid arthritis. A new classification of antirheumatic drugs proposes that disease-controlling antirheumatic therapies decrease inflammatory synovitis and prevent structural joint damage or significantly reduce its rate of progression. However, few existing drugs meet these criteria. The 12-month results of a disease-controlling antirheumatic therapy clinical trial with a blinded radiological end-point, named GRISAR (Gruppo Reumatologi Italiani Studio Artrite Reumatoide) comparing cyclosporin with conventional DMARDs in patients with early rheumatoid arthritis provide strong evidence that cyclosporin offers better control of ongoing joint damage than do conventional DMARDs.

  15. Aggressive rheumatoid arthritis registry in Italy. Characteristics of the early rheumatoid arthritis subtype among patients classified according to the ACR criteria.

    PubMed

    2003-01-01

    The Italian Society of Rheumatology in the year 2000 decided to sponsor the creation of a data base (Registry) of consecutive patients who fulfilled the diagnosis of rheumatoid arthritis (RA) according to the American College of Rheumatology (ACR) criteria. The registry is designed to collect data on the "aggressive" type of RA all over the country in order to determine the percentage of patients who satisfy the established criteria among incident cases of RA and to define the therapeutic approach according to the characteristics of the enrolled patients. Predefined criteria set up by eight recognized opinion leaders on the disease were used by all the centers to create the database. The GIARA registry (Gruppo Italiano Artrite Reumatoide Aggressiva) has now enrolled 706 patients who will be followed up for 24 months. They have been divided into two major subsets--patients with early (< 4 months' disease duration) and late (> 4 months) RA--with the aim of establishing whether differences in clinical, serological, radiographic and therapeutic (DMARDs: disease modifying antirheumatic drugs) parameters may distinguish the two subsets. The major conclusion of this preliminary analysis is that an overall tendency to undertreatment is discernable.

  16. Foundry waste recycling in moulding operations and in the ceramic industry.

    PubMed

    Zanetti, Maria Chiara; Fiore, Silvia

    2003-06-01

    An industrial treatment was performed by the Sasil plant of Brusnengo (Biella, Northern Italy), which is part of the Gruppo Minerali S.p.A. (Novara, Northern Italy), to consider the reclamation of bentonite bonded moulding sands obtained from the Teksid Italia S.p.A. cast iron foundry plant in Crescentino (Vercelli, Northern Italy). An evaluation of the fine particles produced by the wet-mechanical regeneration treatment was made with the purpose of proposing their recycling as binding agents in moulding operations in the cast iron foundry and for the production of tiles in the ceramic industry. The pre-mixed product sold by bentonite suppliers (35% coal dust and 65% bentonite, 0.15 Euro/kg) could be made from the recovered fine fraction below 0.025 mm with the addition of active clay and coal dust, thus obtaining a product that will have physico-chemical properties similar to those of calcic bentonite. The improvements due to the addition of the fine particles to the usually employed clay for tile production were also underlined from the results of several baking tests. The recovery and recycling of sands and fine particles obtained from the reclamation of bentonite moulding sands will lead to a saving of raw materials and landfill space, with economic and environmental advantages.

  17. Clinical evaluation of 451 patients with HIV related non-Hodgkin's lymphoma: experience on the Italian cooperative group on AIDS and tumors (GICAT).

    PubMed

    Tirelli, U; Spina, M; Vaccher, E; Errante, D; Tavio, M; Simonelli, C; Sinicco, A; Gastaldi, R; Rossi, G; Rizzardini, G

    1995-12-01

    We report the clinical experience in 451 patients with HIV related non-Hodgkin's lymphoma (HIV-NHL) observed within the Italian Cooperative Group on AIDS and Tumors (GICAT: Gruppo Italiano Cooperativo AIDS e Tumori), a significant number of them being treated at the Aviano Cancer Center (ACC). High grade histology according to the Working Formulation, stages III-IV and B symptoms were detected in the majority of patients. The median survival was 6 months. Based on the Cox model, three factors appeared to influence survival: advanced stage, treatment received and failure to obtain complete remission (CR). In another study aimed at comparing between chemotherapy with or without G-CSF it was shown that G-CSF significantly reduced white blood cells (WBC) nadir duration, the mean delays between cycles, the mean hospitalization time for toxicity per patient treated, without increasing significantly the overall costs. Furthermore, of 77 GICAT patients treated at the ACC with (group A) or without (group B) long-lasting CR, performance status and the mean CD4+ cell count at time of NHL diagnosis were the only parameters of statistical relevance. Based on our data HIV related NHLs are highly aggressive malignancies which are associated with a poor prognosis per se, and because of the underlying HIV infection. Long-term survivals and possible cures can, nonetheless, be obtained in a subgroup of patients, who have a better performance status and a less advanced immune dysfunction related to HIV infection.

  18. Multicentre study of allergic contact cheilitis from toothpastes.

    PubMed

    Francalanci, S; Sertoli, A; Giorgini, S; Pigatto, P; Santucci, B; Valsecchi, R

    2000-10-01

    The present work reports the results of a multicentre study of toothpaste allergic contact cheilitis (TACC) conducted by GIRDCA (Gruppo Italiano Ricerca Dermatiti da Contatto e Ambientali). The study examined 54 patients with eczematous lesions on the lips, the possible cause of which was suspected to be the use of toothpastes. Patch tests were conducted with a standard series, a specially-targeted series (toothpaste cheilitis series, TCS), and with suspected toothpaste(s). A stop-restart test (SRT) was carried out with these, together with a use test to identify possible alternative products. The TCS produced 17 positive reactions in 13 patients, the most frequent being to spearmint oil. Of the 54 patients, 5 displayed positive reactions only to the TCS. The patch tests with toothpaste produced positive reactions in 11/32 patients, the SRT a positive response in 10/12 cases. The diagnosis of TACC was confirmed in 15/54 patients. Alternative products were identified for 5 patients. In conclusion, the allergens most frequently responsible for TACC were the flavourings, and the additional series proved to be useful in many cases (together with patch tests with toothpastes and the SRT) for correct diagnosis and to initiate effective prevention.

  19. Veno-occlusive disease nurse management: development of a dynamic monitoring tool by the GITMO nursing group

    PubMed Central

    Botti, Stefano; Orlando, Laura; Gargiulo, Gianpaolo; Cecco, Valentina De; Banfi, Marina; Duranti, Lorenzo; Samarani, Emanuela; Netti, Maria Giovanna; Deiana, Marco; Galuppini, Vera; Pignatelli, Adriana Concetta; Ceresoli, Rosanna; Vedovetto, Alessio; Rostagno, Elena; Bambaci, Marilena; Dellaversana, Cristina; Luminari, Stefano; Bonifazi, Francesca

    2016-01-01

    Veno-occlusive disease (VOD) is a complication arising from the toxicity of conditioning regimens that have a significant impact on the survival of patients who undergo stem cell transplantation. There are several known risk factors for developing VOD and their assessment before the start of conditioning regimens could improve the quality of care. Equally important are early identification of signs and symptoms ascribable to VOD, rapid diagnosis, and timely adjustment of support therapy and treatment. Nurses have a fundamental role at the stages of assessment and monitoring for signs and symptoms; therefore, they should have documented skills and training. The literature defines nurses’ areas of competence in managing VOD, but in the actual clinical practice, this is not so clear. Moreover, there is an intrinsic difficulty in managing VOD due to its rapid and often dramatic evolution, together with a lack of care tools to guide nurses. Through a complex evidence-based process, the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO), cellule staminali emopoietiche e terapia cellulare nursing board has developed an operational flowchart and a dynamic monitoring tool applicable to haematopoietic stem cell transplantation patients, whether they develop this complication or not. PMID:27594906

  20. Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement.

    PubMed

    Savarino, Edoardo; de Bortoli, Nicola; Bellini, Massimo; Galeazzi, Francesca; Ribolsi, Mentore; Salvador, Renato; Savarino, Vincenzo; Penagini, Roberto

    2016-10-01

    Patients with esophageal symptoms potentially associated to esophageal motor disorders such as dysphagia, chest pain, heartburn and regurgitation, represent one of the most frequent reasons for referral to gastroenterological evaluation. The utility of esophageal manometry in clinical practice is: (1) to accurately define esophageal motor function, (2) to identify abnormal motor function, and (3) to establish a treatment plan based on motor abnormalities. With this in mind, in the last decade, investigations and technical advances, with the introduction of high-resolution esophageal manometry, have enhanced our understanding and management of esophageal motility disorders. The following recommendations were developed to assist physicians in the appropriate use of esophageal manometry in modern patient care. They were discussed and approved after a comprehensive review of the medical literature pertaining to manometric techniques and their recent application. This position statement created under the auspices of the Gruppo Italiano di Studio per la Motilità dell'Apparato Digerente (GISMAD), Società Italiana di Gastroenterologia ed Endoscopia Digestiva (SIGE) and Associazione Italiana Gastroenterologi ed Endoscopisti Digestivi Ospedalieri (AIGO) is intended to help clinicians in applying manometric studies in the most fruitful manner within the context of their patients with esophageal symptoms. PMID:27443492

  1. Veno-occlusive disease nurse management: development of a dynamic monitoring tool by the GITMO nursing group

    PubMed Central

    Botti, Stefano; Orlando, Laura; Gargiulo, Gianpaolo; Cecco, Valentina De; Banfi, Marina; Duranti, Lorenzo; Samarani, Emanuela; Netti, Maria Giovanna; Deiana, Marco; Galuppini, Vera; Pignatelli, Adriana Concetta; Ceresoli, Rosanna; Vedovetto, Alessio; Rostagno, Elena; Bambaci, Marilena; Dellaversana, Cristina; Luminari, Stefano; Bonifazi, Francesca

    2016-01-01

    Veno-occlusive disease (VOD) is a complication arising from the toxicity of conditioning regimens that have a significant impact on the survival of patients who undergo stem cell transplantation. There are several known risk factors for developing VOD and their assessment before the start of conditioning regimens could improve the quality of care. Equally important are early identification of signs and symptoms ascribable to VOD, rapid diagnosis, and timely adjustment of support therapy and treatment. Nurses have a fundamental role at the stages of assessment and monitoring for signs and symptoms; therefore, they should have documented skills and training. The literature defines nurses’ areas of competence in managing VOD, but in the actual clinical practice, this is not so clear. Moreover, there is an intrinsic difficulty in managing VOD due to its rapid and often dramatic evolution, together with a lack of care tools to guide nurses. Through a complex evidence-based process, the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO), cellule staminali emopoietiche e terapia cellulare nursing board has developed an operational flowchart and a dynamic monitoring tool applicable to haematopoietic stem cell transplantation patients, whether they develop this complication or not.

  2. [Valutazione delle guardie di sicurezza privata attraverso la Suicide Probability Scale e la Brief Symptom Inventory].

    PubMed

    Dogan, Bulent; Canturk, Gurol; Canturk, Nergis; Guney, Sevgi; Özcan, Ebru

    2016-01-01

    RIASSUNTO. Scopo. Lo scopo di questo studio è stato quello di investigare l'influenza della probabilità di suicidio, con le sue caratteristiche sociodemografiche, e di procurare i dati per la prevenzione del suicidio tra le guardie di sicurezza privata che lavorano in condizioni di stress, essendo a contatto ininterrottamente con eventi negativi e traumatici di vita durante il loro lavoro. Metodi. Hanno partecipato allo studio 200 guardie di sicurezza privata e 200 persone dell'Università di Ankara. Per raccogliere i dati sono stati utilizzati un questionario riguardante le condizioni sociodemografiche dei partecipanti, la Suicide Probability Scale (SPS) e la Brief Symptom Inventory (BSI). Risultati. Genere, stato civile, stipendio, credenze religiose, vivere una situazione di pericolo di vita, passato di tentativi di suicidio, fumare e non avere una malattia cronica hanno causato statisticamente una differenza significativa sui punteggi di SPS tra il gruppo di guardie di sicurezza privata e quello di controllo. In aggiunta, c'è stata una correlazione positiva statisticamente significativa tra i punteggi totali delle sottoscale di SPS e quelli di BSI. Conclusioni. Allo stesso modo degli agenti di polizia e dei gendarmi, le guardie di sicurezza privata sono ad alto rischio di commettere e tentare il suicidio trovandosi in condizioni stressanti di lavoro e anche soffrendo del trauma secondario. È necessario che essi siano consapevoli della propria tendenza al suicidio e avere controlli psichiatrici regolari. PMID:27183512

  3. A challenging diagnosis for potential fatal diseases: recommendations for diagnosing acute porphyrias.

    PubMed

    Ventura, Paolo; Cappellini, Maria Domenica; Biolcati, Gianfranco; Guida, Claudio Carmine; Rocchi, Emilio

    2014-07-01

    Acute porphyrias are a heterogeneous group of metabolic disorders resulting from a variable catalytic defect of four enzymes out of the eight involved in the haem biosynthesis pathway; they are rare and mostly inherited diseases, but in some circumstances, the metabolic disturbance may be acquired. Many different environmental factors or pathological conditions (such as drugs, calorie restriction, hormones, infections, or alcohol abuse) often play a key role in triggering the clinical exacerbation (acute porphyric attack) of these diseases that may often mimic many other more common acute medical and neuropsychiatric conditions and whose delayed diagnosis and treatment may be fatal. In order to obtain an accurate diagnosis of acute porphyria, the knowledge and the use of appropriate diagnostic tools are mandatory, even in order to provide as soon as possible the more effective treatment and to prevent the use of potentially unsafe drugs, which can severely precipitate these diseases, especially in the presence of life-threatening symptoms. In this paper, we provide some recommendations for the diagnostic steps of acute porphyrias by reviewing literature and referring to clinical experience of the board members of the Gruppo Italiano Porfiria (GrIP).

  4. Practice guidelines on the use of esophageal manometry - A GISMAD-SIGE-AIGO medical position statement.

    PubMed

    Savarino, Edoardo; de Bortoli, Nicola; Bellini, Massimo; Galeazzi, Francesca; Ribolsi, Mentore; Salvador, Renato; Savarino, Vincenzo; Penagini, Roberto

    2016-10-01

    Patients with esophageal symptoms potentially associated to esophageal motor disorders such as dysphagia, chest pain, heartburn and regurgitation, represent one of the most frequent reasons for referral to gastroenterological evaluation. The utility of esophageal manometry in clinical practice is: (1) to accurately define esophageal motor function, (2) to identify abnormal motor function, and (3) to establish a treatment plan based on motor abnormalities. With this in mind, in the last decade, investigations and technical advances, with the introduction of high-resolution esophageal manometry, have enhanced our understanding and management of esophageal motility disorders. The following recommendations were developed to assist physicians in the appropriate use of esophageal manometry in modern patient care. They were discussed and approved after a comprehensive review of the medical literature pertaining to manometric techniques and their recent application. This position statement created under the auspices of the Gruppo Italiano di Studio per la Motilità dell'Apparato Digerente (GISMAD), Società Italiana di Gastroenterologia ed Endoscopia Digestiva (SIGE) and Associazione Italiana Gastroenterologi ed Endoscopisti Digestivi Ospedalieri (AIGO) is intended to help clinicians in applying manometric studies in the most fruitful manner within the context of their patients with esophageal symptoms.

  5. Italian Guidelines.

    PubMed

    Annibale, Bruno; Carabotti, Marilia; Cuomo, Rosario

    2016-10-01

    Diverticular disease (DD) is a widespread condition, however limited evidences are available about its management and complications. In the last years, an Italian Consensus Conference promoted by GRIMAD (Gruppo Italiano Malattia Diverticolare, Italian Group on Diverticular Diseases) and a Guideline, by Italian Society of Colorectal Surgery (SICCR) were published. The aim of the Consensus was to provide clinical recommendation for appropriate definition, diagnosis, and management of DD, in particular 4 areas of interest were identified, namely: (i) definition and epidemiology, (ii) pathophysiology, (iii) diagnosis, and (iv) medical and surgical treatment. A total of 55 statements graded according to different level of evidence and strength of recommendation were approved. However, if we consider the grade of recommendation, their strength remains suboptimal, with only 3 statements with grade of evidence A in the area of diagnosis. The Clinical guidelines by SICCR focus mainly on acute diverticulitis, and surgical treatment of complicated DD. One of the main topic analyzed, is represented by the management of the acute uncomplicated diverticulitis, in particular about the use of antibiotics and need of hospitalization. Despite the presence of many recent European and western country guidelines, there is a lack of robust data on epidemiology, risk factors, and medical and surgical management of DD, calling the need of further studies aimed to obtain an evidence-based approach in this condition. PMID:27622363

  6. Risk factors and prevention of vascular complications in polycythemia vera.

    PubMed

    Barbui, T; Finazzi, G

    1997-01-01

    Risk factors for vascular complications in polycythemia vera (PV) include laboratory and clinical findings. Among laboratory values, the hematocrit has been clearly associated with thrombosis, particularly in the cerebral circulation. Platelet count is a possible but not yet clearly established predictor of vascular complications. Platelet function tests are of little help in prognostic evaluation because most attempts to correlate these abnormalities with clinical events have been disappointing. Clinical predictors of thrombosis include increasing age and a previous history of vascular events. Identifying risk factors for thrombosis is important to initiate therapy. Phlebotomy is associated with an increased incidence of thrombosis in the first 3 to 5 years, whereas chemotherapy may induce a higher risk of secondary malignancies after 7 to 10 years of follow-up. New cytoreductive drugs virtually devoid of mutagenic risk include interferon-alpha and anagrelide, but their role in reducing thrombotic complications remains to be demonstrated. Antithrombotic drugs, such as aspirin, are frequently used in PV, despite doubts regarding safety and efficacy. Two recent studies from the Gruppo Italiano Studio Policitemia Vera (GISP) assessed the rate of major thrombosis as well as the tolerability of low-dose aspirin in PV patients. These investigations created a favorable scenario for launching a European collaborative clinical trial (ECLAP study) aimed at testing the efficacy of low-dose aspirin in preventing thrombosis and prolonging survival in patients with PV.

  7. Veno-occlusive disease nurse management: development of a dynamic monitoring tool by the GITMO nursing group.

    PubMed

    Botti, Stefano; Orlando, Laura; Gargiulo, Gianpaolo; Cecco, Valentina De; Banfi, Marina; Duranti, Lorenzo; Samarani, Emanuela; Netti, Maria Giovanna; Deiana, Marco; Galuppini, Vera; Pignatelli, Adriana Concetta; Ceresoli, Rosanna; Vedovetto, Alessio; Rostagno, Elena; Bambaci, Marilena; Dellaversana, Cristina; Luminari, Stefano; Bonifazi, Francesca

    2016-01-01

    Veno-occlusive disease (VOD) is a complication arising from the toxicity of conditioning regimens that have a significant impact on the survival of patients who undergo stem cell transplantation. There are several known risk factors for developing VOD and their assessment before the start of conditioning regimens could improve the quality of care. Equally important are early identification of signs and symptoms ascribable to VOD, rapid diagnosis, and timely adjustment of support therapy and treatment. Nurses have a fundamental role at the stages of assessment and monitoring for signs and symptoms; therefore, they should have documented skills and training. The literature defines nurses' areas of competence in managing VOD, but in the actual clinical practice, this is not so clear. Moreover, there is an intrinsic difficulty in managing VOD due to its rapid and often dramatic evolution, together with a lack of care tools to guide nurses. Through a complex evidence-based process, the Gruppo Italiano per il Trapianto di Midollo Osseo (GITMO), cellule staminali emopoietiche e terapia cellulare nursing board has developed an operational flowchart and a dynamic monitoring tool applicable to haematopoietic stem cell transplantation patients, whether they develop this complication or not.

  8. Foundry waste recycling in moulding operations and in the ceramic industry.

    PubMed

    Zanetti, Maria Chiara; Fiore, Silvia

    2003-06-01

    An industrial treatment was performed by the Sasil plant of Brusnengo (Biella, Northern Italy), which is part of the Gruppo Minerali S.p.A. (Novara, Northern Italy), to consider the reclamation of bentonite bonded moulding sands obtained from the Teksid Italia S.p.A. cast iron foundry plant in Crescentino (Vercelli, Northern Italy). An evaluation of the fine particles produced by the wet-mechanical regeneration treatment was made with the purpose of proposing their recycling as binding agents in moulding operations in the cast iron foundry and for the production of tiles in the ceramic industry. The pre-mixed product sold by bentonite suppliers (35% coal dust and 65% bentonite, 0.15 Euro/kg) could be made from the recovered fine fraction below 0.025 mm with the addition of active clay and coal dust, thus obtaining a product that will have physico-chemical properties similar to those of calcic bentonite. The improvements due to the addition of the fine particles to the usually employed clay for tile production were also underlined from the results of several baking tests. The recovery and recycling of sands and fine particles obtained from the reclamation of bentonite moulding sands will lead to a saving of raw materials and landfill space, with economic and environmental advantages. PMID:12870643

  9. Imaging detection of new HCCs in cirrhotic patients treated with different techniques: Comparison of conventional US, spiral CT, and 3-dimensional contrast-enhanced US with the Navigator technique (Nav 3D CEUS)().

    PubMed

    Giangregorio, F; Comparato, G; Marinone, M G; Di Stasi, M; Sbolli, G; Aragona, G; Tansini, P; Fornari, F

    2009-03-01

    Sommario INTRODUZIONE: Il sistema “Navigator” di Esaote consente di ottenere ricostruzioni 3-D di tutto il fegato (corrette volumetricamente da un sistema di guida) mediante singola acquisizione con CEUS (mediante scansione perpendicolare all'asse lungo del fegato, per una completa acquisizione 2-D del suo asse corto) e sovrappone tali ricostruzioni 3-D con quelle ottenute con la TC. SCOPO: valutare la capacità di tale sistema di diagnosticare nuovi HCC rispetto all'US e alla TC in una popolazione di HCC su cirrosi precedentemente trattati con varie metodiche. MATERIALI E METODI: Settantadue cirrotici con pregressi HCC (M/F: 38/34; tutti HCV +vi, Child A/B: 58/14, con detection di 49 nuovi noduli (N) in 34 pazienti; 10 nuovi HCC multinodulari (NMulti); 6 riprese locali di malattia (Ri) in 4 pazienti (3 riprese singole, in un paziente tre noduli con ripresa di malattia); 47 HCC trattati efficacemente (neg) in 22 pazienti + 2 pazienti con HCC multinodulare senza segni di ripresa (neg-Multi) sono stati sottoposti a 100 esami (1 esame: 48 pazienti; 2 esami: 20 pazienti; 3 esami: 4 pazienti) dal 1 novembre 2006 al novembre 2007. La Nav 3D CEUS è stata eseguita con SonoVue (BR1; Bracco) e con l'ecografo Esaote MPX collegato a un sistema “Navigator” con software di ricostruzione 3-D dedicato. La TC spirale di controllo è stata eseguita entro 30 giorni dall'esecuzione di Nav 3D CEUS. Sono stati valutati sensibilità, specificità, accuratezza diagnostica (ODA), valore predittivo positivo (PPV) e negativo (NPV). RISULTATI: La diagnosi finale fu: 34 pazienti con 49 nuove lesioni (N), 10 con HCC multiN e 6 recidive loco-regionali in 4 pazienti; 47 noduli in 24 pazienti senza nuove lesioni durante il follow-up. Gli US hanno ottenuto: 29 N (+5 multinodularN e 3 LR), 20 falsi negativi (+5 Nmulti e 3 LR) (sensibilità: 59,2, specificità: 100%; accuratezza diagnostica: 73;6; VPP: 100; VPN: 70, 1); la TC spirale ha ottenuto: 42 N (+9 multinodularN e 7 LR), 7 falsi

  10. Update on the surgical management of breast cancer.

    PubMed

    Franceschini, Gianluca; Sanchez, Alejandro Martin; Di Leone, Alba; Magno, Stefano; Moschella, Francesca; Accetta, Cristina; Natale, Maria; Di Giorgio, Danilo; Scaldaferri, Assunta; D'Archi, Sabatino; Scardina, Lorenzo; Masetti, Riccardo

    2015-02-20

    Il trattamento chirurgico dei tumori della mammella ha subito continui e profondi cambiamenti negli ultimi 30 anni. La chirurgia conservativa ha progressivamente e definitivamente sostituito la mastectomia nel trattamento dei tumori in stadio iniziale; associata alla radioterapia, essa è in grado di garantire alle pazienti le stesse percentuali di sopravvivenza globale e migliori risultati estetici con un accettabile rischio di recidiva locale. Grazie alla diffusione dei programmi di screening ed al perfezionamento delle indagini diagnostiche si è assistito ad un progressivo incremento della diagnosi dei tumori infraclinici ed all’elaborazione di sempre più accurate tecniche di localizzazione e trattamento mini-invasivo dei tumori non palpabili. Nell’ambito della chirurgia conservativa, l’introduzione della chirurgia oncoplastica, coniugando tecniche di chirurgia generale con quelle proprie della chirurgia plastica, ha consentito di superare il conflitto tra estensione della resezione chirurgica e risultato estetico finale, contribuendo in maniera importante a migliorare la qualità di vita delle pazienti. La mastectomia resta una valida alternativa chirurgica in casi selezionati ed è associata preferibilmente a procedure ricostruttive immediate che minimizzano l’impatto psicologico negativo dell’atto demolitivo. La tecnica del linfonodo sentinella per i tumori in stadio iniziale ha permesso di evitare in casi selezionati la dissezione ascellare di principio senza rinunciare alle importanti informazioni prognostiche dei linfonodi locoregionali. L’obiettivo di questo lavoro è di riassumere le recenti evoluzioni nella terapia chirurgica dei tumori della mammella e di mettere in evidenza i vantaggi e le questioni irrisolte delle diverse opzioni chirurgiche di trattamento.

  11. Severe breathing and swallowing difficulties during routine restorative dentistry.

    PubMed

    Lococo, Filippo; Trabucco, Laura; Leuzzi, Giovanni; Salvo, Fulvio; Paci, Massimiliano; Sgarbi, Giorgio; Ferrari, Anna Maria

    2015-04-30

    Una donna di 57 anni si sottoponeva ad trattamento odontoiatrico per una carie del secondo molare superiore di destra. Durante la visita odontoiatrica veniva utilizzato uno strumento ad aria compressa, secondo lo standard di cura. Improvvisamente, la paziente accusava deglutizione e difficoltà respiratorie ed un notevole gonfiore del viso che coinvolgeva il collo e parzialmente il volto. La paziente veniva pertanto trasportata d’urgenza al Pronto Soccorso con il sospetto di reazione allergica. L’esame clinico rivelava un crepitio palpabile a livello dei tessuti sottocutanei del volto, del collo e della regione pre- sternale senza però rilevare nessun segno di infiammazione, trisma o raccolta di liquidi. Una radiografia del torace prima ed una tomografia computerizzata successivamente confermavano la presenza d’aria nei tessuti molli delle regioni profonde dagli spazi peri-mandibolare e retro-mandibolari e nella zona sub-mascellare e latero –cervicale estendendosi lungo il solco vascolare e nello spazio retrofaringeo discendente fino a livello del mediastino. La paziente veniva quindi sottoposta ad osservazione clinica e monitoraggio respiratorio, e si cominciava la somministrazione endovenosa di antibiotici ad ampio spettro ed analgesici. Il successivo decorso ospedaliero risultava regolare e la paziente veniva dimessa in 5° giornata di ricovero dopo miglioramento del quadro clinico e radiologico. Tre mesi dopo la dimissione, la paziente risultava in buone condizioni cliniche in assenza di recidiva. Come risulta nel caso sopra riportato, l’enfisema sottocutaneo e lo pneumomediastino, sebbene raramente possono essere legati ad alcune manovre odontoiatriche che utilizzano sistemi ad immissione di aria ad alta pressione. Nonostante l’esordio acuto ed la sintomatologia spesso allarmante (al punto da poter essere erroneamente scambiata per una reazione allergica), si tratta di una condizione benigna e sostanzialmente ad auto-risoluzione pur necessitando

  12. Choledochal cysts in pregnancy A case report and literature review.

    PubMed

    Panebianco, Annunziata; Carbotta, Giuseppe; Prestera, Antonio; Laforgia, Rita; Volpi, Annalisa; Sallustio, Pierluca

    2016-04-19

    La paziente, 30 anni, primipara (36 settimane), giunge alla nostra osservazione per algie addominali localizzate maggiormente a livello epigastrico e subittero. Anamnesi remota negativa. Per l’accentuarsi della addominalgia, si decide per parto cesareo. In seconda giornata post-partum, mostra ittero franco ed incremento di transaminasi e gGT aumentate, pertanto esegue RMN che descrive notevole dilatazione delle VBE e VBI e formazione cistica della VBP delle dimensioni di 10 x 7 cm. Dopo valutazione mediante ERCP e per il persistere di ittero elevato, si sottopone la paziente ad intervento chirurgico con resezione della via biliare contenente il coledococele, colecistectomia, confezionamento di poliduttodigiunostomia su ansa defunzionalizzata. Si esegue follow-up mediante controlli ecografici ed ematochimici e RMN ogni 3 mesi. A distanza di 6 mesi, la RMN evidenzia dilatazione delle VB soprattutto dell’emisistema sinistro e difetti di riempimento riferibili a presenza di aerobilia. Alla luce del quadro radiologico e scintigrafico e, dopo ricorrenti angiocoliti, si decide per re-intervento con coledocoscopia e colangiografia, dilatazione pneumatica dell’anastomosi biliodigestiva e conseguente clearance biliare. Il decorso post-operatorio è stato buono senza complicanze. Nell’arco di 2 anni il follow up è sempre risultato negativo. Ultima RM documenta riduzione della dilatazione delle VB dell’emisistema di sinistra. Questo caso dimostra le difficoltà nella gestione e nel trattamento del coledococele in una paziente gravida e soprattutto nella valutazione del rischio di insorgenza di colangiti ricorrenti e di un’eventuale degenerazione maligna. Per prevenire queste condizioni, è importante effettuare una diagnosi differenziale e soprattutto attuare una strategia chirurgica che porti ad una completa resezione della dilatazione, ristabilendo un corretto sistema biliare.

  13. High resolution ultrasound for pre-operative detection of intraperitoneal adhesions: An invaluable diagnostic tool for the general and laparoscopic surgeon.

    PubMed

    Piccolboni, D; Ciccone, F; Settembre, A

    2009-12-01

    Sommario INTRODUZIONE: La possibilità di prevedere la presenza di aderenze intra-addominali, in pazienti già operati, è di grande interesse per il chirurgo. L'eventualità di un'enterotomia accidentale durante il re-intervento o nel posizionamento del primo trocar è una complicanza associata a morbilità e mortalità significative, che si verifica nel 20% dei casi in chirurgia open e tra l'1% e il 100% in laparoscopia. MATERIALI E METODI: Lo studio ecografico del movimento dei visceri (il “va e vieni” del peritoneo con gli atti del respiro, rispetto al piano fasciale immobile) è stato considerato patognomonico per un libero accesso in addome. Abbiamo effettuato l'ecografia con un apparecchio Aloka 5.500 (Aloka; Tokyo, Giappone) con sonde convex e lineari multifrequenza, in 60 pazienti, di età compresa fra 28-77 anni, con pregressa chirurgia addominale. RISULTATI: La possibilità di effettuare un accesso laparoscopico con TUOL (trans-umbilical open laparoscopy) è stata valutata ecograficamente in 35 pazienti (58,3%). La TUOL è stata effettuata con successo in 26 pazienti (74,3%). In 2 (5,7%) è stata tentata senza successo per la presenza di aderenze non evidenziate. In 7 pazienti (20%) lo pneumoperitoneo è stato indotto con ago di Veress posizionato nel quadrante supero-esterno, per la presenza di aderenze in sede mediana, che sono state confermate dopo l'inserzione del trocar. Su 25 pazienti sottoposti a re-laparotomia (41,6%), l'incisione è stata effettuata al di fuori della linea mediana in 8 pazienti (32%), per la presenza di sospette aderenze, confermate in 6 (24%). CONCLUSIONI: Nella nostra esperienza l'ecografia ha avuto un'accuratezza diagnostica del 93,3%.

  14. NOTCH1, SF3B1, BIRC3 and TP53 mutations in patients with chronic lymphocytic leukemia undergoing first-line treatment: correlation with biological parameters and response to treatment.

    PubMed

    Chiaretti, Sabina; Marinelli, Marilisa; Del Giudice, Ilaria; Bonina, Silvia; Piciocchi, Alfonso; Messina, Monica; Vignetti, Marco; Rossi, Davide; Di Maio, Valeria; Mauro, Francesca Romana; Guarini, Anna; Gaidano, Gianluca; Foà, Robin

    2014-12-01

    In chronic lymphocytic leukemia, NOTCH1, SF3B1, BIRC3 and TP53 disruptions are recurrent and affect survival. To define their incidence and clinical impact in patients undergoing first-line treatment, we evaluated 163 cases enrolled in the GIMEMA (Gruppo Italiano Malattie EMatologiche dell'Adulto) LLC0405 protocol (fludarabine plus alemtuzumab or fludarabine plus cyclophosphamide), for young patients, or in the ML21445 protocol (chlorambucil plus rituximab), for elderly patients. NOTCH1, SF3B1, BIRC3 and TP53 disruptions were detected in 15.9%, 12.2%, 8.6% and 10.4% of cases. NOTCH1 mutations correlated with a shorter treatment-free interval (p = 0.058), an unmutated immunoglobulin heavy variable gene (IGHV) status (p < 0.0001), CD38 and ZAP-70 expression (p = 0.0025 and 0.026, respectively) and trisomy 12 (p = 0.0028), SF3B1 mutations with an unmutated IGHV status (p = 0.02), and BIRC3 disruptions with an unmutated IGHV configuration (p = 0.01) and 11q deletion (p < 0.0001). NOTCH1 and SF3B1 did not appear to impact on overall response, while an inferior response was observed for BIRC3- and TP53-disrupted cases in the LLC0405 and ML21445 protocols, respectively. Progression-free survival, evaluable in the LLC0405 protocol - not affected by NOTCH1, SF3B1 and TP53 - appeared inferior for BIRC3 disruption. NOTCH1 and SF3B1 mutations may be overcome by aggressive regimens, while BIRC3 might impact on outcome also in intensive regimens.

  15. The PAX5 gene is frequently rearranged in BCR-ABL1-positive acute lymphoblastic leukemia but is not associated with outcome. A report on behalf of the GIMEMA Acute Leukemia Working Party

    PubMed Central

    Iacobucci, Ilaria; Lonetti, Annalisa; Paoloni, Francesca; Papayannidis, Cristina; Ferrari, Anna; Storlazzi, Clelia Tiziana; Vignetti, Marco; Cilloni, Daniela; Messa, Francesca; Guadagnuolo, Viviana; Paolini, Stefania; Elia, Loredana; Messina, Monica; Vitale, Antonella; Meloni, Giovanna; Soverini, Simona; Pane, Fabrizio; Baccarani, Michele; Foà, Robin; Martinelli, Giovanni

    2010-01-01

    Background Recently, in genome-wide analyses of DNA copy number abnormalities using single nucleotide polymorphism microarrays, genetic alterations targeting PAX5 were identified in over 30% of pediatric patients with acute lymphoblastic leukemia. So far the occurrence of PAX5 alterations and their clinical correlation have not been investigated in adults with BCR-ABL1-positive acute lymphoblastic leukemia. Design and Methods The aim of this study was to characterize the rearrangements on 9p involving PAX5 and their clinical significance in adults with BCR-ABL1-positive acute lymphoblastic leukemia. Eighty-nine adults with de novo BCR-ABL1-positive acute lymphoblastic leukemia were enrolled into institutional (n=15) or GIMEMA (Gruppo Italiano Malattie EMatologiche dell’Adulto) (n=74) clinical trials and, after obtaining informed consent, their genome was analyzed by single nucleotide polymorphism arrays (Affymetrix 250K NspI and SNP 6.0), genomic polymerase chain reaction analysis and re-sequencing. Results PAX5 genomic deletions were identified in 29 patients (33%) with the extent of deletions ranging from a complete loss of chromosome 9 to the loss of a subset of exons. In contrast to BCR-ABL1-negative acute lymphoblastic leukemia, no point mutations were found, suggesting that deletions are the main mechanism of inactivation of PAX5 in BCR-ABL1-positive acute lymphoblastic leukemia. The deletions were predicted to result in PAX5 haploinsufficiency or expression of PAX5 isoforms with impaired DNA-binding. Deletions of PAX5 were not significantly correlated with overall survival, disease-free survival or cumulative incidence of relapse, suggesting that PAX5 deletions are not associated with outcome. Conclusions PAX5 deletions are frequent in adult BCR-ABL1-positive acute lymphoblastic leukemia and are not associated with a poor outcome. PMID:20534699

  16. Surface denudation rate of gypsum in Sicily

    NASA Astrophysics Data System (ADS)

    Madonia, Giuliana; Vattano, Marco; Di Maggio, Cipriano; De Waele, Jo

    2016-04-01

    Studies on surface denudation rate of karst rocks were carried out for many years with different methods, although researches on limestones are much more numerous than those on gypsum. In Sicily the most large and complete Messinian evaporite succession of Gruppo Gessoso - Solfifero outcrops and since 1993-1994 surface denudation measurements were performed on different types of gypsum by the Micro-Erosion Meter (M.E.M.) method. MEM stations were placed on natural sites representing different lithological features of gypsum outcrops of the Island: 1) selenite gypsum with centimetre-sized crystals; 2) selenite gypsum with sub-centimetre crystals; 3) gypsum arenite; 4) microcrystalline gypsum; and 5) gypsum laminite (balatino type). The measuring stations are positioned in three localities in western and central Sicily: Santa Ninfa (Trapani), Ciminna (Palermo) and Campofranco (Caltanissetta). The average lowering rates vary in the different lithofacies: from 0.25 mm yr-1 in microcrystalline gypsum to 0.74 mm yr-1 in selenite gypsum with centimetre-sized crystals. The average surface denudation rates are 0.40 mm yr-1 in balatino gypsum and gypsum arenite, and 0.37 mm yr-1 in selenite gypsum with sub-centimetre crystals. These different values are connected to several factors such as: rock texture, dip of gypsum surfaces, climatic conditions, troubles on the measurement sites (e.g.: presence of lichens, soil, remains of vegetation, etc.). The aim of this paper is to show the results of roughly twenty years of experimental measurements, and to compare the surface denudation rate of gypsum in Sicily with those of other evaporite areas characterised by different climatic settings.

  17. Aspirin in polycythemia vera and essential thrombocythemia: current facts and perspectives.

    PubMed

    Landolfi, R; Patrono, C

    1996-09-01

    The role of aspirin in the antithrombotic strategy of patients with polycythemia vera (PV) and essential thrombocythemia (ET) is highly controversial. Long considered unsafe on the basis of a single clinical trial testing very high doses in PV patients, aspirin is being increasingly used at lower dosage. The rationale for the use of aspirin in patients with PV and ET is provided by the efficacy of this agent in the treatment of microcirculatory disturbances of thrombocythemic states associated with myeloproliferative disorders and by recent evidence that asymptomatic PV and ET patients have persistently increased thromboxane (TX) A2-biosynthesis. This increase, which most likely reflects enhanced platelet activation in vivo, is independent of the platelet mass and blood viscosity and largely supressed by a short term low-dose aspirin regimen (50 mg/day for 7 days). Since enhanced TXA2 biosynthesis may play a role in transducing the increased thrombotic risk associated with PV and ET, long-term low-dose aspirin administration has been proposed as a possible antithombotic strategy in these subjects. The safety of this treatment in PV patients has been recently reassessed by the Gruppo Italiano per lo Studio della Policitemia Vera (GISP) which has followed for over one year 112 patients randomized to receive 40 mg/day aspirin or placebo. In the same study, serum TXB2 measurements provided evidence that the low-dose aspirin regimen tested was fully effective in inhibiting platelet cyclooxygenase activity. On this basis, a large scale trial aimed at assessing the antithrombotic efficacy of this approach is currently being organized. In patients with ET both the minimal aspirin dose required for complete inhibition of platelet cyclooxygenase and the safety of long-term aspirin administration need to be established prior to extensive clinical evaluation of this strategy.

  18. Stability analysis of the Ischia Mt. Nuovo block, Italy, under extreme seismic shaking

    NASA Astrophysics Data System (ADS)

    Ausilia Paparo, Maria; Tinti, Stefano

    2016-04-01

    In this work we investigate the equilibrium conditions of the Mt. Nuovo block, a unit that is found on the northwestern flank of Mt. Epomeo in the Ischia Island, Italy, using the Minimum Lithostatic Deviation Method (Tinti and Manucci 2006, 2008; Paparo et al. 2013). The block, involved in a deep-seated gravitational slope deformation (DSGSD, Della Seta et al., 2012) process, forms an interesting scenario to study earthquake-induced instability because i) Ischia is a seismically active volcanic island; ii) the slopes of Mt. Epomeo are susceptible to mass movements; iii) there exist an abundant literature on historical local seismicity and on slope geology. In our slope stability analysis, we account for seismic load by means of peak ground acceleration (PGA) values taken from Italian seismic hazard maps (Gruppo di Lavoro MPS, 2004), and integrated with estimates based on local seismicity and suitable (MCS) I - PGA regression laws. We find that the Mt Nuovo block could not be destabilised by the 1883 Casamicciola earthquake (that is the largest known historical earthquake in the island taking place on a fault to the north of the block), but we find also that if an earthquake of the same size occurred in the Mt. Nuovo zone, the block would be mobilised and therefore generate a tsunami (Zaniboni et al, 2013), with disastrous consequences not only for Ischia, but also for the surrounding region. This work was carried out in the frame of the EU Project called ASTARTE - Assessment, STrategy And Risk Reduction for Tsunamis in Europe (Grant 603839, 7th FP, ENV.2013.6.4-3)

  19. Prognostic significance of early ischemia after acute myocardial infarction in low-risk patients. IRES (Ischemia Residua) Study Group.

    PubMed

    Silva, P; Galli, M; Campolo, L

    1993-05-15

    Early postinfarction angina is generally believed to imply an unfavorable prognosis. However, most of the published information devices from data collected in the prethrombolytic era, with widely differing populations and definitions of early angina, and very little data pertinent to low-risk patients are available. This collaborative study prospectively assessed the incidence of early recurrent ischemia after thrombolysis, as well as its prognostic significance, in 453 consecutive patients aged < or = 70 years with an uncomplicated course in the first 24 hours of a first myocardial infarction participating in the second Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2) trial. Early recurrent ischemia (spontaneous, transient ST depression or elevation of > 1 mm and/or T-wave inversion), assessed in the coronary care unit with continuous clinical and electrocardiographic monitoring, was documented in 35 of 453 patients (8%) and was unrelated to sex, age, electrocardiographic location, Q-wave or non-Q-wave infarction, thrombolytic agent and time to its administration. In-hospital cardiac events (7 deaths, 19 nonfatal reinfarctions and 8 urgent revascularizations) occurred in 15 of 35 patients (43%) with versus 19 of 418 without (4.5%) recurrent ischemia (p < 0.001). At the 6-month follow-up of 352 medically treated patients who did not have in-hospital events, the incidence of death, reinfarction and recurrent angina was comparable between patients with (2 of 18, 11%) and without (62 of 334, 19%) early ischemia (p = NS). With use of stepwise multivariate analysis, early ischemia was the only significant predictor of in-hospital cardiac events (p < 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

  20. [The Italian Group for the Study of Streptokinase in Myocardial Infarct: Study of electrocardiographic changes].

    PubMed

    Piccolo, E; Delise, P; Zuin, G; Bonso, A; Romano, S; Ricciardiello, V; Fischer, D; Tani, F; Forleo, C; Portulano, V

    1987-01-01

    The twofold purpose of the ECG sub-group study of G.I.S.S.I. (Gruppo Italiano per lo Studio della Streptokinasi nell'Infarto miocardico) is to evaluate whether exist different ECG evolution in pts with AMI treated with streptokinase (SK YES) and/or with coronary reperfusion (early CK peak) with respect to pts non treated with streptokinase (SK NO) and/or without coronary reperfusion (late CK peak) and to establish whether the ECG is useful to recognize the patients in which reperfusion occurs. Among 365 pts randomized for G.I.S.S.I., 209 pts with first myocardial infarction, admitted within 6 hours from the onset of pain, alive for at least 24 hours, were included. 98 were SK YES and 111 SK NO: 48 cases (group A) had the CK peak before 15th hour; 59 cases (group B) had the CK peak between 15th and 21th hour: 102 cases (group C) had the CK peak after 21th hour. In all the patients ECG was analyzed on admission and thereafter at 3rd, 6th, 9th, 12th, 24th hours and on 2nd, 3rd, 7th and 14th days. RESULTS--Anterior myocardial infarction--SK YES pts had in respected to SK NO pts a significantly lower sum of ST elevation on anterior leads (sigma ST increases V1-V6) at all times after admission starting from 6th hour. A similar behaviour was observed in groups A and B in respect to group C. SK YES pts when compared to SK NO pts had an earlier loss of the sum of R wave in anterior leads (sigma RV1-V6), although the difference was not statistically significant.(ABSTRACT TRUNCATED AT 250 WORDS)

  1. Influence of fear of movement on total knee arthroplasty outcome.

    PubMed

    Kocic, Mirjana; Stankovic, Anita; Lazovic, Milica; Dimitrijevic, Lidija; Stankovic, Ivona; Spalevic, Marija; Stojiljkovic, Predrag; Milenkovic, Marina; Stojanovic, Zorica; Nikolic, Dejan

    2015-01-01

    RiassuntoLo scopo dello studio è quello di verificare l’incidenza del timore postoperatorio ai movimenti nei pazienti sottoposti ad artroplastica totale del ginocchio (TKA) e di determinare l’associazione di questo timore con i provvedimenti da adottare. Lo studio prospettico riguarda 78 pazienti sottoposti ad TKA primaria per osteoartrite. L’incidenza di timore al movimento è stata detenninata con l’uso della Tampa Scale of Kinesiophobia (TSK). I pazienti sono stati valutati in tre fasi temporali: 2 settimane. 4 settimane e 6 mesi dopo l’intervento chirurgico. In tutte e tre le fasi sono stati valutati il dolore e l’entità della flessione, mentre l’aspetto funzionale è stato preso in considerazione soltanto sei mesi dopo l’intervento, secondo la Oxford knee score 1. Il timore al movimento è stato registrato in 17 pazienti (21,8%). Quelli con maggiore entità di timore hanno dimostrato di conseguire risultati significativamente meno buoni in termini di dolore, grado di flessione e funzionalità rispetto a quelli con limitata paura. Miglioramento del dolore e della flessione sono stati progressivamente conseguiti nel tempo in entrambi i gruppi, ma i risultati migliori vengono raggiunti nel gruppo con minore paura al movimento. Lo studio ha dimostrato che la paura postoperatoria alla motilità si associa significativamente con il dolore, l’entità della flessione e la funzionalità del ginocchio. Altri Autori haImo rilevato che il timore preoperatorio alla motilità del ginocchio fa prevedere limitazioni funzionali postoperatorie. In conclusione il timore della motilità si rileva in una significativa proporzione dei pazienti dopo TKA e si associa con gonalgia, e minore flessione e funzionalità, e dunaue questa paura rappresenta un richio di scarsi risultati dopo artroplastica totale del ginocchio.

  2. Ultrasound in the evaluation of interstitial pneumonia.

    PubMed

    Lo Giudice, V; Bruni, A; Corcioni, E; Corcioni, B

    2008-03-01

    ecografico associate a ring down). In 34 (61,82%) casi sono stati descritti associati aspetti di patologia pleurica. CONCLUSIONI: Attraverso l'osservazione di segni ultrasonografici e la correlazione di questi con quelli clinico-laboratoristico-strumentali di routine, gli autori valutano la possibilità di attribuire rilievo anche alla indagine US nella diagnosi di polmonite interstiziale ad eziologia infettiva e, senza voler sostituire gli US alle tradizionali e opportune tecniche di approccio e diagnosi, la propongono quale complementare tecnica metodologica di indagine.

  3. Multimodality imaging of bilateral pheochromocytoma. A case report.

    PubMed

    Paladino, Nunzia Cinzia; Lowery, Aoife; Guérin, Carole; Taïeb, David; Sebag, Frédéric

    2015-06-22

    . La TEP alla 18 FDG, grazie all’uso della metodica qualitativa e quantitativa nell’analisi della lesione, è stata molto utile nello svelarne la natura. Veniva pertanto eseguita una surrenalectomia sinistra per via laparoscopica. L’esame istologico per entrambe le lesioni era in favore di feocromocitoma, Pass score 0. Nella fase post-operatoria la paziente veniva trattata con idrocortisone a dosi decrescenti fino ad un dosaggio giornaliero di 30 mg in associazione a 50 mg di fludrocortisone. Questo caso clinico dimostra ancora una volta la possibilità di falsi negativi da parte di tecniche di imaging funzionale specifiche. In questa esperienza, la TEP alla 18 FDG è stata molto utile. La RMN ha senza dubbio mostrato un valore incontestabile. In questa paziente non è stata trovata nessuna mutazione germinale a carico dei geni RET, VHL, SDHx.

  4. Melena as presentation of primary small intestine inflammatory myofibroblastic tumor in an adult woman. A case report.

    PubMed

    Alloni, Rossana; Ancona, Gianluca; Gallo, Ida; Crescenzi, Anna; Coppola, Roberto

    2015-07-29

    È il caso di una paziente di 32 anni affetta da Miofibroblastoma non noto, trasferita da altra struttura sanitaria presso il nostro reparto perché affetta da melena da fonte non determinata. All’anamnesi risultava un precedente ricovero in altro Pronto Soccorso per un quadro clinico caratterizzato da dispnea, cefalea, tachicardia e astenia profonda., oltre a profonda anemia (Hg 5.8 g/dl). La gastroscopia non aveva evidenziato alcun motivo di sanguinamento e l’ecografia addomino-pelvica era risultata negativa. Dopo ripetute emotrasfusioni la tentata rettosigmoidoscopia era stata interrotto per intolleranza della paziente. Una volta stabilizzata si era proceduto al trasferimento presso la nostra struttura, e qui alla Risonanza Magnetica dell’addome veniva evidenziato, un ispessimento parietale esteso per 8 cm a del digiuno medio distale, in corrispondenza del fianco destro, antero – lateralmente al duodeno, ed adiacente ad esso una formazione ipervascolare solida di 20 mm. In prima ipotesi poteva trattarsi di un tratto invaginato del piccolo intestino con all’apice una lesione parietale solida, verosimile causa del sanguinamento. Persistendo il quadro anemico e avendo localizzato una lesione sospetta, la paziente è stata sottoposta ad intervento chirurgico, che portava alla conferma dell’esistenza di una lesione nodulare parietale del piccolo intestino, per cui si procedeva ad una sua resezione segmentaria comprendente la suddetta massa, sottoponendo il pezzo operatorio ad esame istologico definitivo. L’anatomo-patologo formulava la diagnosi isto-immunologica di pseudotumore infiammatorio (c.d. Tumore miofibroblastico infiammatorio) responsabile di invaginazione digiuno-digiunale. I margini di resezione risultavano indenni. Dimessa dopo un decorso postoperatorio senza complicanze, al follow-up di 6 mesi non si è ripresentato alcun sintomo di nuovo sanguinamento. Il sanguinamento della neoformazione responsabile della melena da fonte ignota era

  5. Successful surgical resection of solitary plasmacytoma of the liver mimicking hepatocellular carcinoma. A case report.

    PubMed

    Mirarchi, Mariateresa; De Raffele, Emilio; Bacci, Francesco; Cuicchi, Dajana; Lecce, Ferdinando; Cola, Bruno

    Il plasmocitoma extramidollare solitario (SEMP) del fegato è una neoplasia estremamente rara. Viene riferito il caso di un’anziana donna affetta da un voluminoso SEMP con caratteristiche simili a quelle di un carcinoma epatocellulare (HCC). Si tratta di una donna di 89 anni giunta alla nostra osservazione con un dolore addominale piuttosto severo, di recente insorgenza, ed una voluminosa massa situata nell’ipocondrio destro. I dati di laboratorio all’ingresso non evidenziavano alterazioni della funzionalità epatica; i valori di alfa-fetoproteinemia erano nella norma; non erano presenti markers di un’infezione da virus dell’epatite B e C. Una tomografia assiale computerizzata (TC) multifasica documentava la presenza di una voluminosa neoplasia dell’emifegato sinistro, ipodensa alle immagini senza mezzo di contrasto, disomogeneamente iperdensa in fase arteriosa, e con “washout” nelle fasi portale e di equilibrio. Una tomografia ad emissione di positroni con 18F-FDG (18FFDG PET)-TC evidenziava una marcata captazione del radiocomposto da parte della neoplasia, in assenza peraltro di metastasi a distanza. Le caratteristiche cliniche e radiologiche della lesione erano interpretate come compatibili con una diagnosi di HCC scarsamente differenziato con aree di necrosi intralesionale verosimilmente in evoluzione verso la rottura spontanea. La valutazione clinica complessiva ci faceva reputare accettabile il rischio chirurgico e la paziente veniva sottoposta ad un’epatectomia sinistra con resezione parziale dell’emidiaframma destro. Il decorso postoperatorio era sostanzialmente regolare e la paziente veniva dimessa in 12° giornata postoperatoria. L’esame istologico definitivo deponeva per un plasmocitoma extramidollare. L’analisi immunoistochimica dimostrava che le cellule tumorali esprimevano CD45, CD38, IRF4, HTPD52, catene leggere kappa ma non catene leggere lambda; l’indice di proliferazione Mib-1 era del 50%. La successiva valutazione

  6. A project for a solar sail propelled spaceship

    NASA Astrophysics Data System (ADS)

    Bevilacqua, Franco; Cesare, Stefano

    1994-02-01

    The idea of using the solar radiation pressure for propelling a space vehicle dates back to the 1920s and was suggested by the Russian space pioneer Konstantin Tsiolkovsky and the Russian engineer Fridrickh Arturovich Tsander. NASA began technology studies in the mid-1960s in which various design and technology requirements were examined for solar sailing vehicles without reference to specific missions. In 1977 a Jet Propulsion laboratory team undertook a 1-year study under a NASA contract to assess the practical possibilities of carrying out a rendezvous mission to Halley's Comet using a solar sail. Despite the confidence of the technical team and the completion of a valid preliminary design, NASA thought the technology of solar sailing was not sufficiently 'mature' to be implemented in time for a 1981 launch to the comet and the project was abandoned. Efforts to design and develop the solar sailing concept have been continued since then by private organizations i.e. the Union pour la Promotion de la Propulsion Photonique (U3P) in France, and the World Space Foundation in the United States. The latter has already fabricated a prototype square sail of about 700 sq m, and is seeking NASA support for flying a test vehicle. U3P is also seeking sponsorship for its design and development of solar sailing spacecraft and has proposed a race to the Moon between solar sails. In December 1988 the Christopher Columbus Quincentenary Jubilee Commission, a Presidential commission created by the Congress of the United States, approved the establishment of a Columbus 500 Space Sail Cup competition to commemorate his voyage to the Americas. The intent of the Space Sail Cup was to bring about the launch of at least three solar sail vehicles representing the Americas, Europe and Asia, selected among all the presented projects, that would have travelled from a High Earth Orbit (HEO) toward the Moon and then toward Mars. The space company then called Aeritalia Gruppo Sistemi Spaziali

  7. Poor mobilizer: a retrospective study on proven and predicted incidence according to GITMO criteria.

    PubMed

    Piccirillo, Nicola; Vacca, Michele; Lanti, Alessandro; Ipsevich, Francesco; Maresca, Maddalena; Fiorelli, Elena; Bianchi, Maria; Adorno, Gaspare; Pierelli, Luca; Majolino, Ignazio; Leone, Giuseppe; Zini, Gina

    2012-10-01

    The Italian Group for Bone Marrow Transplantation (Gruppo Italiano Trapianto di Midollo Osseo, GITMO) recently formalized criteria for a shared definition of poor mobilizer in order to facilitate randomized clinical trials and study comparison focusing on the efficacy of current mobilizing regimens. The availability of a standardized tool for poor mobilizer definition suggested us to retrospectively test GITMO criteria feasibility and applicability. Therefore we analyzed medical and laboratory records of adult patients affected by myeloma (MM) or lymphoma undergoing mobilization for autologous peripheral blood HSC collection from January 2010 to June 2011, at Servizio di Emotrasfusione, Istituto di Ematologia, Università Cattolica Del Sacro Cuore, Roma, UOC SIMT AO S. Camillo Forlanini Roma and SIMT Fondazione Policlinico Tor Vergata Roma. We collected data about 227 patients (134 male, 93 female) affected by MM (31.3%) NHL (58.6%) e HD (10.1%). Thirty-nine patients, 21 male and 18 female met proven poor mobilizer criteria definition resulting in a incidence of 17.2% (12.7% in MM, 21.8% in NHL and 4.3% in HD). Eleven patients, seven affected by lymphoma and four affected by myeloma, were defined predicted PM according to major criteria. Eight patients, seven affected by lymphoma and one affected by myeloma, were define predicted PM according to minor criteria. Sixteen out of 39 patients defined as poor mobilizer either according to major or minor criteria underwent collection procedures and eight (20.5%) achieved a cell dose ⩾2×10(6)/kg CD34(+) cells. GITMO criteria application was easy and resulted in poor mobilizer incidence comparable to current literature. Definitions of proven poor mobilizer and predicted poor mobilizer according to major criteria were very effective while minor criteria were less predictive. These results came from a retrospective analysis and therefore should be validated in future prospective trial. On the other hand these data could be

  8. Recombinant human erythropoietin in very elderly patients with myelodysplastic syndromes: results from a retrospective study.

    PubMed

    Tatarelli, Caterina; Piccioni, Anna Lina; Maurillo, Luca; Naso, Virginia; Battistini, Roberta; D'Andrea, Mariella; Criscuolo, Marianna; Nobile, Carolina; Villivà, Nicoletta; Mancini, Stefano; Neri, Benedetta; Breccia, Massimo; Fenu, Susanna; Buccisano, Francesco; Voso, Maria Teresa; Latagliata, Roberto; Aloe Spiriti, Maria Antonietta

    2014-08-01

    Myelodysplastic syndromes (MDS) are common in elderly patients. Recombinant human erythro-poietin (rHuEPO) has been widely used to treat anemia in lower risk MDS patients, but few data are known about rHuEPO treatment in the very elderly patient group. In order to investigate the role of rHuEPO treatment in terms of response, overall survival (OS), and toxicity in a very elderly MDS patient group, 93 MDS patients treated with rHuEPO when aged ≥80 years were selected among MDS cases enrolled in a retrospective multicenter study by the cooperative group Gruppo Romano Mielodisplasie (GROM) from Jan 2002 to Dec 2010. At baseline, median age was 82.7 (range 80-99.1) with a median hemoglobin (Hb) level of 9 g/dl (range 6-10.8). The initial dose of rHuEPO was standard (epoetin alpha 40,000 IU/week or epoetin beta 30,000 IU/week) in 59 (63.4 %) patients or high in 34 (36.6 %) (epoetin alpha 80,000 IU/week) patients. We observed an erythroid response (ER) in 59 (63.4 %) patients. No thrombotic event was reported. Independent predictive factors for ER were low transfusion requirement before treatment (p = 0.004), ferritin <200 ng/ml (p = 0.017), Hb >8 g/dl (p = 0.034), and a high-dose rHuEPO treatment (p = 0.032). Median OS from rHuEPO start was 49.3 months (95 % CI 27.5-68.4) in responders versus 30.6 months (95 % CI 7.3-53.8) in resistant patients (p = 0.185). In conclusion, rHuEPO treatment is safe and effective also in the very elderly MDS patients. However, further larger studies are warranted to evaluate if EPO treatment could be worthwhile in terms of quality of life and cost-efficacy in very old patients. PMID:24647684

  9. Structural resistance of reinforced concrete buildings under pyroclastic flows: a study of the Vesuvian area

    NASA Astrophysics Data System (ADS)

    Petrazzuoli, S. M.; Zuccaro, G.

    2004-05-01

    The analysis of the effects of pyroclastic flows on humans and on buildings represents the main tool to define the boundary of the most hazardous area around an active volcano such as Somma-Vesuvius. Estimation of the lateral pressure on buildings derived from analogies with the damages observed after a nuclear explosion [Valentine (1998) J. Volcanol. Geotherm. Res. 87, 117-140] lead to pressure values and/or structural resistance which are not realistic (too high). Recent evidence [Baxter (2000) Human and Structural Vulnerability Assessment for Emergency Planning in a Future Eruption of Vesuvius. Final Report EC Project ENV4-CT98-0699; Young et al. (1997) EOS, Trans. Am. Geophys. Union, 78, 401] have shown that beyond 2-3 km from the vent, even after a great eruption, resistance to collapse of buildings affected by a pyroclastic flow is still possible. Neri et al. [(2000) Numerical simulation of pyroclastic flows. In: Human and Human and Structural Vulnerability Assessment for Emergency Planning in a Future Eruption of Vesuvius. Final Report EC Project ENV4-CT98-0699], by means of a numerical model of a collapsing column, show that the peak overpressures of the pyroclastic flows range from 1 to 2 kPa at a distance from the vent of about 4-5 km, where important historical centres of the Vesuvian area are located. A detailed analysis of urban settlement of the area [Cherubini et al. (2001) Vulnerabilita' Sismica dell'Area Vesuviana. Gruppo Nazionale per la Difesa dai Terremoti, CNR, Roma] has shown that most of the people live in reinforced concrete (r.c.) structures, not designed to resist horizontal seismic actions. The present work is aimed at analyzing the collapse limit load of r.c. structures to horizontal pressure for different structural design typologies (strong aseismic, weak aseismic, strong non-aseismic, weak non-aseismic). The simulations performed have also taken into account the specific features of the r.c. structures of the area (local building

  10. Highly purified omega-3 polyunsaturated fatty acids are effective as adjunct therapy for secondary prevention of myocardial infarction.

    PubMed

    Verboom, Cees N

    2006-12-01

    Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione was the first large randomized trial to produce evidence that a pharmaceutical preparation of highly purified omega-3 polyunsaturated fatty acids (PUFAs), administered as an adjunct to other accepted interventions, had a favorable effect on hard clinical end-points in post-myocardial infarction patients. Much of the 20% all-cause mortality benefit recorded during the study could be attributed to a 45% reduction in sudden death--a fatal outcome that traditionally has proved resistant to medical intervention. These results were obtained with an omega-3 PUFA dose of 1 g/day, which is much lower than was routinely being used at the time the study was initiated (e.g. 4 g/day for hypertriglyceridemia). One consequence of this low-dose regimen was that the tolerability profile of omega-3 PUFAs during GISSI-Prevenzione was considered highly satisfactory, with low adverse event incidence rates and low rates of discontinuation due to adverse events. Time-course analysis established that much of the survival benefit of omega-3 PUFA treatment in GISSI-Prevenzione was realized during the early months of the trial. The beneficial effects of omega-3 PUFA treatment were observed on top of standard, secondary pharmacological prevention therapy like anti-platelet agents, statins, beta-blockers and angiotensin-converting enzyme (ACE) inhibitors. The benefits of omega-3 PUFA therapy were also apparent in patients at all standards of adherence to a healthy diet and may have been augmented in patients with the best dietary profile. Patients with diabetes mellitus (approximately 15% of the study cohort) appeared to benefit from omega-3 PUFAs to at least the same extent as the general study population; the treatment effect on sudden death was progressively more pronounced as left ejection fraction declined. Cost-effectiveness analyses undertaken from a third-party payer perspective for Italy

  11. Prognostic evaluation by clinical exercise test scores in patients treated with primary percutaneous coronary intervention or fibrinolysis for acute myocardial infarction (a Danish Trial in Acute Myocardial Infarction-2 Sub-Study).

    PubMed

    Valeur, Nana; Clemmensen, Peter; Grande, Peer; Saunamäki, Kari

    2007-10-01

    The prognostic accuracy of exercise testing after myocardial infarction is low, and different models have been proposed to enhance the predictive value for subsequent mortality. This study tested a simple score against 3 established scores. Patients with ST-elevation myocardial infarctions were randomized in the Danish Trial in Acute Myocardial Infarction-2 (DANAMI-2) to either primary percutaneous coronary intervention or fibrinolysis with predischarge exercise testing. Clinical and exercise test data were collected prospectively and were available for 1,115 patients. A simple score was derived, awarding 1 point for history or new signs of heart failure, 1 point for a left ventricular ejection fraction <40%, 1 point for age >65 years in men and age >70 years in women, and 1 point for exercise capacity <5 METs in men and exercise capacity <4 METs in women. This DANAMI score was compared with the Veterans Affairs Medical Center score, the Duke treadmill score, and the Gruppo Italiano per lo Studio Della Sopravvivenza nell'Infarto Miocardico-2 (GISSI-2) score in multivariate Cox models and receiver-operating characteristic plots. All scoring systems were predictive of adverse outcomes. The DANAMI score performed better, with greater chi-square values (142 vs 53 to 88 for the prediction of death). Areas under the receiver-operating characteristic curves were compared and were larger for the DANAMI score (C-statistic 0.79 vs 0.71 to 0.74 for the other tests regarding mortality). The DANAMI score stratified patients into a small high-risk group (8% of the population with 43% mortality in 6 years), an intermediate-risk group (13% with 16% mortality in 6 years), and a low-risk group (79% with 4% mortality in 6 years). In conclusion, a simple exercise test score composed of age, METs, heart failure, and a left ventricular ejection fraction <40% seems to outperform the Duke treadmill score, Veterans Affairs Medical Center score, and GISSI-2 score in risk stratifying

  12. Stem cell transplantation from HLA-matched related donor for Fanconi's anaemia: a retrospective review of the multicentric Italian experience on behalf of AIEOP-GITMO.

    PubMed

    Dufour, C; Rondelli, R; Locatelli, F; Miano, M; Di Girolamo, G; Bacigalupo, A; Messina, C; Porta, F; Balduzzi, A; Iorio, A P; Buket, E; Madon, E; Pession, A; Dini, G; Di Bartolomeo, P

    2001-03-01

    Twenty-seven consecutive Italian patients with Fanconi's anaemia (FA) underwent stem cell transplantation (SCT) from an HLA-matched related donor in 10 Italian centres of the Associazione Italiana Ematologia ed Oncologia Pediatrica (AIEOP), Gruppo Italiano di Trapianto di Midollo Osseo (GITMO). Twenty-two patients (81.5%) were conditioned with low-dose (median 20 mg/kg) cyclophosphamide (Cy) and thoraco-abdominal or total body irradiation (median dose 500 cGy), five patients (18.5%) with high-dose Cy (median 120 mg/kg). Graft-vs.-host disease (GVHD) prophylaxis was carried out with cyclosporin A in 26 cases; methotrexate (MTX) was added in eight cases. One patient received MTX alone. The median follow-up was 36 months. Ninety-two percent of patients (25 out of 27) engrafted, grade II and III acute GVHD occurred in 28% and 8% of patients, respectively, with chronic GVHD in 12.5%. Conditioning-related toxicity was mild: 4% of patients had grade III mucositis, 7.4% had grade II haemorrhagic cystitis, 14.8% had grade III liver toxicity and 11.1% had grade III renal toxicity. Transplant-related mortality at 12 months was 19.2%, survival at 36 months was 81.5%, with a median Karnofsky score of 100%. No late tumours occurred after a mean follow-up of the survivors of 5 years. None of the studied variables significantly affected the survival, including conditioning regimen, acute GVHD and clinical non-haematological phenotype. Among the studied variables, only conditioning regimens containing high-dose Cy and the presence of genital abnormalities were significantly (P < 0.05) associated with an increased rate of acute GVHD. Our study demonstrates that the Italian FA patients undergoing SCT from an HLA-matched related donor have a very good outcome. These patients, when compared with others of different ethnic origin who underwent allogeneic bone marrow transplantation, showed a less severe non-haematological phenotype, raising the possibility that this milder phenotype may

  13. Introduzione Nuove tecnologie in urologia.

    PubMed

    Bianchi, Giampaolo

    2011-03-30

    Negli ultimi anni sono state introdotte in urologia nuove tecniche chirurgiche alcune già applicabili nella pratica clinica, altre ancora in corso di sperimentazione. Quella che ha trovato attualmente applicazione è la LESS (Laparo Endoscopic Single-site Surgery); essa riguarda tutte le metodiche che utilizzano una sola porta (multiaccesso) per eseguire interventi laparoscopici. I vantaggi apparenti di questa metodica rispetto alla laparoscopia tradizionale sono soltanto un dimostrato miglior risultato estetico. Mancano studi prospettici randomizzati. NOTES (Natural Orifices Transluminal Endoscopic Surgery) È una metodica ancor più nuova che sfrutta gli orifizi naturali (bocca, retto, vagina, vescica per accedere alla cavità addominale. Rispetto alla LESS questa tecnica utilizza prevalentemente i gastroscopi e lo strumentario dei gastoenterologi per eseguire interventi demolitivi. In urologia l'impiego di questa metodica è puramente sperimentale, comunque piccoli passi sono stati fatti nel migliorare lo strumentario. I chirurghi stanno consolidando questa metodica sull'uomo riguardo alla colecistectomia, ma i risultati sono scarsi, discordanti sulla via d'accesso e limitati a case reports. Oggi i risultati più incoraggianti li ha descritti Estevao Lima, un ingegnoso portoghese che utilizzando una tecnica NOTES di terza generazione (accesso combinato trans-vescicale e trans-gastrico) è riuscito ad eseguire una serie di nefrectomie sul maiale. Tanto si sa e si è speculato riguardo al robot da Vinci®, che oggi la prostatectomia senza di lui non è più competitiva. Moltissimi sono i centri che lo hanno, molti quelli che lo usano, tanti quelli che hanno risultati migliori rispetto alla tecnica laparoscopica classica. Ancora ad oggi però non esistono studi prospettici randomizzati che dimostrino la sua superiorità; inoltre una spina nel fianco sono i costi. Un ulteriore sviluppo futuro di da Vinci® forse potrebbe vedersi nell'assistere le nuove tecniche

  14. Recent developments in human biomonitoring: non-invasive assessment of target tissue dose and effects of pneumotoxic metals

    PubMed Central

    Mutti, A.; Corradi, M.

    2006-01-01

    di ottenere una migliore comprensione dei meccanismi attraverso i quali i tossici inalati inducono un danno polmonare, la valutazione della dose a livello dell’organo bersaglio, in questo caso il polmone, potrebbe essere molto utile. Il condensato dell’aria espirata (CAE) è un fluido ottenuto raffreddando l’aria esalata durante la respirazione a volume corrente ed è una nuova tecnica che può fornire una valutazione della patobiologia polmonare. Il CAE è formato quasi completamente da acqua, quindi rappresenta una matrice biologica ideale per la determinazione d’elementi metallici. Dati presenti in letteratura dimostrano come nel CAE si possono dosare vari metalli tossici ed elementi di transizione, permettendo quindi di proporre questa matrice per la quantificazione della dose al bersaglio di sostanze pneumotossiche. La quantificazione della dose al bersaglio consente di avere informazioni aggiuntive rispetto a quelle ottenute con i tradizionali metodi di monitoraggio biologico in lavoratori esposti, che generalmente consentono di stimare la dose sistemica, ma non l’esposizione delle vie respiratorie ad inquinanti aerodispersi né la frazione trattenuta nel polmone, verosimilmente implicata nella patologia infiammatoria e degenerativa a livello polmonare. In questa breve rassegna sono discussi i dati ottenuti in lavoratori professionalmente esposti a metalli duri ed in fumatori con o senza bronco-pneumopatica cronica ostruttiva (BPCO), per mostrare come il CAE – oltre agli indicatori di esposizione – consente di valutare indicatori di effetto campionati direttamente dal film che riveste le vie respiratorie, fornendo quindi nuovi spunti per meglio comprendere sia gli aspetti cinetici che quelli dinamici della tossicologia dei metalli. PMID:17017350

  15. Management of blunt splenic injuries Retrospective cohort study of early experiences in an Acute Care Surgery Service recently established.

    PubMed

    Occhionorelli, Savino; Morganti, Lucia; Andreotti, Dario; Cappellari, Lorenzo; Stano, Rocco; Portinari, Mattia; Vasquez, Giorgio

    2015-01-01

    Soccorso e durante la degenza, dati sulla mortalità, sul fallimento del trattamento conservativo e sulla durata della degenza. E’ stata eseguita un’analisi statistica che ha evidenziato risultati statisticamente significativi (p≤0.05) sui dati clinici all’ingresso (pressione arteriosa, livelli di emoglobina, grado di lesione splenica, presenza di lesioni ad altri organi addominali) che hanno indirizzato verso una gestione conservativa o chirurgica. Inoltre, è stato dimostrato che nonostante il follow-up intraospedaliero nei traumi conservativi richieda uno stretto monitoraggio clinico, laboratoristico e strumentale, questo non determina una maggiore durata delle degenza. I dati raccolti concordano con la letteratura internazionale che afferma come i traumi splenici di basso gradi (I-II) possano essere trattati con sicurezza in modo conservativo, mentre per quanto riguarda i traumi severi (IV-V grado) l’applicazione del trattamento conservativo può essere seguita da un tasso di fallimento fino al 75% nel V grado con un tasso di mortalità del 12%, a fronte di un tasso di mortalità < dell’1%, correlato all’intervento chirurgico di splenectomia. In conclusione, i pazienti con lesioni spleniche di grado I, II, III, senza traumi di altri organi intraddominali che necessitano di un intervento chirurgico in regime d'urgenza, dovrebbero essere trattati in modo conservativo, non precludendo tuttavia tale possibilità anche a lesione di grado IV, in pazienti selezionati. Il monitoraggio intraospedaliero dei pazienti trattati conservativamente può essere effettuato in maniera semplice con ecografie addominali seriate o ecografie addominali con mezzo di contrasto; l’osservazione e lo stretto monitoraggio clinico non influenza la durata dell’ospedalizzazione. Studi prospettici su pazienti con lesioni spleniche di III grado sarebbero necessari per identificare i fattori correlati al successo del trattamento conservativo.

  16. A new class of non-hormonal contragestational agents: pharmacodynamic-pharmacokinetic relationships.

    PubMed

    Assandri, A; Omodei-Salé, A; Galliani, G

    1982-01-01

    As part of a research program designed to find new potential antifertility agents, new non-hormonal, non-prostaglandin-like compounds belonging to the class of 2-phenyl-triazole (5,1-a) isoindoles Ia and the corresponding dehydro-isoquinolines Ib were identified in the laboratories of the Departments of Pharmacokinetics, Organic Chemsitry, and Endocrinology (Gruppo Lepetit, Milan, Italy). These new structures were shown to be effective at nontoxic doses in several animal species as post-implantation, early pregnancy termination agents. Starting from these leader compounds, studies designed to clarify simultaneously both their spectrum of activity and the structure-activity relationships were undertaken. Following this initial explorative phase, keeping in mind that an antifertility agent must be highly effective over a period of time sufficiently long to block a dynamic process such as pregnancy, selected compounds were studied in depth in order to determine the relationships between their bioavailability and their effectiveness. This manuscript reviews the multidisciplinary research which led to the selection of the 1st generation compounds that have not only the very high potencies but also the diverse kinetic characteristics to make them suitable for potential use in animals and in humans. In the development of these new contragestational agents, it was apparent early that the achievement of the biological effect would be strictly dependent upon prolonged availability. Thus, in the primary screening, the period of treatment in pregnancy (most effective time), the route (subcutaneous), and the schedule of treatment (multiple daily doses) chosen, were those least affected by kinetic and metabolic factors. Structure-activity relationships studies in 2 species with marked differences in sensitivity (rat, hamster) made it possible to ascertain the key portions of the molecules and the types of substituents that could either improve the activity or reduce the species

  17. Problems, solutions, and perspectives in the evaluation of interval cancers in Italian mammography screening programmes: a position paper from the Italian group for mammography screening (GISMa).

    PubMed

    Bucchi, Lauro; Frigerio, Alfonso; Zorzi, Manuel; Fedato, Chiara; Angiolucci, Giovanni; Bernardi, Daniela; Campari, Cinzia; Crocetti, Emanuele; Ferretti, Stefano; Giorgi, Daniela; Marchisio, Francesca; Morrone, Doralba; Naldoni, Carlo; Petrella, Marco; Ponti, Antonio; Ravaioli, Alessandra; Saguatti, Gianni; Santini, Dolores; Sassoli de Bianchi, Priscilla; Serafini, Monica; Vergini, Viviana; Giordano, Livia

    2015-01-01

    In this position paper, a self-convened team of experts from the Italian Group for Mammography Screening (Gruppo italiano screening mammografico, GISMa) pointed out the problems that increasingly hamper the feasibility and validity of the estimate of the proportional incidence of interval breast cancer (IBC) in Italy, suggested potential solutions and an agenda for research, and proposed that the question of the sensitivity of mammography be viewed in a larger perspective, with a greater attention to radiological review activities and breast radiology quality assurance programmes. The main problems are as follows: the coverage of cancer registration is incomplete; the robustness of using the pre-screening incidence rates as underlying rates decreases with time since the start of screening; the intermediate mammograms performed for early detection purposes may cause an overrepresentation of IBCs; the classification of many borderline screening histories is prone to subjectivity; and, finally, the composition of cohorts of women with negative screening results is uncertain, because several mammography reports are neither clearly negative nor clearly positive, and because of the limitations and instability of the electronic mammography records. Several possibilities can be considered to cope with these issues: standard methods for using the hospital discharge records in the identification of IBCs should be established; for the calculation of regional estimates of the underlying incidence, a suitable mathematical model should be identified; the definition of IBC according to the 2008 GISMa guidelines needs to be updated, especially with respect to in situ cancers and to invasive cancers with borderline screening histories; a closer adherence to standard screening protocols, with a simplified patient management, would make it easier to objectively identify IBCs; alternative methods for estimating the sensitivity of mammography should be taken into consideration; and

  18. Seismotectonics investigations in the internal Cottian Alps (Italian Western Alps)

    NASA Astrophysics Data System (ADS)

    Perrone, Gianluigi; Eva, Elena; Solarino, Stefano; Cadoppi, Paola; Balestro, Gianni; Fioraso, Gianfranco; Tallone, Sergio

    2010-05-01

    -Early Miocene) is related to transtensive/extensional movements along the LTZ and the development of minor sub-parallel N-S faults. This kinematic evolution fits in a model of dextral-transtension at regional scale. The more recent activity of the LTZ may have caused the development of Pleistocene lacustrine basin, several hundred metres thick, in the Lower Chisone and Pellice valleys, which did not hosted glacial tongues. Along the LTZ, however, Pleistocene deposits showing evidence of brittle deformation were also found. With the aim to better understand the relation between the current seismic activity and faults, an analysis was carried out by selecting the best located earthquakes (location error less than 3 km) recorded by the seismic network of the North Western Italy (RSNI). This selection is made necessary by the relatively small size of the structures under investigations in order to avoid fake attributions. In addition to get qualitative information about the seismogenic source, the focal mechanisms of four earthquakes occurring along the mapped faults were calculated sorting out the best locatable events among those occurred in the area. The good geometric and kinematic agreement between structural and seismological data indicates a possible dependence of the seismicity of the inner Cottian Alps with the current tectonic activity of the LTZ and its associated minor structures. Balestro G. et al. (2009) Ital. J. Geosci., 128(2), 331-339. Bertotti G., Mosca P. (2009) Tectonophysics, 475, 117-127. Eva C. et al. (1990) Atti del Convegno Gruppo Nazionale Difesa dai terremoti, Ed. Ambiente, Pisa, 1, 25-34. Perrone G. et al. (2009) Ital. J. Geosci., 128(2), 541-549.

  19. New mapping of Radlandi basin and detailed analysis of its inner plains

    NASA Astrophysics Data System (ADS)

    Minelli, Francesco; Giorgetti, Carolina; Mondini, Alessandro; Pauselli, Cristina; Mancinelli, Paolo

    2013-04-01

    NEW MAPPING OF RADITLADI BASIN AND DETAILED ANALYSIS OF ITS INNER PLAINS. Francesco Minelli 1, Carolina Giorgetti 1, Alessandro C. Mondini 2, Cristina Pauselli 1, Paolo Mancinelli1. 1 Gruppo di Geologia Strutturale e Geofisica (GSG), Dipartimento di Scienze della Terra, Università degli Studi di Perugia, 06123, Perugia, Italy . Email: minelli91@yahoo.it. 2 CNR IRPI Perugia, 06123, Perugia. Introduction: The Raditladi basin is a large peak-ring impact crater discovered during the MESSENGER (MErcury Surface, Space ENvironment, GEochemistry, and Ranging) first flyby of Mercury in January 2008 [1]. The Raditladi basin is relatively young [2], and the study of the internal structures give an indication of the processes that acted recently in Mercury's geological history. Geological mapping: We first present the geological mapping of Raditladi crater. In the map we defined different sub-units on the base of previous studies [4][5] and surface morphology and reflectance. Through a GIS software we associated a polygonal layer to each sub-unit, this allowed to distinguish nine different layers. Due to the similarities with the Rachmaninoff basin, to define sub-units mapped on Raditladi, we adopted Rachmaninoff crater's units definitions made by Marchi et al. (2011) [4]. Structures analysis : We also mapped secondary structures consisting in concentric troughs arranged in a circular pattern. We defined two different kinds of troughs: (i) structures characterized by a distinct flat floor and interpretable as grabens, and (ii) structures with linear and curvilinear segments [5]. Inner plain deposit: The analysis of the topography made possible the estimation of the deposit's thickness. The measurement of the thickness is possible thanks to the presence of two small craters, crater A and crater, located in Raditladi's Inner plain. Observing the morphology of the two small craters' rim and hummocky central floor, we distinguished two different units: the shallower consists in

  20. PREFACE: A tribute to Virginio Bortolani

    NASA Astrophysics Data System (ADS)

    Brivio, Gian Paolo

    2007-08-01

    I met Virginio Bortolani at a meeting in Salerno (Italy) in summer 1977, when I was a fresh post-doc, just back to Italy after two years at the University of Liverpool (UK). At that time since 1972, Bortolani was the first Chairman of the Surface Physics Section of GNSM (Gruppo Nazionale di Struttura della Materia) of the Italian science research council (CNR), position which he held for about a decade. So I approached him with the formal respect due to a senior scientist by a younger fellow, which was customary at Italian Universities. However, his manners looked very non-conventional for those times. While smoking his daily nth cigarette, first he said to me 'Diamoci del tu' The literal translation would be: let us switch from 'you' to 'thou', and in modern English it is equivalent to being on first-name terms, and then started getting information about my work in a way which was both friendly and fatherly. Since then we crossed each other at several meeting, often discussing physics, but we only began to collaborate at a summer school at ICTP (Trieste) in 1988. There Bortolani, one of the Directors, had the excellent idea of involving T B Grimley and myself in a project in order to investigate theoretically trapping/desorption phenomena of noble gases at metal surfaces owing to phonon interaction. Eventually we understood the limits of validity of Knudsen's law for phenomena out of equilibrium such as those in chopped beam experiments. During that school, which lasted for many weeks, I was most impressed by the relaxed atmosphere that Bortolani was able to create and maintain throughout the event. Everyone from the newcomer student from Asia, Africa or Latin America, to the top scientist felt at ease. This helped students from developing countries to interact with the lecturers beneficially, and allowed other people like me to start a few very fruitful collaborations. By the way the proceedings of that school, edited by V Bortolani, N H March and M P Tosi, and

  1. PREFACE: A tribute to Virginio Bortolani

    NASA Astrophysics Data System (ADS)

    Brivio, Gian Paolo

    2007-08-01

    I met Virginio Bortolani at a meeting in Salerno (Italy) in summer 1977, when I was a fresh post-doc, just back to Italy after two years at the University of Liverpool (UK). At that time since 1972, Bortolani was the first Chairman of the Surface Physics Section of GNSM (Gruppo Nazionale di Struttura della Materia) of the Italian science research council (CNR), position which he held for about a decade. So I approached him with the formal respect due to a senior scientist by a younger fellow, which was customary at Italian Universities. However, his manners looked very non-conventional for those times. While smoking his daily nth cigarette, first he said to me 'Diamoci del tu' The literal translation would be: let us switch from 'you' to 'thou', and in modern English it is equivalent to being on first-name terms, and then started getting information about my work in a way which was both friendly and fatherly. Since then we crossed each other at several meeting, often discussing physics, but we only began to collaborate at a summer school at ICTP (Trieste) in 1988. There Bortolani, one of the Directors, had the excellent idea of involving T B Grimley and myself in a project in order to investigate theoretically trapping/desorption phenomena of noble gases at metal surfaces owing to phonon interaction. Eventually we understood the limits of validity of Knudsen's law for phenomena out of equilibrium such as those in chopped beam experiments. During that school, which lasted for many weeks, I was most impressed by the relaxed atmosphere that Bortolani was able to create and maintain throughout the event. Everyone from the newcomer student from Asia, Africa or Latin America, to the top scientist felt at ease. This helped students from developing countries to interact with the lecturers beneficially, and allowed other people like me to start a few very fruitful collaborations. By the way the proceedings of that school, edited by V Bortolani, N H March and M P Tosi, and